AUTHOR: Biomed Mom TITLE: ZINC DEFICIENCY, METAL METABOLISM, AND BEHAVIOR DISORDERS DATE: 6/29/2007 06:07:00 AM ----- BODY:
ZINC DEFICIENCY, METAL METABOLISM, AND BEHAVIOR DISORDERS by William J. Walsh INTRODUCTION Most Americans receive all the zinc they need if they have a reasonably well-balanced diet involving the major food groups. However, many persons are born with a metal-metabolism disorder which results in zinc depletion regardless of diet. Zinc is a component of more than 80 enzymes. High concentrations have been found in brain hippocampus, and many medical researchers believe that zinc is a neurotransmitter. Low zinc levels at these sites could reduce the inhibition of neuron activity, thus leading to abnormal behavior. The discovery of zinc "finger proteins" in the past decade has led to a vastly improved understanding of how cells replicate and divide. There role in behavior is not yet clear, but could be involved in the transport or availability of zinc. Recent research has shown zinc to be far more important than previously believed and low levels of zinc are associated with behavior disorders. Many of the patients of the Carl Pfeiffer Treatment Center suffer from behavior disorders. The most common ones are attention deficit hyperactive disorder (ADHD), oppositional defiant disorder (ODD), obsessive compulsive disorder (OCD), and conduct disorder (CD). These patients typically have a history of extensive counseling and multiple medications and many have experienced residential care. They represent a narrow and rather uncharacteristic segment of the general population. A high percentage of behavior disordered persons exhibit abnormal levels of copper, zinc, lead, cadmium, calcium, magnesium and manganese in blood, urine, and tissues, based on chemical analysis results from thousands of patients. With regard to zinc, this condition appears to involve a malfunction of the metal-binding protein metallothionein. Most of these patients have symptoms of zinc deficiency along with depressed levels of zinc in their blood plasma. The high incidence of zinc deficiency in assaultive young males was illustrated in a recent study1 which found elevated serum copper and depressed plasma zinc concentration, compared to normal controls. This study confirmed our clinical observations of zinc depletion in more than 4,000 behavior disordered patients. Our clinical observations and research have indicated that the copper/zinc ratio appears to be more decisively important than either of the individual metals alone. Zinc deficiency often results in elevated blood levels of copper, due to the dynamic competition of these metals in the body. Elevated blood copper has been associated with episodic violence, hyperactivity, learning disabilities, and depression. DIAGNOSIS OF ZINC DEFICIENCY Zinc deficiency is difficult to diagnose since no single laboratory test or combination of tests is decisive in every case. For example, blood levels are sometimes normal in zinc deficient persons due to homeostasis. Urine and hair tissue levels are often elevated in zinc deficiency because of "short circuiting" of zinc through the body and high rates of excretion. The two principal factors which lead our Center's physicians to a diagnosis of zinc deficiency are: 1) depressed plasma zinc, and 2) presence of clinical symptoms of zinc depletion which are alleviated by zinc supplementation2, 3, 4, 5, 6, and 7. Since zinc tolerance tests show plasma levels to be affected for 6 hours following zinc supplementation8 and 9, zinc supplements are avoided for 24 hours prior to sampling of plasma. The clinical symptoms associated with zinc deficiency or depletion include the following: * Eczema, acne, and/or psoriasis10, 11, 12, 13, and 14, * Poor wound healing, including leg ulcers and oral lesions15 and 16, * Lines of Beau on the fingernails17, * Growth retardation18, 19, 20, and 21, * Delayed sexual maturation22, * Hypogeusia or poor taste acuity23 and 24, and * Chronic immunodeficiency and frequent infections25 and 26. A "working diagnosis" of zinc deficiency can be made if clinical symptoms of zinc deficiency are clearly evident from the initial physical examination and medical history. Usually more than one or the above symptoms are present in zinc deficiency. This initial diagnosis is later supported or negated by laboratory analysis for plasma zinc along with observed response (or non-response) to zinc supplementation. The Carl Pfeiffer Treatment Center generally retests plasma zinc and evaluates symptoms after 4-6 months of treatment to determine if dosages need adjustment. TREATMENT OF ZINC DEPLETION Zinc depletion is corrected by supplementation with zinc (picolinate or gluconate) along with augmenting nutrients including L-cysteine, pyridoxine, ascorbic acid, and vitamin E. Manganese is also useful in promoting proper metallothionein function. If copper levels are elevated, effective treatment must also enhance the release of copper from tissues and copper excretion. L-cysteine helps mobilize and excrete copper while enhancing zinc absorption. Correction of zinc deficiency is best accomplished under the care of a physician or nutritionist who is experienced in metal metabolism disorders. Indiscriminant dosages of zinc to persons who do not need it can cause anemia and imbalanced trace metals. Treatment of mild or moderate zinc depletion can take months to complete. Some cases of severe zinc depletion require a year or more to resolve. Achievement of a proper zinc balance is slowed by growth spurts, injury, illness, or severe stress. In addition, persons with malabsorption or Type A blood respond to treatment more slowly. DISCUSSION We find that zinc deficient individuals usually respond well to inexpensive supplementation with zinc and augmenting nutrients. Many patients who previously experienced years of counseling, psychotherapy, aggressive medication programs, and/or residential treatment become greatly improved and respond to less intensive (and less expensive) therapies. Zinc deficiency can be corrected, but not cured. If treatment is discontinued, the prior zinc deficiency will reemerge with all symptoms gradually returning. Zinc deficiency, like diabetes, requires life long treatment. Fortunately, it is a simple, low cost, safe treatment. The Center involves the collaboration of biochemists and medical doctors. We believe that this coupling of disciplines provides an ideal capability for biochemical evaluation and medical treatment. REFERENCES 1. Walsh, W.J., Isaacson, H.R., Rahman, F., Hall, A., and Young, I.J., "Elevated blood copper:zinc ratios in assaultive young males", Neuroscience Annual Meeting, Abstract of Papers, Miami Beach, 1994 (In Print). 2. Cunnane, S.C., Zinc: Clinical and Biochemical Significance, CRC Press, Inc., Boca Raton, FL (1988). 3. Prasad, A.S., "Deficiency of zinc in man and its toxicity", in Trace Elements in Human Health and Disease, Vol. 1, Academic Press, New York, 1976. 4. Prasad, A.S., "Clinical and biochemical spectrum of zinc deficiency in human subjects", in Current Topics in Nutrition and Disease, Vol 6, New York, 1982. 5. Smith, J.C., Holbrook, J.T., and Danford, D.E., "Analysis and evaluation of zinc and copper in human plasma and serum", J. Amer. College of Nutr., 4:627-638 (1985). 6. Kleimola, V., et al, "The zinc, copper, and iron status in children with chronic diseases", in Trace Element Analytical Chemistry in Medicine and Biology, Walter de Gruyter, New York (1983). 7. Reding, P., DuChateau, J., and Bataille, C., "Oral zinc supplementation improves hepatic encephalopathy", Lancet, ii, 493 (1984). 8. Pohit, J., Saha, K.C., and Pal, B., "A zinc tolerance test", Clin. Chim. Acta, 114: 279 (1981). 9. Pecoud, A., Donzel, P., and Schelling, J.L., "Effects of foodstuffs on the absorption of zinc sulphate", Clin. Pharmacol. Ther., 17, 469 (1975). 10. Molokhia, M.M. and Portnoy, B., "Zinc and copper in dermatology", in Zinc and Copper in Medicine, Charles C. Thomas, Springfield, IL (1980). 11. Schmidt, K., et.al., "Determination of trace element concentrations in psoriatic and non-psoriatic scales with special attention to zinc", in Trace Element Analytical Chemistry in Medicine and Biology, Vol. 1, Walter de Gruyter, New York (1980). 12. McMillan, E.M., and Rowe, D., "Plasma zinc in psoriasis. Relation to surface area involvement", Br. J. Dermatol., 108, 301 (1983). 13. Ecker, R.J. and Schroeder, A.L., "Acrodermatitis and acquired zinc deficiency", Arch. Dermatol., 114: 937 (1978). 14. Withers, A.F., Baker, H., and Musa, M, "Plasma zinc in psoriasis", Lancet, ii: 278 (1968). 15. Van Rij, A.M., "Zinc supplements in surgery", in Zinc and Copper in Medicine, Charles C. Thomas, Springfield, IL (1982). 16. Henzel, J.H., et al., "Zinc concentrations within healing wounds: significance of post-operative zincuria on availability and requirements during tissue repair", Arch. Surg., 349: 357 (1970). 17. Weismann, K., "Lines of Beau: Possible markers of zinc deficiency", Acta Dermatol. Venereol., 57: 88 (1977). 18. Collipp, P.J., et al., "Zinc deficiency: Improvement in growth and growth hormone levels with oral zinc therapy", Ann. Nutr. Metab., 26: 287 (1982). 19. Hambridge, K.M., and Walravens, P.A., "Zinc deficiency in infants and preadolescent children", in Trace Elements in Human Health and Disease, Vol. 1, Prasad, A.S. and Oberleas, D., Eds., Academic Press, New York (1976). 20. Golden, B.E. and Golden, M.H.N., "Effect of zinc supplementation on the dietary intake, rate of weight gain and energy cost of tissue deposition in children recovering from severe malnutrition", Am. J. Clin. Nutr., 34: 900 (1981). 21. Laditan, A.O. and Ette, S.I., "Plasma zinc and copper during the acute phase of protein-energy malnutrition (PEM) and after recovery", Trop. Geogr. Med., 34: 77 (1982). 22. Sandstead, H.H., Prasad, A.S., et al., "Human zinc deficiency, endocrine manifestations, and response to treatment", Amer. J. Clin. Nutr., 20:422 (1967). 23. Heinkin, R.I., and Bradley, D.F., "Hypogeusia corrected by nickel and zinc", Life Sci., 9: 701 (1970). 24. Sprenger, K.B.G. et al., "Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study", Kidney Int., Suppl. 16: 5315 (1983). 25. Cunningham-Rundles, C., et al., "Zinc deficiency, depressed thymic hormones and T-lymphocyte dysfunction in patients with hypogammaglobulinemia", Clin. Immunol. Immunopathol., 21: 387 (1981). 26. Good, R.A., et al., "Zinc and immunity", in Clinical, Biochemical, and Nutritional Aspects of Trace Elements, Prasad, A.S. Ed., Alan R. Liss, New York (1982). Health Research Institute Pfeiffer Treatment Center HRI Pharmacy 4575 Weaver Parkway - Warrenville, IL 60555-4039 (630) 505-0300 - (630) 836-0667 fax Questions or Comments:info@HRIPTC.org | Home Page | Services | Pharmacy | Research | Education | Patient Info | Directions | All contents Copyright (c) 2004 Health Research Institute. All rights reserved. HRI is a Not-for-Profit 501c3.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Biochemical Individuality and Nutrition DATE: 6/29/2007 06:03:00 AM ----- BODY:
Biochemical Individuality and Nutrition by Bill Walsh, Ph.D. Pfeiffer Treatment Center Introduction Each of us has innate biochemical factors which influence personality, behavior, mental health, immune function, allergic tendencies, etc. Scientists tell us that the number of different genetic combinations possible in a child from the same two parents exceeds 42 million. It’s interesting to note that we do not possess a combination of characteristics from our parents, but instead have a diverse collection of characteristics from many ancestors on both sides of the family. Except for identical twins, each human being has unique biochemistry resulting in quite diverse nutritional needs. Shakespeare was correct when he wrote "One man’s meat is another man’s poison." For example, some of us are genetically suited for a vegetable-based diet and others are not. Some persons can satisfy their nutritional needs by diet alone and others must have nutritional supplements to overcome genetic aberrations. Because of genetic differences in the way our bodies process foods, most of us are quite deficient in certain nutrients and overloaded in others. Even with an ideal diet, most of us have certain nutrients that are at very low levels with many times the RDA required to achieve a healthy balance. The nutrients in overload must be carefully avoided in vitamin supplements or serious health problems can develop. After studying the biochemistry of 10,000 persons, I’ve learned that the greatest mischief is usually caused by nutrients that are stored in excessive amounts, rather than those at depleted levels. The most common nutrients in overload include copper, iron, folic acid, calcium, methionine, manganese, choline, and omega-6 fatty acids. Of course, these same nutrients may be in deficiency in other persons. I am amused by supplement manufacturers who attempt to develop the ideal combination of vitamins, minerals, and amino acids for the general population. This is a bit like trying to determine the ideal shoe size for the population. The truth is that multiple vitamins and minerals are too indiscriminate, and may do as much harm as good. Each of us should ask the question, "Who am I nutritionally?" The answer to this question is important for all, but may be especially critical for persons with mental health problems. Nutrients and Mental Health As we enter the new millennium, the medical and scientific communities agree on the tremendous influence of neurotransmitters on behavior disorders, ADHD, depression, and schizophrenia. Most persons with these disorders were born with a predisposition for these problems due to genetically-aberrant levels of specific neurotransmitters. Our mental health is dependent upon having the proper amounts of these critical brain chemicals. Some psychiatrists express their scorn for nutrient therapies, claiming that they are too puny to have any real clinical potency. They often say, "You really need a drug medication to get the job done for a serious condition like depression." My favorite response begins by asking the question, "Where do our neurotransmitters come from?" The brain is a chemical factory which produces serotonin. dopamine, norepinephrine, and other brain chemicals 24 hours a day. The only raw material for these syntheses are nutrients, namely amino acids, vitamins, minerals, etc. If the brain receives improper amounts of these nutrient building blocks, we can expect serious problems with our neurotransmitters. For example, some depression patients have a genetic pyrrole disorder which renders them grossly depleted in vitamin B-6. These individuals cannot efficiently create serotonin since B-6 is an important co-factor in the last step of its synthesis. Many of these persons report benefits from Prozac, Paxil, Zoloft, or other serotonin-enhancing medications. However, similar benefits may also be achieved by simply giving these patients sufficient amounts of B-6 along with augmenting nutrients. Most neurotransmitter problems appear to be genetic in nature and involve abnormal absorption, metabolism or storage of key nutrients. As neuroscience advances, biochemical treatments to correct brain chemistry become better defined. Nutrient therapy can be very potent and does not involve side effects, since no molecules foreign to the body are needed. This therapeutic approach may eventually eliminate the need for most psychiatric medications. Biochemical Factors In Behavior Disorders, ADHD and Mental Illness The Pfeiffer Treatment Center has amassed a large database of biochemical information from more than 10,000 patients with mental health problems. Examination of this data shows that most of these persons have striking abnormalities in specific nutrients required for neurotransmitter production. The most common chemical imbalances we encounter include the following: Over-Methylation Many persons who suffer from anxiety and depression are over-methylated which results in excessive levels of dopamine, norepinephrine and serotonin. Typical symptoms include chemical and food sensitivities, underachievement, upper body pain, and an adverse reaction to serotonin-enhancing substances such as Prozac, Paxil, Zoloft, St. John’s Wort, and SAMe. They have a genetic tendency to be very depressed in folates, niacin, and Vitamin B-12, and biochemical treatment focuses on supplementation of these nutrients. These persons are also overloaded in copper and methionine and supplements of these nutrients must be strictly avoided. Under-Methylation Many patients with obsessive-compulsive tendencies, oppositional-defiant disorder, or seasonal depression are under-methylated which is associated with low serotonin levels. They generally exhibit seasonal allergies, perfectionism, competitiveness, and other distinctive symptoms and traits. They have a genetic tendency to be very depressed in calcium, magnesium, methionine, and Vitamin B-6 with excessive levels of folic acid. These under-methylated persons may benefit nicely from Paxil, Zoloft, and other serotonin-enhancing medications, although nasty side effects are common. A more natural approach is to directly correct the underlying problem using methionine, calcium, magnesium, and B-6. SAMe, St. John’s Wort, Kava Kava, and inositol are also very useful in treating these individuals. Metal-Metabolism A common problem in ADHD, behavior disorders, and hormonal depression is an genetic inability to control copper, zinc, manganese, and other trace metals in the body due to improper functioning of the metallothionine protein. These patients are often deficient in zinc, manganese, cysteine, serine, and vitamin B-6 and overloaded in copper, lead, and cadmium. They must avoid supplements and "enriched" foods containing copper. In addition we recommend they drink bottled water and limit use of swimming pools and jacuzzis treated with copper sulfate anti-algae agents. Foods to be limited due to high copper content include shellfish, chocolate, and carob. Elevated copper levels are associated with hormonal imbalances and a classic symptom is intolerance to estrogen. Biochemical treatment focuses on stimulation of metallothionein using zinc, manganese, cysteine, serine, and Vitamin B-6. Pyrrole Disorder A common feature of many behavior and emotional disorders is pyroluria, an inborn error of pyrrole chemistry which results in a dramatic deficiency of zinc, Vitamin B-6, and arachidonic acid. Common symptoms include explosive temper, emotional mood swings, poor short-term memory, and frequent infections. These patients are easily identified by their inability to tan, poor dream recall, abnormal fat distribution, and sensitivity to light and sound. The decisive laboratory test is analysis for kryptopyrroles in urine. Treatment centers on zinc and B-6 supplements together with omega-6 essential fatty acids. Glucose Dyscontrol Our database indicates a significant number of our patients have chronic low blood glucose levels. This problem doesn’t appear to be the cause of behavior disorders, depression, etc., but instead is an aggravating factor which can trigger striking symptoms. Typical symptoms include drowsiness after meals, irritability, craving for sweets, trembling, anxiety, and intermittent poor concentration and focus. Treatment includes chromium, manganese, and other glucose-stabilizing nutrients, but the primary focus of treatment is on diet. These patients benefit from six or more small meals daily with emphasis on complex carbohydrates and protein. In essence, they cannot tolerate large meals or quick sugars. Complex carbohydrates provide the necessary glucose in a slow, gradual manner and may be thought of as "time-release" sugar. Toxic Substances Occasionally we encounter a patient whose condition has resulted from a heavy-metal overload (lead, cadmium, mercury, etc.) or toxic levels of pesticides or other organic chemicals. Our database indicates that persons with a metallothionein disorder are especially sensitive to toxic metals, and that over-methylation is associated with severe chemical sensitivities. Effective treatment requires a three-part approach: (1) avoidance of additional exposures, (2) biochemical treatment to hasten the exit of the toxic from the body, and (3) correction of underlying chemical imbalances to minimize future vulnerability to the toxic. Malabsorption Although only 10% of our database case histories involve serious malabsorption, more than 90% of autistics exhibit this problem. There are three primary classes of absorption problems: (1) stomach problems, including excessive or insufficient HCl levels, (2) incomplete digestion in the small intestine, and (3) problems at the brush-border of the intestine where most nutrients are absorbed into the portal blood stream. The consequences can include nutrient deficiencies, irritation of the intestinal tract, candida, and mental health problems. Incomplete breakdown of protein and fats can adversely affect brain neurotransmission, and is associated with impulsivity and academic underachievement. Treatment depends on the type of malabsorption present and may involve adjustment of stomach HCl levels, digestive enzymes which survive stomach acid, nutrients to enhance digestion, and special diets. Essential Fatty Acids The brain is 20% fat (by dry weight) and these fatty substances fulfill very important functions. The myelin sheaths which surround our brain cells contain essential fatty acids which are directly involved in receptor formation and nerve transmission. A 1998 Symposium at the National Institute of Mental Health presented strong evidence of the important roles for omega-3 oils (especially EPA and DHA) and omega-6 oils (especially AA and DGLA) in ADHD, depression, and schizophrenia. A recent Harvard study showed EPA and DHA supplements to be more effective than psychiatric medications in combating bipolar depression. Typical American diets usually result in insufficient omega-3 and excessive omega-6, and some nutritionists routinely recommend supplements of omega-3 oils. However, biochemical individuality also exists with oils and certain persons are innately low in omega-6 oils. A review of symptoms and specialized plasma and red-cell-membrane lab tests can identify individual needs. Health Research Institute Pfeiffer Treatment Center HRI Pharmacy 4575 Weaver Parkway - Warrenville, IL 60555-4039 (630) 505-0300 - (630) 836-0667 fax Questions or Comments:info@HRIPTC.org | Home Page | Services | Pharmacy | Research | Education | Patient Info | Directions | All contents Copyright (c) 2004 Health Research Institute. All rights reserved. HRI is a Not-for-Profit 501c3.

Labels: , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Calcium Imbalance DATE: 6/29/2007 05:54:00 AM ----- BODY:
Proper Name: Calcium Common Name: Calcium Evidence of Efficacy: statement to the effect of Calcium deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between calcium and aggression1,2, anxiety3,4,5,6,7 and ADHD8,9, bipolar disorder10,11,12,13,14,15,16,17, depression18,19,20,21,22,23 and premenstrual syndrome24,25,26,27,28. References: 1. Walsh, William J., analytical chemist, Argonne National Laboratory; Sci News 124:122-2, 1983. 2. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Bioscocial 2(1), 1981. 3. Carlson RJ. Longitudinal observations of two cases of organic anxiety syndrome. Psychsomatics 27(7):529-31, 1986. 4. Lawlor BA. Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry. 1988 Aug;49(8):317-8. 5. Crammer JL. Calcium metabolism and mental disorder. Psychol Med 7(4):557-60, 1977. 6. Houssain M. Neurological and psychiatric manifestations in idiopathic hypoparathyroidism: Response to treatment. J Neurol Neurosurg Psychiatry 33:153-6, 1970. 7. Joborn C etal. Psychiatric symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci 91(1):77-87, 1986. 8. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. Deficiency of certain trace elements in children with hyperactivity. Psychiatr Pol. 1994 May-Jun;28(3):345-53. 9. Walker S III. Drugging the American child: We’re too cavalier about hyperactivity. J Learn Disabil 8:354, 1975. 10. Bowden CL, Huang LG, Javors MA, Johnson JM, Seleshi E, McIntyre K, Contreras S, Maas JW. 11. Calcium function in affective disorders and healthy controls. Biol Psychiatry. 1988 Feb 15;23(4):367-76. 12. Groat RD, Mackenzie TB. The appearance of mania following intravenous calcium replacement. J Nerv Ment Dis 168:562-3, 1980. 13. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Harris RA. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry. 1989 Jul;46(7):632-8. 14. Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 1992 Jan;149(1):118-20. 15. Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatry Clin Neurosci. 1992 Winter;4(1):3-14. 16. Carman JS, Wyatt RJ. Calcium: pacesetting the periodic psychoses. Am J Psychiatry. 1979 Aug;136(8):1035-9. 17. Carman JS, Wyatt RJ. Calcium: bivalent cation in the bivalent psychoses. Biol Psychiatry. 1979 Apr;14(2):295-336. 18. Depression and hypercalcemia. Am J Med. 1996 Jul;101(1):111-7. 19. Joborn C etal. Psychiatric symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci 91(1):77-87, 1986. 20. Alarcon RD, Franceschini JA. Hyperparathyroidism and paranoid psychosis. Br J Psychiatry. 1984 Nov;145:477-86. 21. Webb WL Jr, Gehi M. Electrolyte and fluid imbalance: neuropsychiatric manifestations. Psychosomatics. 1981 Mar;22(3):199-203. 22. Linder J, Brismar K, Beck-Friis J, Saaf J, Wetterberg L.Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand. 1989 Dec;80(6):527-37. 23. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999;39(2):63-70. 24. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr. 2000 Apr;19(2):220-7. 25. Goei GS, Abraham GE. Effect of a nutritional supplement, optivite, on symptoms of premenstrual tension. J Reprod Med. 1983 Aug;28(8):527-31. 26. Abraham GE. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med. 1983 Jul;28(7):446-64. 27. Alvir JM, Thys-Jacobs S. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacol Bull. 1991;27(2):145-8. 28. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med. 1989 May-Jun;4(3):183-9.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Potassium Imbalance DATE: 6/29/2007 05:52:00 AM ----- BODY:
Proper Name: Potassium Common Name: Potassium Evidence of Efficacy: statement to the effect of Potassium deficiency or imbalance plays a role in the symptoms of mood disorders1. Observational and experimental studies have shown an association between potassium and aggression2,3,4, anxiety5 , bipolar disorder6,7,8,9, and depression10,11. References: 1. Webb WL, Gehi M. Electrolyte and fluid imbalance: Neuropsychiatric manifestations. Psychosomatics 22(3):199-203, 1981 2. William J. Walsh, analytical chemist, Argonne National Laboratory – reported in Sci News 124:122-5, 1983 3. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981 4. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977 5. McCleane GJ, Watters CH. Pre-operative anxiety and serum potassium. Anaesthesia 45(7):583-5, 1990 6. Klemfuss H. Dietary potassium effects on lithium concentration and toxicity in humans. Biol Psychiatry 37:42-7, 1995 7. Jefferson JW. Potassium supplementation in lithium patients: a timely intervention or premature speculation? J Clin Psychiatry 53:10, 1992 8. Bkaskara Rao Tripuraneni, fellow in child psychiatry, Harbo-UCLA Medical Center, Torrance, California – reported in Clin Psychiatry News 18(10):3, October, 1990 and presented to the 143rd Annual Mtg of the Am Psychiatric Assoc, May 12-17, 1990, Abstracts NR 100 and NR 210 9. Cater RE. The use of sodium and potassium to reduce toxicity and toxic side effects from lithium. Med Hypotheses 20(4):359-83, 1986 10. Webb WL, Gehi M. Electrolyte and fluid imbalance: Neuropsychiatric manifestations. Psychosomatics 22(3):199-203, 1981 11. Cox JR et al. Changes in sodium, potassium and fluid spaces in depression and dementia. Gerontology Clin 13:232-45, 1971 Aggressive Behavior

Labels: , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Selenium Imbalance DATE: 6/29/2007 05:50:00 AM ----- BODY:
Proper Name: Selenium Common Name: Selenium Evidence of Efficacy: statement to the effect of Selenium deficiency or imbalance plays a role in the symptoms of mood disorders1. Observational and experimental studies have shown an association between selenium and anxiety1, depression2,3, and schizophrenia4,5,6,7,8,9,10. References: 1. Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 29(11):1092-8, 1991. 2. Hawkes WC, Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 39:121-8, 1996. 3. Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 29(11):1092-8, 1991. 4. Brown JS Jr. Role of selenium and other trace elements in the geography of schizophrenia. Schizophr Bull 20(2):387-98, 1994. 5. Foster HD. Schizophrenia and esophageal cancer: comments on similarities in their spatial distributions. J Orthomol Med 5(3):129-34, 1990. 6. Foster HD. The geography of schizophrenia: possible links with selenium and calcium deficiencies, inadequate exposure to sunlight and industrialization. J Orthomol Med 3(3):135-40, 1988. 7. Alertsen AR, Aukrust A, Skaug OE. Selenium concentrations in blood and serum from patients with mental diseases. Acta Psychiatr Scand 74(2):217-19, 1986. 8. Buckman TD, Kling AS, Eiduscon S, et al. Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiatry 22(11):1349-56, 1987. 9. Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 32(5):805-7, 1986. 10. Berry T. A selenium transport protein model of a sub-type of schizophrenia. Med Hypotheses 43(6):409-14, 1994.

Labels: , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Manganese Imbalance DATE: 6/29/2007 05:48:00 AM ----- BODY:
Proper Name: Manganese Common Name: Manganese Evidence of Efficacy: statement to the effect of Manganese deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between manganese and aggression1,2,3,4,5,6, ADHD7,8,9 , and schizophrenia10,11,12,13,14,15. References: 1. Roger D. Masters, Nelson A. Rockefeller Professor of Government, Dartmouth College, Hanover, New Hampshire. Unpublished data, June, 1995. 2. Marlowe M, Bliss L, Schneider HG. Hair trace element content of violence prone male children. J Advancement Med 7(1):5-18, 1994. 3. Gottschalk LA et al. Abnormalities in hair trace-elements as indicators of aberrant behavior. Compr Psychiatry 32:229-37, 1991. 4. Schmidt K, Wier WR, ASch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981. 5. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A repot on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977. 6. Schauss AG. Comparative hair mineral analysis results of 21 elements in a random behaviorally “normal” 19-59 year old population and violent adult criminal offenders. Int J Biosoc Res 1:21-41, 1981. 7. Collipp PJ, Chen SY, Maitinsky S. Manganese in infant formulas and learning disability. Ann Nutr Metab 27:488-94, 1983. 8. Keen CL, Bell JG, Lonnerdal B. The effect of age on manganese uptake and retention from milk and infant formulas in rats. J Nutr 116:395-402, 1986. 9. Barlow PJ. A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses 11(3):309-18, 1983. 10. Barlow P. Hair metal analysis and its significance to certain diseases. Presentation at the 2nd Annual Trace Minerals in Health Seminar. Boston, MA, September 8-9, 1979. 11. Pfeiffer CC. Observations on trace and toxic elements in hair and serum. J Orthomol Psychiatry 3(4):259-64, 1974. 12. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenics. J Orthomol Psychiatry 12:215-34, 1983. 13. Pfeiffer CC, Iliev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Neurobiol, p. 141. 1972. 14. Hoskins RG. The manganese treatment of schizophrenic disorders. J Nerv Ment Dis 79:59-62, 1934. 15. English WM. Report of the treatment with manganese chloride in dementia praecox. Can Med Asoc J 21:96-149, 1929.

Labels: , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Vitamin B6 Imbalance DATE: 6/29/2007 05:46:00 AM ----- BODY:
Proper Name: Pyridoxine Hydrochloride Common Name: Vitamin B6 Evidence of Efficacy: statement to the effect of Vitamin B6 deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between vitamin B6 and aggression1, anxiety2,3,4, ADHD5,6,7,8,9,10,11,12, bipolar disorder13,14, depression15, 16 ,17 ,18 ,19 ,20 ,21 ,22 ,23 ,24 ,25 ,26, obsessive compulsive disorder27,28, premenstrual syndrome29, 30, 31, 32, 33,3 4,3 5,36 ,37, 38, ,39 ,40, 41, 42,43 ,44, 45, 46, 47, 48, 49, 50 ,5 1,52, 53,and schizophrenia54, 55, 56, 57, 58, 59,6 0,6 1,62 ,63 ,64 .65 References: 1. Noted in McLaren DS. Clinical manifestations of nutritional disorders, in ME Shils, VR Young, Eds. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 2. Heseker H, Kubler W, Pudel V, Westenhoffer J. Psychological disorders as early symptoms of a mild-moderate vitamin deficiency. Ann N Y Acad Sci 669:352-7, 1992. 3. Hoes MJ et al. Hyperventilation syndrome, treatment with L-tryptophan and pyridoxine; Predictive value of xanthurenic acid excretion. J Orthomol Psychiatry 10(1):7-15, 1981. 4. Buist RA. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev 5:1-4, 1985. 5. Coleman M et al. Serotonin in Down’s syndrome. Amsterdam, North Holland, 1973. 6. Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 29(9):931-41, 1991. 7. Haslam RH, Dalby JT. Blood serotonin levels in the attention-deficit disorder. Letter. N Engl J Med 309(31):1328-9, 1983. 8. Brenner A. The effects of megadoses of selected B complex vitamins on children with hyperkinesis: Controlled studies with long-term follow-up. J Learn Disabil 15(5):258-64, 1982. 9. Klieger JA, Altshuler CH, Krakow L, Hollister L. Abnormal pyridoxine metabolism in toxemia of pregnancy. Ann N Y Acad Sci 166:288-96, 1969. 10. Coleman M et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double-blind crossover comparison with methylphenidate. Biol Psychiatry 14(5):741-51, 1979. 11. Brenner A, Wapnir R. A pyridoxine-dependent behavioral disorder unmasked by Isoniazid. Am J Dis Child 132:773-6, 1978. 12. Bhagavan HN et al. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics 55:437-41, 1975. 13. Moller SE et al. Tryptophan availability in endogenous depression – relation to efficacy of L-tryptophan treatment. Adv Biol Psychiatry 10:30-46, 1983. 14. The pharmacokinetics of oral L-tryptophan: Effects of dose and concomitant pyridoxine, allopurinol or nicotinamide administration. Adv Biol Psychiatry 10:67-81, 1983. 15. Noted in McLaren DS. Clinical manifestations of nutritional disorders, in ME Shils, VR Young, Eds. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 16. Bell I et al. Complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc 39:252-7, 1991. 17. Stewart TW, Harrison W, Quitkin F, et al. Low B6 levels in depressed outpatients. Biol Psychiatry 19(4):613-16, 1984. 18. Russ CS et al. Vitamin B6 status of depressed and obsessive-compulsive patients. Nutr Rep Int 27(4):867-73, 1983. 19. Carney MW, Ravindran A, Rinsler MG, et al. Thiamine, riboflavin and pyridoxine deficiency in psychiatric inpatients. Br J Psychiatry 141:271-2, 1982. 20. Carney MW, Williams DG, Sheffield BF. Thiamin and pyridoxine lack in newly-admitted psychiatric patients. Br J Psychiatry 135:249-54, 1979. 21. Nobbs B. Pyridoxal phosphate status in clinical depression. Letter. Lancet i:405, 1974. 22. Bermond P. Therapy of side effects of oral contraceptive agents with vitamin B6. Acta Vitaminol Enzymol 4(1-2):45-54, 1982. 23. Adams PW, Wynn V, Rose DP, et al. Effect of pyridoxine hydrocholoride (vitamin B6) upon depression associated with oral contraception. Lancet ii:899-904, 1973. 24. Adams PW, Wynn V, Seed M, Folkard J. Vitamin B6, depression, and oral contraception. Letter. Lancet ii:516-17, 1974. 25. Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology 32(2):98-105, 1995. 26. Hallert C, Astrom J, Walan A. Reversal of psychopathology in adult coeliac disease with the aid of pyridoxine (vitamin B6). Scand J Gastroenterol 18(2):299-304, 1983. 27. Yaryura-Tobias JA. Presentation to the Third World Congress of Biological Psychiatry, Stockholm – reported in Clinical Psychiatrty News. September, 1981. 28. Yaryura-Tobias JA, Bhagavan HN. L-tryptophan in obsessive-compulsive disorders. Am J Psychiatry 134(11):1298-9, 1977. 29. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 47(4):636-41, 1988. 30. Gallant MP, Bowering J, Short SH, et al. Pyridoxine and magnesium status in women with premenstrual syndrome. Nutr Res 7:243-52, 1987. 31. Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32(6):435-41, 1987. 32. Richie CD, Singkamani R. Plasma pyridoxal-5’-phosphate in women with the premenstrual syndrome. Hum Nutr Clin Nutr 40C:75-80, 1986. 33. Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology 35:1466-8, 1985; Waterston JA, Gilligan BS. Pyridoxine neuropathy. Med J Aust 146:640-2, 1987. 34. Guy Abraham – personal communication reported in Piesse JW. Nutrition factors in the premenstrual syndrome: A review. Int Clin Nutr Rev 4(2):54-81, 1984. 35. Abraham GE. Nutrition and the premenstrual tension syndromes. J Appl Nutr 36(2):103-17, 1985; Hargrove JT, Abraham GT. Effect of vitamin B6 on infertility in women with the premenstrual syndrome. Infertility 2:315: 1979. 36. Leklem JE. Vitamin B6: The pill, pregnancy and premenstrual syndrome. Abstract. J Am Coll Nutr. 11(5):624, 1992. 37. Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of premenstrual syndrome – a review. Br J Obstet Gynaecol 97(9):847-52, 1990. Berman MK et al. Vitamin B-6 in premenstrual syndrome. J Am Diet Assoc 90(6):859-61, 1990. 38. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: A randomized crossover trial. J R Coll Gen Pract 39:364-8, 1989. 39. Brush MG, Bennett T, Hansen K. Pyridoxine in the treatment of premenstrual syndrome: A retrospective survey in 630 patients. Br J Clin Pract 42(11):448-52, 1988. 40. Kendall KE, Schnurr PP. The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet Gynecol 70(2):145-9, 1987. 41. David R. Rubinow, biological psychiatry branch, National Institute of Mental Health (USA) – quoted by Clin Psychiatry News, December, 1987. 42. Hagen I et al. No effect of vitamin B-6 against premenstrual tension: A controlled clinical study. Acta Obstet Gynecol Scand 64:667, 1985. 43. Williams MJ, Harris RI, Dean BC. Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res 13:174-9, 1985. 44. Barr W. Pyridoxine supplements in the premenstrual syndrome. Practitioner 228:425-7, 1984. 45. Mattes JA, Martin D. Pyridoxine in premenstrual depression. Hum Nutr Appl Nutr 36(2):131-3, 1982. 46. Abraham GE, Hargrove JT. Effect of vitamin B-6 on premenstrual symptomatology in women with premenstrual tension syndrome: A double-blind crossover study. Infertility 3:155-65, 1980. 47. Day JB. Clinical trials in the premenstrual syndrome. Curr Med Res Opin (Suppl 6) 5:40-5, 1979. 48. Kerr GD. The management of the premenstrual syndrome. Curr Med Res Opin (Suppl 4) 4:29-34, 1977. 49. Stokes J, Mendels J. Pyridoxine and premenstrual tension. Letter. Lancet i:1177-8, 1972. 50. Piesse JW. Nutrition factors in the premenstrual syndrome. Int Clin Nutr Rev 4(2):54-81, 1984. 51. Lee CM, Leklem JE. Blood magnesium constancy with vitamin B-6 supplementation in pre- and post-menopausal women. Ann Clin Lab Sci 14(2):151-4, 1984. 52. Abraham GE et al. Effect of vitamin B6 on plasma and red blood cell magnesium levels in premenopausal women. Ann Clin Lab Sci 11(4):333-6, 1981. 53. Holley J et al. Effect of vitamin B6 nutritional status on the uptake of [3H]-oestradiol into the uterus, liver and hypothalamus of the rat. J Steroid Biochem 18:161-6, 1983. 54. Pfeiffer CC, Audette L. Pyroluria – Zinc and B6 deficiencies. Int Clin Nutr Rev 8(3):107-10; 1988. 55. Pfeiffer CC. The schizophrenias ’76. Biol Psychiatry 2:773-5, 1976. 56. Pfeiffer CC, Bacchi D. Copper, zinc, manganese, niacin and pyridoxine in the schizophrenias. J Appl Nutr 27:9-39, 1975. 57. Pfeiffer CC. Observations on trace and toxic elements in hair and serum. J Orthomol Psychiatry 3(4):259-64, 1974. 58. Cruz R, Vogel WH. Pyroluria: A poor marker in chronic schizophrenia. Am J Psychiatry 135(10):1239-40, 1978. 59. Parry GJ. Sensory neuropathy with low-dose pyridoxine. Neurology 35:1466:8, 1985. 60. Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 29(9):931-41, 1991. 61. Brooks SC et al. An unusual schizophrenic illness responsive to pyridoxine HCl (B6) subsequent to phenothiazine and butyrophenone toxicities. Biol Psychiatry 18(11):1321-8, 1983. 62. Yamauchi M. Effects of L-dopa and vitamin B6 on electroencephalograms of schizophrenic patients: A preliminary report. Folia Psychiatrica et Neurologica Japonica 30(2):121-51, 1976. 63. Sandyk R, Pardeshi R. Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patients. J Neurosci 53(3-4):225-32, 1990. 64. Petrie WM, Ban TA, Anath JV. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia. Int Pharmacopsychiatry 16(4):245-50, 1981. 65. Ananth JV, Ban TA, Lehmann HE. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Can Psychiatr Assoc J 18:377-83, 1973.

Labels: , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Magnesium Imbalance DATE: 6/29/2007 05:42:00 AM ----- BODY:
Proper Name: Magnesium Common Name: Magnesium Evidence of Efficacy: Magnesium deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between magnesium and aggression 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, anxiety 11, 12, 13, 14, 15, ADHD 16, 17, 18, bipolar disorder 19, 20 ,21, depression 22,23,24,25,26,27,28,29,30,31,32,33,34,35, premenstrual syndrome 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, and schizophrenia 58, 59, 60, 61, 62, 63, 64, 65 ,66 ,67 ,68 ,69, 70. References: 1. Izenwasser SE et al. Stimulant-like effects of magnesium on aggression in mice. Pharmacol Biochem Behav 25(6):1195-9, 1986. 2. Henrotte JG. Type A behavior and magnesium metabolism. Magnesium 5:201-10, 1986. 3. Bennett CPW, McEwen LM, McEwen HC, Rose EL. The Shipley Project: treating food allergy to prevent criminal behaviour in community settings. J Nutr Environ Med 8:77-83, 1998. 4. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 5. Kantak KM. Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci 102(2):304-11, 1988. 6. Izenwasser SE, Garcia-Valdez K, Kantak KM. Stimulant-like effects of magnesium on aggression in mice. Pharmacol Biochem Behav 25(6):1195-9, 1986. 7. Struempler RE et al. Hair mineral analysis and disruptive behavior in clinically normal young men. J Learn Disabil 18(10):609-12, 1985. 8. Banki CM, Vojnik M, Papp Z, et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20(2):163-71, 1985. 9. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981. 10. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 "incorrigible" adolescents. Am Lab 107:22-49, 1977. 11. Buist RA. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev 5:1-4, 1985. 12. Seelig MS, Berger AR, Spieholz N. Latent tetany and anxiety, marginal Mg deficit, and normocalcemia. Dis Nerv Syst 36:461-5, 1975. 13. Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res 7(3/4):313-28, 1994. 14. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 15. Weston PG et al. Magnesium sulphate as a sedative. Am J Med Sci 165:431-3, 1923. 16. Durlach J. Clinical aspects of chronic magnesium deficiency, in MS Seelig, Ed. Magnesium in Health and Disease. New York, Spectrum Publications, 1980. 17. Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 10(2):143-8, 1997. 18. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 10(2):149-56, 1997. 19. George MS, Rosenstein D, Rubinow DR, et al. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res 51(2):139-46, 1994. 20. Kirov GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms. Neuropsychobiology 1994;30(2-3):73-8, 1994. 21. Chouinard G, Beauclair L, Geiser R, Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 14(2):171-180, 1990. 22. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 23. Linder J et al. Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand 80:527-37, 1989. 24. Frazer A et al. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 5(2):103-13, 1983. 25. Bjorum N. Electrolytes in blood in endogenous depression. Acta Psychiatr Scand 48:59-68, 1972. 26. Cade JFJA. A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med J Aust 1:195-6, 1964. 27. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 28. Hall RCW, Joffe JR. Hypomagnesemia: Physical and psychiatric symptoms. JAMA 224:1749-51, 1973. 29. Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Br J Psychiatry 115:1375-7, 1969. 30. Frizel D et al. Plasma calcium and magnesium in depression. Br J Psychiatry 115:1375-7, 1969. 31. Hasey GM, D'Alessandro E, Cooke RG, Warsh JJ. The interface between thyroid activity, magnesium, and depression: A pilot study. Biol Psychiatry 33:133-5, 1993. 32. Linder J et al. Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand 80:527-37, 1989. 33. Frazer A et al. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 5(2):103-13, 1983]. 34. Banki CM et al. Aminergic studies and cerebrospinal fluid cations in suicide. Ann N Y Acad Sci 487:221-30, 1986. 35. Banki CM et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20:163-71, 1985. 36. Posaci C, Erten O, Uren A, Acar B. Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452-5, 1994. 37. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 38. Chuong CJ, Dawson EB., Magnesium levels in premenstrual syndrome. Nutr Res 14(11):1623-34, 1994. 39. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 47:636-41, 1988. 40. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667;70, 1986. 41. Stebbing JB et al., Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 42. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 43. Stewart A., Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 44. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667-70, 1986. 45. Stebbing JB et al., Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 46. Abraham GE. Magnesium deficiency in premenstrual tension. Magnesium Bull 1:68-73, 1982. 47. Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 34(11):2364-6, 1981. 48. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 49. Stewart A., Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 50. Stebbing JB et al. Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 51. Brown RC, Bidlack WR. Regulation of glucuronyl transferase by intracellular magnesium, in Proceedings of the International Symposium on Magnesium and its Relationship to Cardiovascular, Renal and Metabolic Disorders. Los Angeles, 1985:24. 52. Curry DL et al. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 101:203, 1977. 53. Abraham GE. Management of the premenstrual tension syndromes: Rationale for a nutritional approach, in J Bland, Ed. 1986: A Year in Nutritional Medicine. New Canaan, CT, Keats Publishing, 1986:125-66. 54. Brown RC, Bidlack WR. Regulation of glucuronyl transferase by intracellular magnesium, in Proceed Int Sympos Magnesium and its Relationship to Cardiovascular, Renal and Metabolic Disorders. Los Angeles, 1985:24. 55.Cunnane SC, Horrobin DF. Parnteral linoleic and gamma-linolenic acids ameliorate the gross effects of zinc deficiency. Proc Soc Exp Biol Med 164:583, 1980. 56. Facchinetti F, Bolrella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 78(2):177-81, 1991. 57. Facchinetti F et al. Magnesium prophylaxis of menstrual migraine: effects of intracellular magnesium. Headache 31:298-304, 1991. 58. Levine J, Rapoport A, Mashiah M, Dolev E. Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients. Neuropsychobiology 33(4):169-72, 1996. 59. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 60. Kanofsky JD et al. Is iatrogenic hypomagnesemia common in schizophrenia? Abstract. J Am Coll Nutr 10(5):537, 1991. 61. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 62. Chhatre SM et al. Serum magnesium levels in schizophrenia. Ind J Med Sci 39(11):259-61, 1985. 63. Paul EA et al. Serum calcium and magnesium in schizophrenia. Relationship to clinical phenomena and neuroleptic treatment. Br J Psych 133:143-9, 1978. 64. Daly RM, Gold G. Serum magnesium levels in nonacute schizophrenics. N Y State J Med 76:188-9, 1976. 65. Hakim AH et al. A comparative study of serum calcium and magnesium in cases of endogenous depression, reactive depression, schizophrenia and conversion reaction. J Assn Phys Ind 23:513-17, 1975. 66. Pandey SK et al. An estimation of magnesium and calcium in serum and CSF in schizophrenia. J Assn Phys Ind 21:203-5, 1973. 67. Chugh TD et al. Magnesium in schizophrenia. Ind J Med Res 61:998-1001, 1973. 68. Cade JFJ. A significant elevation of plasma magnesium level in schizophrenia and depressive states. Med J Aust 1:195-6, 1964. 69. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 70. Levine J, Rapoport A, Mashiah M, Dolev E. Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients. Neuropsychobiology 33(4):169-72, 1996.

Labels: , , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Copper imbalance DATE: 6/29/2007 05:40:00 AM ----- BODY:
Proper Name: Copper Common Name: Copper Evidence of Efficacy: statement to the effect of Copper deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between copper and ADHD1,2,3, depression4,5,6, premenstrual syndrome7, and schizophrenia8,9,10,11,12,13,14,15,16,17,18,19,20. References: 1. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 2. Brenner A. Trace mineral levels in hyperactive children responding to the Feingold diet. J Pediatr 94 (60):944-5, 1979. 3. Pfeiffer CC, Mailloux R. Excess copper as a factor in human diseases. J Orthomol Med 2(3):171-82, 1987. 4. Hansen Cr Jr et al. Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 18(3):395-401, 1983. 5. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 6. Ali SA et al. Blood levels of vanadium, caesium, and other elements in depressive patients. J Affect Disord 9:187-91, 1985. 7. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 8. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 9. Shore D et al. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry 140(6):754-7, 1983. 10. Tyrer SP et al. CSF copper in schizophrenia. Am J Psychiatry 136(7):937-9, 1979. 11. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 12. Olatunbosun DA at al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:119-21, 1975. 13. Pfeiffer CC, Illiev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Biol Suppl 1, 1972. 14. Heilmeyer L, Keiderling W, Struve C. Kupfer and eisen als. Korpereigene Wirkstoffe und Ihre Bedeutung Beim Krankheitgeschehen. Fischer, Jena, Germany, 1941. 15. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenias. J Orthomol Psychiatry 12:215-34, 1983. 16. Bowman MB, Lewis MS. The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 6:321-8, 1982. 17. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 18. Mattke JD, Adler M. Mode of action of D-penicillamine in chronic schizophrenia. Dis Nerv Sys 32:388, 1971. 19. Affleck JW et al., Penicillamine and schizophrenia – A clinical trial. Br J Psychiatry 115:173, 1969. 20. Nicholson GA et al. Effect of D-penicillamine on schizophrenic patients. Lancet i:344, 1966.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Zinc Imbalance DATE: 6/29/2007 05:36:00 AM ----- BODY:
Proper Name: Zinc Common Name: Zinc Evidence of Efficacy: statement to the effect of Zinc deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between zinc and aggression2,3,4,5,6, ADHD7,8,9,10,11,12,13, depression14,15,16,17,18,19, and premenstrual syndrome20,21,22,23,24. References: 1. Walwork JC et al. Distribution of minerals and catecholamines in rat brain: effects of zinc deficiency, in CJ Frederickson et al, Eds. The Neurobiology of Zinc, Part B: Deficiency, Toxicity and Pathology (Neurology and Neurobiology V. 11B). New York, Alan R. Liss, 1984:49-64. 2. Prasad AS. Clinical manifestations of zinc deficiency. Nutr Rev 41(7):197, 1983. Schauss AG et al. A critical analysis of the diets of chronic juvenile offenders, Part II. J Orthomol Psychiatry 8(4):222-6, 1979. 3. William J. Walsh, analytical chemist, Argonne National Laboratory – reported in Sci News 124:122-5, 1983. 4. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977. 5. William J. Walsh. Zinc deficiency, metal metabolism, and behavior disorders. Unpublished monograph. Health Research Institute, 1804 Centre Point Dr., Suite 106, Naperville, IL 60503, March 1995. 6. Bennett CPW, McEwen LM, McEwen HC, Rose EL. The Shipley Project: treating food allergy to prevent criminal behavior in community settings. J Nutr Environ Med 8:77-83, 1998. 7. Ward NI. Assessment of chemical factors in relation to child hyperactivity. J Nutr Environ Med 7:333-42, 1997. 8. Bekaroglu M, Aslan Y, Gedik Y, et al. Relationships between serum free fatty acids and zinc, and attention deficity hyperactivity disorder: a research note. J Child Psychol Psychiatry 37(2):225-7, 1996. 9. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 10. Ward NI et al. The influence of the chemical additive tartrazine on the zinc status of hyperactive children – a double-blind placebo-controlled study. J Nutr Med 1:51-7, 1990. 11. Arnold LE, Votalato NA, Kleykamp D, et al. Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neruosci 50(1-2):103-7, 1990. 12. Barlow PJ. A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses 11(3):309-18, 1983. 13. Golub MR, Takeuchi PT, Keen CL, et al. Activity and attention in zinc-deprived adolescent monkeys. Am J Clin Nutr 64:908-15, 1996. 14. Tasman-Jones C. Zinc deficiency states. Adv Intern Med 26:97-114, 1980. 15. Maes M, Vandoolaeghe E, Neels H, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42(5):349-58, 1997. 16. Maes M, D’Haese PC, Scharpe S, et al. Hypozincemia in depression. J Affect Disord 31(2):135-40, 1994. 17. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 18. McLoughlin IJ, Hodge JS. Zinc in depressive disorder. Acta Psychiatr Scand 82(6), 451-3, 1990. 19. Little KY, Castellanos X, Humphries LL, Austin J. Altered zinc metabolism in mood disorder patients. Biol Psychiatry 26:646-8, 1989. 20. Posaci C, Erten O, Uren A, Acar B. Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452-5, 1994. 21. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 22. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Cin Nutr 47(4):636-41, 1988. 23. Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 24. Chuong CJ et al, Baylor College of Medicine, Houston – presented at the 46th Annual Mtg. Of the Am. Fertility Society, Washington, DC, 1991.

Labels: , , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Walsh - reduced violent behavior due to nutrient therapy DATE: 6/29/2007 05:33:00 AM ----- BODY:
Reduced violent behavior following biochemical therapy William J. Walsh*, Laura B. Glab, Mary L. Haakenson Pfeiffer Treatment Center, 4575 Weaver Parkway, Warrenville, IL 60555, United States Received 5 May 2003; received in revised form 23 June 2004; accepted 29 June 2004 Abstract Reduced violent behavior following biochemical therapy. We conducted an outcome study to measure the effectiveness of biochemical therapy for 207 consecutive patients presenting with a diagnosed behavior disorder. The treatment protocols were based on clinical evaluation and our past experience in the treatment of 8000 patients with behavior disorders at the Pfeiffer Treatment Center (PTC) over a 10-year period. Each test subject was screened for chemical imbalances previously found in high incidence in this population, including metal-metabolism disorders, methylation abnormalities, disordered pyrrole chemistry, heavy-metal overload, glucose dyscontrol, and malabsorption. The clinical procedure included a medical history, assay of 90 biochemical factors, and a physical examination. Standardized treatment protocols were applied for each imbalance that was identified. The frequencies of physical assaults and destructive episodes were determined using a standardized behavior scale before and after treatment, with follow-up ranging from 4 to 8 months. Results: Seventy-six percent of the test subjects achieved compliance during the treatment period. The remaining 24% were reported to have discontinued the therapy. A reduced frequency of assaults was reported by 92% of the compliant assaultive patients, with 58% achieving elimination of the behavior. A total of 88% of compliant destructive patients exhibited a reduced frequency of destructive incidents and 53% achieved elimination of the behavior. Statistical significance was found for reduced frequency of assaults (t=7.74, pb0.001) and destructive incidents (t= 8.77, pb0.001). The results of this outcome study strongly suggest that individualized biochemical therapy may be efficacious in achieving behavioral improvements in this patient population.

Labels: , , , , , ,

----- -------- AUTHOR: Biomed Mom TITLE: Neuroarcheology of Childhood Trauma DATE: 6/28/2007 10:21:00 AM ----- BODY:
Child Trauma Academy Home Child Trauma Academy Materials Child Trauma Academy Materials Child Trauma Academy Materials About Child Trauma Academy Child Trauma Academy Services Child Trauma Academy Materials Our Impact Resources & Links Forum The Neuroarcheology of Childhood Maltreatment The Neurodevelopmental Costs of Adverse Childhood Events Bruce D. Perry, M.D., Ph.D. The ChildTrauma Academy www.ChildTrauma.org For: "The Cost of Child Maltreatment: Who Pays? We All Do" (Ed., B. Geffner) Haworth Press July 27, 2000 Introduction Childhood maltreatment has profound impact on the emotional, behavioral, cognitive, social and physical functioning of children. Developmental experiences determine the organizational and functional status of the mature brain and, therefore, adverse events can have a tremendous negative impact on the development of the brain. In turn, these neurodevelopmental effects may result in significant cost to the individual, their family, community and, ultimately, society. In essence, childhood maltreatment alters the potential of a child and, thereby, robs us all. The present chapter will review some of those costs from a neurodevelopmental perspective. The premise is that when the core principles of neurodevelopment are understood, the costs of adverse childhood events and maltreatment become obvious. Following a brief presentation of the key concepts of neurodevelopment, two primary forms of maltreatment will be considered: (1) neglect and (2) traumatic stress. Maltreatment of children often involves both neglect and trauma; a more complete understanding of the complex neurodevelopmental impact of the combination, however, is best understood after presenting the potential effects of each separately. This chapter presents the current articulation of a neurodevelopmental perspective of childhood maltreatment originally outlined in 1994 (Perry. 1994) and further elaborated over the last five years (Perry, Pollard, Blakley, Baker, & Vigilante. 1995) (Perry & Pollard. 1998) This most recent articulation outlines the issue of maltreatment through the lens of developmental neurobiology and coins a descriptive phrase, "neuroarcheology," to capture the impact of adverse events on the developing brain, with the implicit suggestion that experiences leave a 'record' within the matrix of the brain. The nature and location of this record will depend upon the nature of the experience and the time in development when the event took place – much as with the archeological record of the earth. While this phrase may be simplistic to some, it conveys important conceptual principles about the nature of childhood experience which have been lacking all too often in clinical and research formulations regarding maltreatment. Not a single psychometric instrument measuring traumatic or adverse events, for example, uses time of trauma as a meaningful variable despite the fact that it may be the most important determinant of functional outcome following maltreatment. The neuroarcheological perspective on childhood experience, therefore, simply posits that the impact of a childhood event (adverse or positive) will be a reflection of (1) the nature, intensity, pattern and duration of the event and (2) that the resulting strengths (e.g., language) or deficits (e.g., neuropsychiatric symptoms) will be in those functions mediated by the neural systems that are most rapidly organizing (i.e., in the developmental "hot zone") at the time of the experience. Brain Organization and Function The human brain is the remarkable organ that allows us to sense, process, perceive, store and act on information from outside and inside the body to carry out the three prime directives required for the survival of our species: (1) survive, (2) affiliate and mate and then, (3) protect and nurture dependents. In order to carry out these core and overarching responsibilities, thousands of inter-related functions have evolved. In the human brain, structure and function have co-evolved. As we have a hierarchy of increasingly complex functions related to our optimal functioning, our brain has evolved a hierarchical structural organization (see Table 1). This hierarchy starts with the lower, simpler brainstem areas and increases in complexity up through the neocortex (Figure 1). In each of these many areas of the brain are neural systems that mediate our many brain-related functions (Figure1; Table1). The 'lower' parts of the brain (brainstem and midbrain) mediate simpler regulatory functions (e.g., regulation of respiration, heart rate, blood pressure, body temperature) while more complex functions (e.g., language and abstract thinking) are mediated by the more complex neocortical structures of the human brain. This hierarchical structure is the heart of a neuroarcheological understanding of adverse childhood events. This structure becomes the multi-layered soil within which the fossilized evidence of maltreatment can be found – each layer organizing at a different time and each layer reflecting the experiences –good and bad - of that era in the individual's life. Key insights to understanding human functioning, then, will come from understanding neurodevelopment. neuroarcheology1.jpg (33179 bytes) Figure 1: Hierarchical Organization of the Human Brain: The brain can be divided into four interconnected areas: brainstem, diencephalons, limbic and neocortex. The complexity of structure, cellular organization and function increases from the lower, simpler areas such as the brainstem to the most complex, the neocortex. Neurodevelopment Our brain's complex structure is comprised of 100 billion neurons and ten times as many glial cells – all interconnected by trillions of synaptic connections – and communicating in a non-stop, ever-changing dynamic of neurochemical activity. The brain doesn't just pop into existence. This most complex of all biological systems in the known universe is a product of neurodevelopment – a long process orchestrating billions upon billions of complex chemical transactions. It is through these chemical actions that a human being is created. The developing child is a remarkable phenomenon of nature. In a few short years, one single cell – the fertilized egg – becomes a walking, talking, learning, loving, and thinking being. This physical transformation is equivalent to a 6-foot tall, 200 pound man growing to the size of Connecticut in three years. In each of the billions and billions of cells in the body, a single set of genes has been expressed in millions of different combinations with precise timing. Development is a breathtaking orchestration of precision micro-construction that allows the healthy development of a human being. And the most remarkable and complex of all the organs in the human body is the human brain. In order to create the brain, a small set of pre-cursor cells must divide, move, specialize, connect and create specialized neural networks that form functional units. The key processes in neurodevelopment are summarized below. Core Processes of Neurodevelopment 1. Neurogenesis: The brain starts as a few cells present early in the first weeks of life. From a few specialized cells in the unformed brain, come billions of nerve cells and trillions of glia. This, of course, requires that cells be "born." Neurogenesis is the birth of new neurons. The vast majority of neurogenesis takes place in utero during the second and third trimester. At birth, the vast majority of neurons, literally more than 100 billion, used for the remainder of life are present. Few neurons are born after birth, although researchers have demonstrated recently that neurogenesis can and does take place in the mature brain (Gould, Reeves, Graziano, & Gross. 1999). This is a very significant observation and may be one of the important physiological mechanisms responsible for the brain's plasticity (i.e., capacity to restore function) following injury. Despite being present at birth, these neurons have yet to organize into completely functional systems. Many neurons need to mature themselves and undergo a set of processes that create the functional neural networks of the mature brain (Table 2). 2. Migration: Developing neurons move. Often guided by glial cells and a variety of chemical markers (e.g., cellular adhesion molecules, nerve growth factor: NGF), neurons cluster, sort, move and settle into a location in the brain that will be their final "resting" place. It is the fate of some neurons to settle in the brainstem, others in the cortex, for example. More than one half of all neurons are in the cortex. The processes of cortical cell migration and fate mapping are some of the most studied in all of developmental neuroscience (Rakic. 1981) (Rakic. 1996). It is clear that both genetic and environmental factors play important roles in determining a neuron's final location. Migration takes place primarily during the intrauterine and immediate perinatal period but continues throughout childhood and, possibly, to some degree into adult life. A host of intrauterine and perinatal insults – including infection, lack of oxygen, alcohol and various psychotropic drugs can alter migration of neurons and have profound impact on functioning (Perry. 1988). Table 1. A Neuroarcheological Chart of Development: Functional Organization neuroarcheology2.jpg (63967 bytes) 3. Differentiation: Neurons mature. Each of the 100 billion neurons in the brain has the same set of genes, yet each neuron is expressing a unique combination of those genes to create a unique identity. Some neurons are large, with long axons; others short. Neurons can mature to use any of a hundred different neurotransmitters such as norepinephrine, dopamine, serotonin, CRF or substance P. Neurons can have dense dendritic fields receiving input from hundreds of other neurons, while other neurons can have a single linear input from one other neuron. Each of these thousands of differentiating "choices" come as a result of the pattern, intensity and timing of various microenvironmental cues which tell the neuron to turn on some genes and turn off others. Each neuron undergoes a series of "decisions" to determine their final location and specialization. These decisions, again, are a combination of genetic and microenvironmental cues. The further along in development, the more differentiated the neuron, the more sensitive it becomes to the environmental signals. From the intrauterine period through early childhood (and to some degree beyond) neurons are very sensitive to experience-based signals, many of which are mediated by patterned neuronal activity in the neural network in which they reside. Neurons are literally designed to change in response to chemical signals. Therefore, any experience or event that alters these neurochemical or microenvironmental signals during development can change the ways in which certain neurons differentiate, thereby altering the functional capacity of the neural networks in which these neurons reside. 4. Apoptosis: Some developing neurons die. In many areas of the brain, there are more neurons born than are needed for any given function. Many of these neurons are redundant and when unable to adequately "connect" into an active neural network will die (Kuan, Roth, Flavell, & Rakic. 2000). Research in this area suggests that these neurons may play a role in the remarkable flexibility present in the human brain at birth. Depending upon the challenges of the environment and the potential needs of the individual, some neurons will survive while others will not. Again, this process appears to have genetic and environmental determinants. Neurons that make synaptic connections with others and have an adequate level of activation will survive; those cells that have little activity resorb. This is one example of a general principle of activity-dependence ("use it or lose it") that appears to be important in many neural processes related to learning, memory and development. 5. Arborization: As neurons differentiate, they send out tiny fiber-like extensions from their cell body. These dendrites become the receptive area where other neurons connect. It is in this receptive field that dozens to hundreds of other neurons are able to send neurochemical signals to the neuron. The density of these dendritic branches appears to be related to the frequency and intensity of incoming signals. When there is high activity, the dendritic network extends, essentially branching out in the same fashion as a bush may create new branches. This arborization allows the neuron to receive, process and integrate complex patterns of activity that will, in turn, determine its activity. Again, the arborization process appears to be to some degree activity-dependent. The density of the dendritic arborization appears to be related to the complexity and activity of incoming neural activity. In turn, these neural signals are often dependent upon the complexity and activity of the environment of the animal (Diamond, Law, Rhodes, et al. 1966; Greenough, Volkmar, & Juraska. 1973). 6. Synaptogenesis: Developing neurons make connections with each other. The major mechanism for neuron-to-neuron communication is 'receptor-mediated' neurotransmission that takes place at specialized connections between neurons called synapses. At the synapse, the distance between two neurons is very short. A chemical (classified as a neurotransmitter, neuromodulator or neurohormone) is released from the 'presynaptic' neuron and into the extra-cellular space (called the synaptic cleft) and binds to a specialized receptor protein in the membrane of the 'postsynaptic' neuron. By occupying the binding site, the neurotransmitter helps change the shape of this receptor which then catalyzes a secondary set of chemical interactions inside the postsynaptic neuron that create second messengers. The second messengers such as cyclic AMP, inositol phosphate and calcium will then shift the intracellular chemical milieu which may even influence the activity of specific genes. This cascade of intracellular chemical responses allows communication from one neuron to another. A continuous dynamic of synaptic neurotransmission regulates the activity and functional properties of the chains of neurons that allow the brain to do all of its remarkable activities. These neural connections are not random. They are guided by important genetic and environmental cues. In order for our brain to function properly, neurons, during development, need to find and connect with the "right" neurons. During the differentiation process, neurons send fiber-like projections (growth cones) out to make physical contact with other neurons. This process appears to be regulated and guided by certain growth factors and cellular adhesion molecules that attract or repel a specific growth cone to appropriate target neurons. Depending upon a given neuron's specialization, these growth cones will grow (becoming axons) and connect to the dendrites of other cells and create a synapse. During the first eight months of life there is an eight-fold increase in synaptic density while the developing neurons in the brain are "seeking" their appropriate connections (Huttenlocher. 1979) (Huttenlocher. 1994). This explosion of synaptogenesis allows the brain to have the flexibility to organize and function in with a wide range of potential. It is over the next few years, in response to patterned repetitive experiences that these neural connections will be refined and sculpted. 7. Synaptic sculpting: The synapse is a dynamic structure. With ongoing episodic release of neurotransmitter, occupation of receptors, release of growth factors, shifts of ions in and out of cells, laying down of new microtubules and other structural molecules, the synapse is continually changing. A key determinant of change in the synapse appears to be the level of presynaptic activity. When there is a consistent active process of neurotransmitter release, synaptic connections will be strengthened with actual physical changes that make the pre- and postsynaptic neurons come closer and the process of neurotransmission more efficient. When there is little activity, the synaptic connection will literally dissolve. The specific axonal branch to a given neuron will go away. Again, this powerful activity-dependent process appears to be very important for understanding learning, memory and the development. At any given moment – all throughout life – we are making and breaking synaptic connections. For the majority of life we are at equilibrium; the rate of creating new synaptic connections is equal to the rate of resorbing older, unused connections. While somewhat simplistic, it appears that the synaptic sculpting is a "use it or lose it" process. During the first eight months following birth the rate of creating new synapses far outstrips the rate of resorbing unused connections. By age one, however, and from then through early childhood, the rate of resorbing new connections is faster than the rate of creating new synapses. By adolescence, in most cortical areas at least, this process again reaches equilibrium. 8. Myelination: Specialized glial cells wrap around axons and, thereby, create more efficient electrochemical transduction down the neuron. This allows a neural network to function more rapidly and efficiently, thereby allowing more complex functioning (e.g., walking depends upon the myelination of neurons in the spinal cord for efficient, smooth regulation of neuromotor functioning.) The process of myelination begins in the first year of life but continues in many key areas throughout childhood with a final burst of myelination in key cortical areas taking place in adolescence. Table 2: Key Processes in Neurodevelopment neuroarcheology3.jpg (68908 bytes) * This refers to the age at which approximately 10% of this specific function is taking place. In most cases, there is evidence that some of these processes have started to some degree. Almost all of these processes continue in some form throughout life, the table is designed to illustrate the relative importance of childhood for the majority of activity in each of these processes. **These are crude estimates based upon data from multiple sources. The major point it to demonstrate that shifting activity from neurogenesis to myelination. All of the neurodevelopmental processes described above are dependent upon both genetic and environmentally determined microenvironmental cues (e.g., neurotransmitters, neuromodulators, neurohormones, ions, growth factors, cellular adhesion molecules and other morphogens). Disruption of the pattern, timing or intensity of these cues can lead to abnormal neurodevelopment and profound dysfunction. The neuroarcheological perspective suggests that the specific dysfunction will depend upon the timing of the insult (e.g., was the insult in utero during the development of the brainstem or at age two during the active development of the cortex), the nature of the insult (e.g., is there a lack of sensory stimulation from neglect or an abnormal persisting activation of the stress response from trauma?), the pattern of the insult (i.e., is this a discreet single event, a chronic experience with a chaotic pattern or an episodic event with a regular pattern?). While we are only beginning to understand the complexity of neurodevelopment, there are several key principles that emerge from the thousands of studies and years of focused research on these neurodevelopmental processes. These principles, as outlined below, suggest that while the structural organization and functional capabilities of the mature brain can change throughout life, the majority of the key stages of neurodevelopment take place in childhood. The core principles of neurodevelopment that support a neuroarcheological perspective of childhood adverse events are summarized below. Core Principles of Neurodevelopment 1. Nature and nurture: For too many years, any conceptual approach to human behavior has been tainted by the nature versus nurture debate. Do genes cause human behavior or is human behavior a product of learning, education and experience? Ultimately, this debate polarizes and distracts from more complex understandings of human functioning. Genes are designed to work in an environment. Genes are expressed by microenvironmental cues, which, in turn, are influenced by the experiences of the individual. How an individual functions within an environment, then, is dependent upon the expression of a unique combination of genes available to the human species. We don't have the genes to make wings. And what we become depends upon how experiences shape the expression – or not - of specific genes we do have. We do have the genes to make forty sounds – and we can have the experiences that turn this genetically determined capacity into a powerful, transforming tool – language. Yet, there are many sad examples of cruel experiments of humanity, where a young child was raised in an environment deprived of language. This child, despite the genetic potential to speak and think and feel in complex humane ways, did not express that potential fully. Genetic potential without appropriately timed experiences can remain unexpressed. Nature and nurture – we are nothing without both; we require both and we are products of both. The influence of gene-driven processes, however, shifts during development. In the just fertilized ovum, all of the chemical processes that are driving development are very dependent upon a genetically determined sequence of molecular events. By birth, however, the brain has developed to the point where environmental cues mediated by the senses play a major role in determining how neurons will differentiate, sprout dendrites, form and maintain synaptic connections and create the final neural networks that convey functionality. By adolescence, the majority of the changes that are taking place in the brain of that child are determined by experience, not genetics. The languages, beliefs, cultural practices, and complex cognitive and emotional functioning (e.g., self esteem) by this age are primarily experience-based. 2. Sequential Developmental: The brain develops in a sequential and hierarchical fashion; organizing itself from least (brainstem) to most complex (limbic, cortical areas). These different areas develop, organize and become fully functional at different times during childhood. At birth, for example, the brainstem areas responsible for regulating cardiovascular and respiratory function must be intact for the infant to survive, and any malfunction is immediately observable. In contrast, the cortical areas responsible for abstract cognition have years before they will be 'needed' or fully functional. This means that each brain area will have its own timetable for development. The neurodevelopmental processes described above will be most active in different brain areas at different times and will, therefore, either require (critical periods) or be sensitive to (sensitive periods) organizing experiences (and the neurotrophic cues related to these experiences). The neurons for the brainstem have to migrate, differentiate and connect, for example, before the neurons for the cortex. The implications of this for a neuroarcheological formulation are profound. Disruptions of experience-dependent neurochemical signals during these periods may lead to major abnormalities or deficits in neurodevelopment. Disruption of critical neurodevelopmental cues can result from 1) lack of sensory experience during sensitive periods (e.g., neglect) or 2) atypical or abnormal patterns of necessary cues due to extremes of experience (e.g., traumatic stress, see below). Insults during the intrauterine period, for example, will more likely influence the rapidly organizing brainstem systems as opposed to the more slowly organizing cortical areas. The symptoms from the intrauterine disruption will alter functions mediated by the brainstem and could include sensory integration problems, hyper-reactivity, poor state regulation (e.g., sleep, feeding, self-soothing), tactile defensiveness and altered regulation of core neurophysiological functions such as respiration, cardiovascular and temperature regulation. This does not mean that neocortical systems are unaffected by disrupting the development of the brainstem. Indeed, one of the most important aspects of the sequential development is that important organizing signals for any given brain area or system (e.g., patterns of neural activity, neurotransmitters acting as morphogens) come from previously organized brain areas or systems. Due to the sequential development of the brain, disruptions of normal developmental processes early in life (e.g., during the perinatal period) that alter development of the brainstem or diencephalon will necessarily alter the development of limbic and cortical areas. This is so because many of the organizing cues for normal limbic and neocortical organization originate in the lower brain areas. Any developmental insult can have a cascade effect on the development of all "downstream" brain areas (and functions) that will receive input from the effected neural system. 3. Activity-dependent neurodevelopment: The brain organizes in a use-dependent fashion. As described above, many of the key processes in neurodevelopment are activity dependent. In the developing brain, undifferentiated neural systems are critically dependent upon sets of environmental and micro-environmental cues (e.g., neurotransmitters, cellular adhesion molecules, neurohormones, amino acids, ions) in order for them to appropriately organize from their undifferentiated, immature forms (Lauder. 1988; Perry. 1994) (Perry & Pollard. 1998). Lack, or disruption, of these critical cues can alter the neurodevelopmental processes of neurogenesis, migration, differentiation, synaptogenesis - all of which can contribute to malorganization and diminished functional capabilities in the specific neural system where development has been disrupted. This is the core of a neuroarcheological perspective on dysfunction related adverse childhood events (Perry. 1994) (Perry & Pollard. 1998; Perry. 1998). These molecular cues that guide development are dependent upon the experiences of the developing child. The quantity, pattern of activity and nature of these neurochemical and neurotrophic factors depends upon the presence and the nature of the total sensory experience of the child. When the child has adverse experiences – loss, threat, neglect, and injury – there can be disruptions of neurodevelopment that will result in neural organization that can lead to compromised functioning throughout life (see Neglect section, below). A neuroarcheological perspective would predict that the dysfunction resulting from a specific adverse event is related to the disrupted (or altered) development of the neural system that is, during the adverse event, most rapidly developing. The degree of disruption is related to the rate of change in the respective neural system. The already organized and functioning neural system is less vulnerable to a developmental insult than the rapidly changing, energy-hungry and microenvironmental cue-sensitive developing system. This is so because of a principle called biological relativity. In any dynamic system, the impact of an event or experience (disruptive or positive) is greatest on the most actively changing or dynamic parts of that system. The power of any experience, therefore, is greatest during the most rapid phases of development. Events taking place during a neural system's most active phase of organization will have more impact than events after the system has organized. 4. Windows of Opportunity/Windows of Vulnerability: The sequential development of the brain and the activity-dependence of many key aspects of neurodevelopment suggest that there must be times during development when a given developing neural system is more sensitive to experience than others (Table 3). In healthy development, that sensitivity allows the brain to rapidly and efficiently organize in response to the unique demands of a given environment to express from its broad genetic potential those characteristics which best fit that child's world. If the child speaks Japanese as opposed to English, for example, or if this child will live in the plains of Africa or the tundra of the Yukon, different genes can be expressed, different neural networks can be organized from that child's potential to best fit that family, culture and environment. We all are aware of how rapidly young children can learn language, develop new behaviors and master new tasks. The very same neurodevelopmental sensitivity that allows amazing developmental advances in response to predictable, nurturing, repetitive and enriching experiences make the developing child vulnerable to adverse experiences. Sensitive periods are different for each brain area and neural system, and therefore, for different functions. The sequential development of the brain and the sequential unfolding of the genetic map for development mean that the sensitive periods for neural system (and the functions they mediate) will be when that system is in the developmental 'hot zone' – when that area is most actively organizing. The brainstem must organize key systems by birth; therefore, the sensitive period for those brainstem-mediated functions is during the prenatal period. The neocortex, in contrast, has systems and functions organizing throughout childhood and into adult life. The sensitive periods for these cortically mediated functions are likely to be very long. With an understanding of the shifting vulnerability of the developing brain to experience, a neuroarcheological perspective becomes apparent. If there are disrupting adverse events during development, they will be mirrored by a matched dysfunctional development in the neural systems whose functioning the adverse experience most altered during the event. If the disruption were the absence of light during the first year of life – the systems most altered would be related to vision. If the disruption activates the stress response, the disruption will be in the neural systems mediating the stress response. The severity and chronicity of the specific dysfunction will be related to the vulnerability of the system affected. Adverse experiences influence the mature brain but in the developing brain, adverse experiences literally play a role in organizing neural systems. It is much easier to influence the functioning of a developing system than to reorganize and alter the functioning of a developed system. Adverse childhood events, therefore, can alter the organization of developing neural systems in ways that create a lifetime of vulnerability. Table 3: Shifting Developmental Activity across Brain Regions neuroarcheology4.jpg (35426 bytes) The simple and unavoidable conclusion of these neurodevelopmental principles is that the organizing, sensitive brain of an infant or young children is more malleable to experience than a mature brain. While experience may alter the behavior of an adult, experience literally provides the organizing framework for an infant and child. Because the brain is most plastic (receptive to environmental input) in early childhood, the child is most vulnerable to variance of experience during this time. In the second half of this chapter two primary forms of extreme childhood adverse experience will be discussed in context of the neuroarcheological perspective of adverse childhood events. The Neurodevelopmental Impact of Neglect in Childhood Neglect is the absence of critical organizing experiences at key times during development. Despite its obvious importance in understanding child maltreatment, neglect has been understudied. Indeed, deprivation of critical experiences during development may be the most destructive yet the least understood area of child maltreatment. There are several reasons for this. The most obvious is that neglect is difficult to "see." Unlike a broken bone, maldevelopment of neural systems mediating empathy, for example, resulting from emotional neglect during infancy, is not readily observable. Another important, yet poorly appreciated, aspect of neglect is the issue of timing. The needs of the child shift during development; therefore, what may be neglectful at one age is not at another. The very same experience that is essential for life at one stage of life may be of little significance or even inappropriate at another age. We would all question the mother who held, rocked and breastfed her pubescent child. Touch, for example, is essential during infancy. The untouched newborn may literally die; in Spitz' landmark studies, the mortality rates in the institutionalized infants was near thirty percent (Spitz. 1945; Spitz. 1946). If one doesn't touch an adolescent for weeks, however, no significant adverse effects will result. Creating standardized protocols, procedures and "measures" of neglect, therefore, are significantly confounded by the shifting developmental needs and demands of childhood. Finally, neglect is understudied because it is very difficult to find large populations of humans where specific and controlled neglectful experiences have been well documented. In some cases, these cruel experiments of humanity have provided unique and promising insights (see below). In general, however, there will never be – and there never should be – the opportunity to study neglect in humans with the rigor that can be applied in animal models. With these limitations, however, what we do know about neglect during early childhood supports a neuroarcheological view of adverse childhood experience. The earlier and more pervasive the neglect is, the more devastating the developmental problems for the child. Indeed, a chaotic, inattentive and ignorant caregiver can produce pervasive developmental delay (PDD; (Anonymous. 1994)) in a young child (Rutter, Andersen-Wood, Beckett, et al. 1999). Yet the very same inattention for the same duration if the child is ten will have very different and less severe impact than inattention during the first years of life. There are two main sources of insight to childhood neglect. The first is the indirect but more rigorous animal studies and the second is a growing number of descriptive reports with severely neglected children. Environmental Manipulation and Neurodevelopment: Animal Studies Some of the most important studies in developmental neurosciences in the last century have been focusing on various aspects of experience and extreme sensory experience models. Indeed, the Nobel Prize was awarded to Hubel and Weisel for their landmark studies on development of the visual system using sensory deprivation techniques (Hubel & Wiesel. 1963). In hundreds of other studies, extremes of sensory deprivation (Hubel & Wiesel. 1970; Greenough, Volkmar, & Juraska. 1973) or sensory enrichment (Greenough & Volkmar. 1973; Diamond, Krech, & Rosenzweig. 1964; Diamond, Law, Rhodes, et al. 1966) have been studied. These include disruptions of visual stimuli (Coleman & Riesen. 1968), environmental enrichment (Altman & Das. 1964; Cummins & Livesey. 1979), touch (Ebinger. 1974; Rutledge, Wright, & Duncan. 1974), and other factors that alter the typical experiences of development (Uno, Tarara, Else, & et.al. 1989; Plotsky & Meaney. 1993; Meaney, Aitken, van Berkal, Bhatnagar, & Sapolsky. 1988). These findings generally demonstrate that the brains of animals reared in enriched environments are larger, more complex and functional more flexible than those raised under deprivation conditions. Diamond's work, for example, examining the relationships between experience and brain cytoarchitecture have demonstrated a relationship between density of dendritic branching and the complexity of an environment (for a good review of this and related data see (Diamond & Hopson. 1998)). Others have shown that rats raised in environmentally enriched environments have higher density of various neuronal and glial microstructures, including a 30% higher synaptic density in cortex compared to rats raised in an environmentally deprived setting (Bennett, Diamond, Krech, & Rosenzweig. 1964; Altman & Das. 1964). Animals raised in the wild have from 15 to 30% larger brain mass than their offspring who are domestically reared (Darwin. 1868; Rohrs. 1955; Rohrs & Ebinger. 1978; Rehkamper, Haase, & Frahm. 1988). Animal studies suggest that critical periods exist during which specific sensory experience was required for optimal organization and development of the part of the brain mediating a specific function (e.g., visual input during the development of the visual cortex). While these phenomena have been examined in great detail for the primary sensory modalities in animals, few studies have examined the issues of critical or sensitive periods in humans. What evidence there is would suggest that humans tend to have longer periods of sensitivity and that the concept of critical period may not be useful in humans. It is plausible, however, that abnormal micro-environmental cues and atypical patterns of neural activity during sensitive periods in humans could result in malorganization and compromised function in a host of brain-mediated functions. Indeed, altered emotional, behavioral, cognitive, social and physical functioning has been demonstrated in humans following specific types of neglect. The majority of this information comes from the clinical rather than the experimental disciplines. The Impact of Neglect in Early Childhood: Clinical Findings Over the last sixty years, many case reports, case series and descriptive studies have been conducted with children neglected in early childhood. The majority of these studies have focused on institutionalized children. As early as 1833, with the famous Kaspar Hauser, feral children had been described (Heidenreich. 1834). Hauser was abandoned as a young child and raised from early childhood (likely around age two) until seventeen in a dungeon, experiencing relative sensory, emotional and cognitive neglect. His emotional, behavioral and cognitive functioning was, as one might expect, very primitive and delayed. At autopsy, Hauser's brain was noted to have a small cerebrum (cortex) with few and non-distinct cortical gyri. These findings are consistent with cortical atrophy (or underdevelopment), a condition we have reported in children following severe total global neglect in childhood (Perry & Pollard. 1997). In the early forties, Spitz described the impact of neglectful caregiving on children in foundling homes (orphanages). Most significant, he was able to demonstrate that children raised in fostered placements with more attentive and nurturing caregiving had superior physical, emotional and cognitive outcomes (Spitz. 1945; Spitz. 1946). Some of the most powerful clinical examples of this phenomenon are related to profound neglect experiences early in life. In a landmark report of children raised in a Lebanese orphanage, the Creche, Dennis (1973) described a series of findings supporting a neuroarcheological model of maltreatment. These children were raised in an institutional environment devoid of individual attention, cognitive stimulation, emotional affection or other enrichment. Prior to 1956 all of these children remained at the orphanage until age six, at which time they were transferred to another institution. Evaluation of these children at age 16 demonstrated a mean IQ of approximately 50. When adoption became common, children adopted prior to age 2 had a mean IQ of 100 by adolescence while children adopted between ages 2 and 6 had IQ values of approximately 80 (Dennis. 1973). This graded recovery reflected the neuroarcheological impact of neglect. A number of similar studies of children adopted from neglectful settings demonstrate this general principle. The older a child was at time of adoption, (i.e., the longer the child spent in the neglectful environment) the more pervasive and resistant to recovery were the deficits. Money and Annecillo (1976) reported the impact of change in placement on children with psychosocial dwarfism (failure to thrive). In this preliminary study, 12 of 16 children removed from neglectful homes recorded remarkable increases in IQ and other aspects of emotional and behavioral functioning. Furthermore, they reported that the longer the child was out of the abusive home the higher the increase in IQ. In some cases IQ increased by 55 points (Money & Annecillo. 1976). A more recent report on a group of 111 Romanian orphans (Rutter & English and Romanian Adoptees study team. 1998; Rutter, Andersen-Wood, Beckett, et al. 1999) adopted prior to age two from very emotionally and physically depriving institutional settings demonstrate similar findings. Approximately one half of the children were adopted prior to age six months and the other half between six months and 2 years old. At the time of adoption, these children had significant delays. Four years after being placed in stable and enriching environments, these children were re-evaluated. While both groups improved, the group adopted at a younger age had a significantly greater improvement in all domains. These observations are consistent with the experiences of our clinic research group working with maltreated children. Over the last ten-year we have worked with more than 1000 children neglected in some fashion. We have recorded increases in IQ of over 40 points in more than 60 children following removal from neglectful environments and placed in consistent, predictable, nurturing, safe and enriching placements (Perry et al., in preparation). In addition, in a study of more than 200 children under the age of 6 removed from parental care following abuse and neglect we demonstrated significant developmental delays in more than 85% of the children. The severity of these developmental problems increased with age, suggesting, again, that the longer the child was in the adverse environment - the earlier and more pervasive the neglect - the more indelible and pervasive the deficits. The impact of deprivation can be approximated by sensory chaos. Indeed, sensory deprivation is much less clinically significant than sensory chaos. The vast majority of children suffering from neglect do so because their experiences are chaotic, dysynchronous, inconsistent and episodic rather than consistent, predictable and continuous. The organizing brain requires patterns of sensory experience to create patterns of neural activity that, in turn, play a role in guiding the various neurodevelopmental processes involved in healthy development. When experience is chaotic or sensory patterns are not consistent and predictable, the organizing systems in the brain reflect this chaos and, typically, organize in ways that result in dysregulation and dysynchronous. Imagine trying to learn a language if you only heard random words without the context, grammar and syntax of the language (i.e., the patterns of use). Even if you heard and perceived all words, you could not develop language. Random exposure to words absent an organizing pattern leads to abnormal development of speech and language. Our clinical group has evaluated many children capable of parroting advertising phrases from television but incapable of simple verbal communication. This requirement for consistent, repetitive and patterned stimuli holds for all experience – cognitive, emotional, social and physical. Repetitive, patterned, consistent experience allows the brain to create an internal representation of the external world. A child growing up in the midst of chaos and unpredictability will develop neural systems and functional capabilities that reflect this disorganization. The Impact of Neglect in Early Childhood: Neurobiological Findings All of these reported developmental problems – language, fine and large motor delays, impulsivity, disorganized attachment, dysphoria, attention and hyperactivity, and a host of others described in these neglected children – are caused by abnormalities in the brain. Despite this obvious statement, very few studies have examined directly any aspect of neurobiology in neglected children. The reasons include a lack of capacity, until the recent past, to examine the brain in any non-invasive fashion. Our group has examined various aspects of neurodevelopment in neglected children (Perry & Pollard. 1997). Neglect was considered global neglect when a history of relative sensory deprivation in more than one domain was obtained (e.g., minimal exposure to language, touch and social interactions). Chaotic neglect is far more common and was considered present if history was obtained that was consistent with physical, emotional, social or cognitive neglect. When possible history was obtained from multiple sources (e.g., investigating CPS workers, family, police). The neglected children (n= 122) were divided into four groups: Global Neglect (GN; n=40); Global Neglect with Prenatal Drug Exposure (GN+PND; n=18); Chaotic Neglect (CN; n=36); Chaotic Neglect with Prenatal Drug Exposure (CN+PND; n=28). Measures of growth were compared across group and compared to standard norms developed and used in all major pediatric settings. Dramatic differences from the norm were observed in FOC (the frontal-occipital circumference, a measure of head size and in young children a reasonable measure of brain size). In the globally neglected children the lower FOC values suggested abnormal brain growth. For these globally neglected children the group mean was below the 8th percentile. In contrast, the chaotically neglected children did not demonstrate this marked group difference in FOC. Furthermore in cases where MRI or CT scans were available, neuroradiologists interpreted 11 of 17 scans as abnormal from the children with global neglect (64.7 %) and only 3 of 26 scans abnormal from the children with chaotic neglect (11.5 %). The majority of the readings were "enlarged ventricles" or "cortical atrophy." While the actual size of the brain in chaotically neglected children did not appear to be different from norms, it is reasonable to hypothesize that organizational abnormalities exist and that with function MRI studies these abnormalities will be more readily detected. These findings strongly suggest that when early life neglect is characterized by decreased sensory input (e.g., relative poverty of words, touch and social interactions) there will be a similar effect on human brain growth as in other mammalian species. The human cortex grows in size, develops complexity, makes synaptic connections and modifies as a function of the quality and quantity of sensory experience. Lack of type and quantity of sensory-motor and cognitive experiences lead to underdevelopment of the cortex – in rats, non-human primates and humans. Studies from other groups are beginning to report similar altered neurodevelopment in neglected children. In the study of Romanian orphans described above, the 38 % had FOC values below the third percentile (greater than 2 SD from the norm) at the time of adoption. In the group adopted after six months, fewer than 3 % and the group adopted after six months 13 % had persistently low FOCs four years later (Rutter & English and Romanian Adoptees study team. 1998; O'Connor, Rutter, & English and Romanian Adoptees study team. 2000). Strathearn (Strathearn et al., submitted) has followed extremely low birth weight infants and shown that when these infants end up in neglectful homes they have a significantly smaller head circumference at 2 and 4 years, but not at birth. This is despite having no significant difference in other growth parameters. Finally in a related population, maltreated children and adolescents with post-traumatic stress disorder (PTSD), De Bellis and colleagues found that subject children have significantly smaller intracranial and cerebral volumes than matched controls on MRI scan. Brain volume in these children correlated "robustly and positively" with the age of onset of PTSD trauma, and negatively with the duration of abuse, suggesting that traumatic childhood experiences may adversely affect brain development. Specific brain areas were affected differentially, in reflection of their importance in the stress response, further support of a neuroarcheological formulation of adverse childhood experience (De Bellis, Keshavan, Clark, et al. 1999). While deprivations and lack of specific sensory experiences are common in the maltreated child, the traumatized child experiences developmental insults related to discrete patterns of over-activation of neurochemical cues. Rather than a deprivation of sensory stimuli, the traumatized child experiences over-activation of important neural systems during sensitive periods of development. The Neurodevelopmental Impact of Traumatic Stress in Childhood Each year in United States more than five million children are exposed to some form of extreme traumatic stressor. These traumatic events include natural disasters (e.g., tornadoes, floods, hurricanes), motor vehicle accidents, life threatening illness and associated painful medical procedures (e.g., severe burns, cancer), physical abuse, sexual assault, witnessing domestic or community violence, kidnapping and sudden death of a parent, among others (Pfefferbaum. 1997; Anonymous. 1998). These events, posing an actual or perceived threat to the individual, activate a stress response. During the traumatic event, the child's brain mediates the adaptive response. Brainstem and diencehpalic stress-mediating neural systems are activated. These systems include the hypothalamic-pituitary-adrenal (HPA) axis, central nervous system (CNS) noradrenergic (NA), dopaminergic (DA) systems and associated CNS and peripheral systems that provide the adaptive emotional, behavioral, cognitive and physiological changes necessary for survival (Perry. 1994; Perry & Pollard. 1998). Individual neurobiological responses during traumatic stress are heterogeneous (Perry, Pollard, Blakley, Baker, & Vigilante. 1995). The specific nature of a child's responses to a given traumatic event may vary with the nature, duration and the pattern of traumatic stressor and the child's constitutional characteristics (e.g., genetic predisposition, age, gender, history of previous stress exposure, presence of attenuating factors such as supportive caregivers). Whatever the individual response, however, the extreme nature of the external threat is matched by an extreme and persisting internal activation of the neurophysiological systems mediating the stress response and their associated functions (Perry, Pollard, Blakley, Baker, & Vigilante. 1995; Perry & Pollard. 1998). As described above, neural systems respond to prolonged, repetitive activation by altering their neurochemical and sometimes, microarchitectural (e.g., synaptic sculpting) organization and functioning. This is no different for the neural systems mediating the stress response. Following any traumatic event children will likely experience some persisting emotional, behavioral, cognitive and physiological signs and symptoms related to the, sometimes temporary, shifts in the activity of these neural systems originating in the brainstem and diencephalon. In general, the longer the activation of the stress-response systems (i.e., the more intense and prolonged the traumatic event), the more likely there will be a 'use-dependent' change in these neural systems (for review see (Perry & Pollard. 1998)). In some cases, then, the stress-response systems do not return to the pre-event homeostasis. In these cases, the signs and symptoms become so severe, persisting and disruptive that they reach the level of a clinical disorder (Perry. 1998). In a new context and in the absence of any true external threat, the abnormal persistence of a once adaptive response becomes maladaptive. Post traumatic stress-related clinical syndromes Post traumatic stress disorder (PTSD) is a clinical syndrome that may develop following extreme traumatic stress (DSM IV) (Anonymous. 1994). Like all other DSM IV diagnoses, it is likely that heterogeneous pathophysiologies underlie the cluster of diagnostic signs and symptoms labeled PTSD. There are six diagnostic criteria for PTSD: 1) extreme traumatic stress accompanied by intense fear, horror or disorganized behavior; 2) persistent re-experiencing of the traumatic event such as repetitive play or recurring intrusive thoughts; 3) avoidance of cues associated with the trauma or emotional numbing; 4) persistent physiological hyper-reactivity or arousal; 5) signs and symptoms present for more than one month following the traumatic event and 6) clinically significant disturbance in functioning. Posttraumatic stress disorder has been studied primarily in adult populations, most commonly combat veterans and victims of sexual assault. Despite high numbers of traumatized children, the clinical phenomenology, treatment and neurophysiological correlates of childhood PTSD remain under studied. The clinical phenomenology of trauma-related neuropsychiatric sequelae is poorly characterized (Terr. 1991; Mulder, Fergusson, Beautrais, & Joyce. 1998). Most of the studies of PTSD have been following single discreet trauma (e.g., a shooting). The least characterized populations are very young children and children with multiple or chronic traumatic events. Clinical presentations If during development, this stress response apparatus are required to be persistently active, the stress response apparatus in the central nervous system will develop in response to constant threat. These stress-response neural systems (and all functions they mediate – including sympathetic-parasympathetic tone, level of vigilance, regulation of mood, attention and sleep) will be poorly regulated, often overactive and hypersensitive. It is highly adaptive for a child growing up in a violent, chaotic environment to be hypersensitive to external stimuli, to be hypervigilant, and to be in a persistent stress-response state. It is important to realize that children exposed to traumatic stress during development literally organize their neural systems to adapt to this kind of environment. In contrast, an adult with no previous traumatic stress can develop PTSD. The cardiovascular reactivity and physiological hypersensitivity that the adult develops, however, is cue specific. This means that they will demonstrate increased heart rate, startle response and other neurophysiological symptoms when exposed to a cue from the original trauma (e.g., the Vietnam vet hearing a helicopter). In contrast, young children will develop a generalized physiological hyper-reactivity and hypersensitivity to all cues that activate the stress response apparatus. This generalized change results when the traumatic stress literally provides the organizing cues for their developing stress response neurobiology (Perry. 1999). Clinically, this is very easily seen in children who are exposed to chronic neurodevelopmental trauma. These children are frequently diagnosed as having attention deficit disorder (ADD-H) with hyperactivity (Haddad & Garralda. 1992). This is somewhat misleading, however. These children are hypervigilant; they do not have a core abnormality of their capacity to attend to a given task. These children have behavioral impulsivity, and cognitive distortions all of which result from a use-dependent organization of the brain (Perry, Pollard, Blakley, Baker, & Vigilante. 1995). During development, these children spent so much time in a low-level state of fear (mediated by brainstem and diencehpalic areas) that they consistently were focusing on non-verbal but not verbal cues. In our clinical population, children raised in chronically traumatic environments demonstrate a prominent V-P split on IQ testing (n = 108; WISC Verbal = 8. 2; WISC Performance = 10.4, Perry et al., in preparation). Often these children are labeled as learning disabled. We have seen these V-P splits in children in the juvenile justice system, child protective system and in the specialized clinical populations referred to our ChildTrauma clinic. These children are also characterized by persisting physiological hyperarousal and hyperactivity (Perry, Pollard, Baker, Sturges, Vigilante, & Blakley. 1995; Perry. 1994; Perry. 2000). These children are observed to have increased muscle tone, frequently a low grade increase in temperature, an increased startle response, profound sleep disturbances, affect regulation problems and anxiety (Kaufman. 1991; Ornitz & Pynoos. 1989; Perry. 2000). In addition, our studies indicate that a significant portion of these children have abnormalities in cardiovascular regulation (Perry, Pollard, Baker, Sturges, Vigilante, & Blakley. 1995; Perry. 2000). All of these symptoms are the result of a use-dependent organization of the brain stem nuclei involved in the stress response apparatus. Children with PTSD may present with a combination of problems including impulsivity, distractibility and attention problems (due to hypervigilance), dysphoria, emotional numbing, social avoidance, dissociation, sleep problems, aggressive (often re-enactment) play, school failure and regressed or delayed development. In most studies examining the development of PTSD following a given traumatic experience, twice as many children suffer from significant post-traumatic signs or symptoms (PTSS) but lack all of the criteria necessary for the diagnosis of PTSD (Friedrich. 1998). In these cases, the clinician may identify the trauma-related symptom as being part of another neuropsychiatric syndrome. The clinician is often unaware of ongoing traumatic stressors (e.g., domestic or community violence) or the family makes no association between the present symptoms and past events (e.g., car accident, death of a relative, exposure to violence) and may provide no relevant history to aid the clinician in the differential. As a result, PTSD is frequently misdiagnosed and PTSS are under recognized. Children with PTSD as a primary diagnosis are often labeled with Attention Deficit Disorder with Hyperactivity (ADHD), major depression, oppositional-defiant disorder, conduct disorder, separation anxiety or specific phobia. Ackerman and colleagues examined the prevalence of PTSD and other neuropsychiatric disorders in 204 abused children (ages 7 to 13) (Ackerman, Newton, McPHerson, Jones, & Dykman. 1998). Thirty four percent of these children met criteria for PTSD. Over fifty percent of the children in this study suffering both physical and sexual abuse had PTSD. Using structured diagnostic interview, the majority of these children met diagnostic criteria for three or more Axis I diagnoses in addition to PTSD. Indeed, only 6 of 204 children met criteria for only PTSD. The broad co-morbidity reported in this study echoes previous studies. Incidence and prevalence Children exposed to various traumatic events have much higher incidence (from 15 to 90+ %) and prevalence rates than the general population (Pfefferbaum. 1997). Furthermore, the younger a child is the more vulnerable they appear to be for the development of trauma-related symptoms. The percentage of children developing PTSD following a traumatic event is significantly higher than the percentage of adults developing PTSD following a similar traumatic stress. Several studies published in 1998 confirm previous reports of high prevalence rates for PTSD in child and adolescent populations. Thirty five percent of a sample of adolescents diagnosed with cancer met criteria for lifetime PTSD (Pelcovitz, Kaplan, Goldenberg, Mandel, Lehane, & Guarrera. 1994); 15 % of children surviving cancer had moderate to severe PTSS (Stuber, Kazak, Meeske, et al. 1997); 93 % of a sample of children witnessing domestic violence had PTSD (Kilpatrick & Williams. 1998); over 80 % of the Kuwaiti children exposed to the violence of the Gulf Crisis had PTSS (Hadi & Llabre. 1998); 73 % of juvenile male rape victims develop PTSD (Ruchkin, Eisemann, & Hagglof. 1998); 34 % of a sample of children experiencing sexual or physical abuse and 58 % of children experiencing both physical and sexual abuse all met criteria for PTSD (Ackerman, Newton, McPHerson, Jones, & Dykman. 1998). In all of these studies, clinically significant symptoms, though not full PTSD, were observed in essentially all of the children or adolescents following the traumatic experiences. Vulnerability and resilience Not all children exposed to traumatic events develop PTSD. A major research focus has been identifying factors (mediating factors) that are associated with increased (vulnerability) or decreased (resilience) risk for developing PTSD following exposure to traumatic stress (Kilpatrick & Williams. 1998). Factors previously demonstrated to be related to risk can be summarized in these broad categories: 1) characteristics of the child (e.g., subjective perception of threat to life or limb, history of previous traumatic exposures, coping style, general level of anxiety, gender, age); 2) characteristics of the event (e.g., nature of the event, direct physical harm, proximity to threat, pattern and duration); 3) characteristics of family/social system (e.g., supportive, calm, nurturing vs. chaotic, distant, absent, anxious) (Briggs & Joyce. 1997; Stuber, Kazak, Meeske, et al. 1997; Winje & Ulvik. 1998). Each of these mediating factors can be related to the degree to which they either prolong or attenuate the child's stress-response activation resulting from the traumatic experience. Factors that increase stress-related reactivity (e.g., family chaos) will make children more vulnerable while factors that provide structure, predictability, nurturing and sense of safety will decrease vulnerability. Persistently activated stress-response neurophysiology in the dependent, fearful child will predispose to a 'use-dependent' changes in the neural systems mediated the stress response, thereby resulting in post-traumatic stress symptoms (see Table 4). Table 4. Post-traumatic Stress Disorder: Risk and Attenuating Factors neuroarcheology5.jpg (94803 bytes) Long-term costs of childhood trauma PTSD is a chronic disorder. Untreated, PTSS and PTSD remit at a very low rate. Indeed the residual emotional, behavioral, cognitive and social sequelae of childhood trauma persist and appear to contribute to a host of neuropsychiatric problems throughout life (Fergusson & Horwood. 1998) including attachment problems (Bell & Belicki. 1998; Alexander, Anderson, Brand, Schaeffer, Grelling, & Kretz. 1998), eating disorders (Rorty & Yager. 1996), depression (Winje & Ulvik. 1998; Fergusson & Horwood. 1998), suicidal behavior (Molnar, Shade, Kral, Booth, & Watters. 1998), anxiety (Fergusson & Horwood. 1998), alcoholism (Fergusson & Horwood. 1998; Epstein, Saunders, Kilpatrick, & Resnick. 1998), violent behavior (O'Keefe. 1995), mood disorders (Kaufman. 1991) and, of course, PTSD (Ford & Kidd. 1998; Schaaf & McCanne. 1998). Childhood trauma impacts other aspects of physical health throughout life, as well (Hertzman & Wiens. 1996; Orr, Lasko, Metzger, Berry, Ahern, & Pitman. 1998; Felliti, Anda, Nordenberg, et al. 1998). Adults victimized by sexual abuse in childhood are more likely to have difficulty in childbirth, a variety of gastrointestinal and gynecological disorders and other somatic problems such as chronic pain, headaches and fatigue (Rhodes & Hutchinson. 1994). The Adverse Childhood Experiences study (Felliti, Anda, Nordenberg, et al. 1998) examined exposure to seven categories of adverse events during childhood (e.g., sexual abuse, physical abuse, witnessing domestic violence: events associated with increase risk for PTSD). This study found a graded relationship between the number of adverse events in childhood and the adult health and disease outcomes examined (e.g., heart disease, cancer, chronic lung disease, and various risk behaviors). With four or more adverse childhood events, the risk for various medical conditions increased 4- to 12-fold. Clearly studies of this sort will help clarify the true costs of childhood maltreatment. Summary and Future Directions The remarkable property of the human brain, unlike any other animal species, is that it has the capacity to take the accumulated experience of thousands of previous generations and absorb it within one lifetime. This capability is endowed by the design of our neural systems. Neurons and neural systems are designed to change in response to microenvironmental events. In turn, our experiences influence the pattern and nature of these microenvironmental signals, allowing neural systems to create a biological record of our lives. The brain, then, becomes an historical organ. In its organization and functioning are memorialized our accumulated, synthesized and transformed experiences. And there is no greater period of sensitivity to experience than when the brain is developing. Indeed, as described above, the neuroarcheological record of maltreatment has pervasive and chronic impact on the child. An event that lasts a few months in infancy can rob a child's potential for a lifetime. The true costs of childhood maltreatment will never be appreciated, and can never be avoided, until clinicians, researchers and policy makers become aware of the core concepts of neurodevelopment and the neuorarcheology of child maltreatment. Acknowledgements This work was supported, in part, by the Brown Family Foundation, the Hogg Foundation for Mental Health, Children's Justice Act/Court Improvement Act, Texas Department of Protective and Regulatory Services, Maconda O'Connor and the Pritzker Cousins Foundation. References Ackerman, P.T., Newton, J.E., McPHerson, W.B., Jones, J.G., & Dykman, R.A. (1998). Prevalence of post traumatic stress disorder and other psychiatric diagnoses in three groups of abused children (sexual, physical, and both). Child Abuse & Neglect, 22, 759-774. Alexander, P.C., Anderson, C.L., Brand, B., Schaeffer, C.M., Grelling, B.Z., & Kretz, L. (1998). Adult attachment and longterm effects in survivors of incest. Child Abuse & Neglect, 22, 45-61. Altman, J., & Das, G.D. (1964). Autoradiographic examination of the effects of enriched environment on the rate of glial multipication in the adult rat brain. Nature, 204, 1161-1165. Bell, D., & Belicki, K. (1998). A community-based study of well-being in adults reporting childhood abuse. Child Abuse & Neglect, 22, 681-685. Bennett, E.L., Diamond, M.L., Krech, D., & Rosenzweig, M.R. (1964). Chemical and anatomical plasticity of the brain. Science, 146, 610-619. Briggs, L., & Joyce, P.R. (1997). What determines post-traumatic stress disorder symptomatology for survivors of childhood sexual abuse? Child Abuse & Neglect, 21, 575-582. Coleman, P.D., & Riesen, A.H. (1968). Environmental effects on cortical dendritc fields: I. rearing in the dark. Journal of Anatomy (London), 102, 363-374. Cummins, R.A., & Livesey, P. (1979). Enrichment-isolation, cortex length, and the rank order effect. Brain Research, 178, 88-98. Darwin, C. (1868). The variations of animals and plants under domestication. London:J. Murray De Bellis, M.D., Keshavan, M.S., Clark, D.B., Casey, B.J., Giedd, J.N., Boring, A.M., Frustaci, K., & Ryan, N.D. (1999). Developmental traumatology part II: brain development. Biol Psychiat, 45, 1271-1284. Dennis, W. (1973). Children of the Creche. New York: Appleton-Century-Crofts. Diamond, M.C., & Hopson, J. (1998). Magic Trees of the Mind: How to nurture your child's intelligence, creativity, and healthy emotions from birth through adolescence. New York: Dutton. Diamond, M.C., Krech, D., & Rosenzweig, M.R. (1964). The effects of an enriched environment on the histology of the rat cerebral cortex. Comparative Neurology, 123, 111-119. Diamond, M.C., Law, F., Rhodes, H., Lindner, B., Rosenzweig, M.R., Krech, D., & Bennett, E.L. (1966). Increases in cortical depth and glia numbers in rats subjected to enriched environments. Comparative Neurology, 128, 117-126. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSM IV). (1994). Washington, DC: American Psychiatric Association. Ebinger, P. (1974). A cytoachitectonic volumetric comparison of brains in wild and domestic sheep. Z.Anat.Entwicklungsgesch, 144, 267-302. Epstein, J.N., Saunders, B.E., Kilpatrick, D.G., & Resnick, H.S. (1998). PTSD as a mediator between childhood rape and alcohol use in adult women. Child Abuse & Neglect, 22, 223-234. Felliti, V.J., Anda, R.F., Nordenberg, D., Wiallamson, D.F., Spitz, A.M., Edwards, V., Koss, M.P., & Marks, J.S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14, 245-258. Fergusson, D.M., & Horwood, L.J. (1998). Exposure to interparental violence in childhood and psychological adjustment in young adulthood. Child Abuse & Neglect, 22, 339-357. Ford, J.D., & Kidd, P. (1998). Early childhood trauma and disorders of extreme stress and predictors of treatment outcome with chronic posttramatic stress disorder. Journal of Traumatic Stress, 11, 743-761. Friedrich, W.N. (1998). Behavioral manifestations of child sexual abuse. Child Abuse & Neglect, 22, 523-531. Gould, E., Reeves, A.J., Graziano, M.S.A., & Gross, C.G. (1999). Neurogenesis in the neocortex of adult primates. Science, 286, 548-552. Greenough, W.T., & Volkmar, F.R. (1973). Pattern of dendritic branching in occipital cortex of rats reared in complex environments. Experimential Neurology, 40, 491-504. Greenough, W.T., Volkmar, F.R., & Juraska, J.M. (1973). Effects of rearing complexity on dendritic branching in frontolateral and temporal cortex of the rat. Experimental Neurology, 41, 371-378. Haddad, P., & Garralda, M. (1992). Hyperkinetic syndrome and disruptive early experiences . British Journal of Psychiatry, 161, 700-703. Hadi, F.A., & Llabre, M.M. (1998). The Gulf crisis experience of Kuwaiti children: Psychological and cognitive factors. Journal of Traumatic Stress, 11, 45-56. Heidenreich, F.W. (1834). Kaspar Hausers verwundung, krankeit und liechenoffnung. Journal der Chirurgie und Augen-Heilkunde, 21 (1834), 91-123. Hertzman, C., & Wiens, M. (1996). Child development and long-term outcomes: a population health perspective and summary of successful interventions. Soc.Sci.Med., 43, 1083-1095. Hubel, D.H., & Wiesel, T.N. (1963). Receptive fields of cells in striate cortex of very young, visually inexperienced kittens. Journal of Neurophysiology, 26, 994-1002. Hubel, D.H., & Wiesel, T.N. (1970). The period of susceptibility to the physiological effects of unilateral eye closure in kittens. Journal of Physiology, 206, 419-436. Huttenlocher, P.R. (1979). Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Research, 163, 195-205. Huttenlocher, P.R. (1994). Synaptogenesis in human cerebral cortex. In G. Dawson & K.W. Fischer (Eds.), Human Behavior and the Developing Brain. (pp. 35-54). New York: Guilford. Kaufman, J. (1991). Depressive disorders in maltreated children. Journal of the American Academy of Child and Adolescent Psychiatry, 30 (2), 257-265. Kilpatrick, K.L., & Williams, L.M. (1998). Potential mediators of post-traumatic stress disorder in child witnesses to domestic violence. Child Abuse & Neglect, 22, 319-330. Kuan, C.-Y., Roth, K.A., Flavell, R.A., & Rakic, P. (2000). Mechanisms of programmed cell death in the developing brain . Trends in Neuroscience, 23, 291-297. Lauder, J.M. (1988). Neurotransmitters as morphogens. Progress in Brain Research, 73, 365-388. Meaney, M.J., Aitken, D.H., van Berkal, C., Bhatnagar, S., & Sapolsky, R.M. (1988). Effect of neonatal handling on age-related impairments associated with the hippocampus. Science, 239 :766-768. Molnar, B.E., Shade, S.B., Kral, A.H., Booth, R.E., & Watters, J.K. (1998). Suicidal behavior and sexual/physical abuse among street youth. Child Abuse & Neglect, 22, 213-222. Money, J., & Annecillo, C. (1976). IQ changes following change of domicile in the syndrome of reversible hyposomatotropinism (psychosocial dwarfism): pilot investigation . Psychoneuroendocrinology, 1, 427-429. Mulder, R.T., Fergusson, D.M., Beautrais, A.L., & Joyce, P.R. (1998). Relationship between dissociation, childhood sexual abuse, childhood physical abuse, and mental illness in a general population sample. American Journal of Psychiatry, 155, 806-811. O'Connor, C., Rutter, M., & English and Romanian Adoptees study team. (2000). Attachment disorder behavior following early severe deprivation: extension and longitudinal follow-up. J.Am.Acad.Child Adolesc.Psychiatry, 39, 703-712. O'Keefe, M. (1995). Predictors of child abuse in maritally violent families. Journal of Interpersonal Violence, 10, 3-25. Ornitz, E.M., & Pynoos, R.S. (1989). Startle modulation in children with post-traumatic stress disorder. American Journal of Psychiatry, 147, 866-870. Orr, S.P., Lasko, N.B., Metzger, L.J., Berry, N.J., Ahern, C.E., & Pitman, R.K. (1998). Psychophysiologic assessment of women with posttraumatic stress disorder resulting from childhood sexual abuse. Journal of Consulting and Clinical Psychology, 66, 906-913. Pelcovitz, D., Kaplan, S., Goldenberg, B.A., Mandel, F., Lehane, J., & Guarrera, J. (1994). Post-traumatic stress disorder in physically abused adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33: (305). 312 Perry, B.D. (1988). Placental and blood element neurotransmitter receptor regulation in humans: potential models for studying neurochemical mechanisms underlying behavioral teratology. Progress in Brain Research, 73, 189-206. Perry, B.D. (1994). Neurobiological sequelae of childhood trauma: post-traumatic stress disorders in children. In M. Murberg (Ed.), Catecholamines in Post-traumatic Stress Disorder: Emerging Concepts. (pp. 253-276). Washington, D.C.: American Psychiatric Press. Perry, B.D. (1998). Anxiety Disorders. In C.E. Coffey & R.A. Brumback (Eds.), Textbook of Pediatric Neuropsychiatry. (pp. 579-594). Washington, D.C: American Psychiatric Press, Inc. Perry, B.D. (1999). The memories of states: how the brain stores and retrieves traumatic experience. In J.M. Goodwin & R. Attias (Eds.), Splintered Reflections: Images of the Body In Trauma. (pp. 9-38). New York: Basic Books. Perry, B.D. (2000). The neurodevelopmental impact of violence in childhood. In D. Schetky & E. Benedek (Eds.), Textbook of Child and Adolescent Forensic Psychiatry. Washington, D.C.: American Psychiatric Press, Inc. Perry, B.D., & Pollard, R. (1997). Altered brain development following global neglect in early childhood. Proceedings from the Society for Neuroscience Annual Meeting (New Orleans), (abstract) Perry, B.D., & Pollard, R. (1998). Homeostasis, stress, trauma, and adaptation: A neurodevelopmental view of childhood trauma. Child and Adolescent Psychiatric Clinics of North America, 7, 33-51. Perry, B.D., Pollard, R.A., Baker, W.L., Sturges, C., Vigilante, D., & Blakley, T.L. (1995). Continuous heartrate monitoring in maltreated children. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Research, (abstract) Perry, B.D., Pollard, R.A., Blakley, T.L., Baker, W.L., & Vigilante, D. (1995). Childhood trauma, the neurobiology of adaptation and use-dependent development of the brain: How states become traits. Infant Mental Health Journal, 16, 271-291. Pfefferbaum, B. (1997). Posttraumatic stress disorder in children: A review of the past 10 years. J.Am.Acad.Child Adolesc.Psychiatry, 36, 1503-1511. Pfefferbaum, B. (Ed.) (1998). Stress in Children. Philadelphia: W.B. Saunders Company. Plotsky, P.M., & Meaney, M.J. (1993). Early, postnatal experience alters hypothalamic corticotropin releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Molec Brain Res, 18, 195-200. Rakic, P. (1981). Development of visual centers in the primate brain depends upon binocular competition before birth. Science, 214, 928-931. Rakic, P. (1996). Development of cerebral cortex in human and non-human primates. In M. Lewis (Ed.), Child and Adolescent Psychiatry: A Comprehensive Textbook. (pp. 9-30). New York: Williams and Wilkins. Rehkamper, G., Haase, E., & Frahm, H.D. (1988). Allometric comparison of brain weight and brain structure volumes in different breeds of the domestic pigeon, columbia livia f. d. Brain Behav.Evol., 31, 141-149. Rhodes, N., & Hutchinson, S. (1994). Labor experiences of childhood sexual abuse survivors. Birth, 21, 213-220. Rohrs, M. (1955). Vergleichende untersuchungen an wild- und hauskatzen. Zool.Anz., 155, 53-69. Rohrs, M., & Ebinger, P. (1978). Die beurteilung von hirngrobenunterschieden zwischen wild- und haustieren. Z.zool.Syst.Evolut.-forsch, 16, 1-14. Rorty, M., & Yager, J. (1996). Histories of childhood trauma and complex post-traumatic sequelae in women with eating disorders. The Psychiatric Clinics of North America, 19, Ruchkin, V.V., Eisemann, M., & Hagglof, B. (1998). Juvenile male rape victims: Is the level of post-traumatic stress related to personality and parenting. Child Abuse & Neglect, 22, 889-899. Rutledge, L.T., Wright, C., & Duncan, J. (1974). Morphological changes in pyramidal cells of mammalian neocortex associated with increased use. Experimental Neurology, 44, 209-228. Rutter, M., Andersen-Wood, L., Beckett, C., Bredenkamp, D., Castle, J., Grootheus, C., Keppner, J., Keaveny, L., Lord, C., O'Connor, T.G., & English and Romanian Adoptees study team. (1999). Quasi-autistic patterns following severe early global privation. J.Child Psychol.Psychiat., 40, 537-49. Rutter, M., & English and Romanian Adoptees study team. (1998). Developmental catch-up, and deficit, following adoption after severe global early privation. J.Child Psychol.Psychiat., 39, 465-476. Schaaf, K.K., & McCanne, T.R. (1998). Relationship of childhood sexual, physical and combined sexual and physical abuse to adult victimization and posttraumatic stress disorder. Child Abuse & Neglect, 22, 1119-1133. Spitz, R.A. (1945). Hospitalism: An inquiry into the genesis of psychiatric conditions in early childhood. Psychoanalytic Study of the Child, 1:53-74. Spitz, R.A. (1946). Hospitalism: A follow-up report on investigation described in Volume I, 1945. Psychoanalytic Study of the Child, 2:113-117. Strathearn,L.; Gray,P.H.; O'Callaghan,M.J.; Wood,D.W. (submitted) Cognitive neurodevelopment in extremely low birth weight infants: nature vs. nurture revisited Stuber, M.L., Kazak, A.E., Meeske, K., Barakat, L., Guthrie, D., Garnier, H., Pynoos, R., & Meadows, A. (1997). Predictors of posttraumatic stress symptoms in childhood cancer survivors . Pediatrics, 100, 958-964. Terr, L. (1991). Childhood traumas: an outline and overview. American Journal of Psychiatry, 148, 1-20. Uno, H., Tarara, R., Else, J., & et.al. (1989). Hippocampal damage associated with prolonged and fatal stress in primates . Journal of Neuroscience, 9, 1705-1711. Winje, D., & Ulvik, A. (1998). Long-term outcome of trauma in children: The psychological consequences of a bus accident. J.Child Psychol.Psychiat., 39, 635-642

Labels: , , , , , ,

----- -------- /* ----------------------------------------------- Blogger Template Style Name: Son of Moto (Mean Green Blogging Machine variation) Designer: Jeffrey Zeldman URL: www.zeldman.com Date: 23 Feb 2004 ----------------------------------------------- */ /* Primary layout */ body { margin: 0; padding: 0; border: 0; text-align: center; color: #554; background: #692 url(http://www.blogblog.com/moto_son/outerwrap.gif) top center repeat-y; font: small tahoma, "Bitstream Vera Sans", "Trebuchet MS", "Lucida Grande", lucida, helvetica, sans-serif; } img { border: 0; display: block; } /* Wrapper */ @media all { #wrapper { margin: 0 auto; padding: 0; border: 0; width: 692px; text-align: left; background: #fff url(http://www.blogblog.com/moto_son/innerwrap.gif) top right repeat-y; font-size:90%; } } @media handheld { #wrapper { width: 90%; } } /* Header */ #blog-header { color: #ffe; background: #8b2 url(http://www.blogblog.com/moto_son/headbotborder.gif) bottom left repeat-x; margin: 0 auto; padding: 0 0 15px 0; border: 0; } #blog-header h1 { font-size: 24px; text-align: left; padding: 15px 20px 0 20px; margin: 0; background-image: url(http://www.blogblog.com/moto_son/topper.gif); background-repeat: repeat-x; background-position: top left; } #blog-header p { font-size: 110%; text-align: left; padding: 3px 20px 10px 20px; margin: 0; line-height:140%; } /* Inner layout */ #content { padding: 0 20px; } @media all { #main { width: 400px; float: left; } #sidebar { width: 226px; float: right; } } @media handheld { #main { width: 100%; float: none; } #sidebar { width: 100%; float: none; } } /* Bottom layout */ #footer { clear: left; margin: 0; padding: 0 20px; border: 0; text-align: left; border-top: 1px solid #f9f9f9; background-color: #fdfdfd; } #footer p { text-align: left; margin: 0; padding: 10px 0; font-size: x-small; background-color: transparent; color: #999; } /* Default links */ a:link, a:visited { font-weight : bold; text-decoration : none; color: #692; background: transparent; } a:hover { font-weight : bold; text-decoration : underline; color: #8b2; background: transparent; } a:active { font-weight : bold; text-decoration : none; color: #692; background: transparent; } /* Typography */ #main p, #sidebar p { line-height: 140%; margin-top: 5px; margin-bottom: 1em; } .post-body { line-height: 140%; } h2, h3, h4, h5 { margin: 25px 0 0 0; padding: 0; } h2 { font-size: large; } h3.post-title { margin-top: 5px; font-size: medium; } ul { margin: 0 0 25px 0; } li { line-height: 160%; } #sidebar ul { padding-left: 10px; padding-top: 3px; } #sidebar ul li { list-style: disc url(http://www.blogblog.com/moto_son/diamond.gif) inside; vertical-align: top; padding: 0; margin: 0; } dl.profile-datablock { margin: 3px 0 5px 0; } dl.profile-datablock dd { line-height: 140%; } .profile-img {display:inline;} .profile-img img { float:left; margin:0 10px 5px 0; border:4px solid #8b2; } #comments { border: 0; border-top: 1px dashed #eed; margin: 10px 0 0 0; padding: 0; } #comments h3 { margin-top: 10px; margin-bottom: -10px; font-weight: normal; font-style: italic; text-transform: uppercase; letter-spacing: 1px; } #comments dl dt { font-weight: bold; font-style: italic; margin-top: 35px; padding: 1px 0 0 18px; background: transparent url(http://www.blogblog.com/moto_son/commentbug.gif) top left no-repeat; color: #998; } #comments dl dd { padding: 0; margin: 0; } .deleted-comment { font-style:italic; color:gray; } /* Feeds ----------------------------------------------- */ #blogfeeds { } #postfeeds { }

Adopt Biomed

This blog gathers information about biomedical interventions for children with adoption trauma and Reactive Attachment Disorder. Posts are gathered from multiple websites in one place. Most posts contain unedited text relating to biomedical treatment, dietary changes, vitamins, homeopathy, herbs, etc. Where possible, the link to the original information is included.

Friday, June 29, 2007

ZINC DEFICIENCY, METAL METABOLISM, AND BEHAVIOR DISORDERS

ZINC DEFICIENCY, METAL METABOLISM, AND BEHAVIOR DISORDERS by William J. Walsh INTRODUCTION Most Americans receive all the zinc they need if they have a reasonably well-balanced diet involving the major food groups. However, many persons are born with a metal-metabolism disorder which results in zinc depletion regardless of diet. Zinc is a component of more than 80 enzymes. High concentrations have been found in brain hippocampus, and many medical researchers believe that zinc is a neurotransmitter. Low zinc levels at these sites could reduce the inhibition of neuron activity, thus leading to abnormal behavior. The discovery of zinc "finger proteins" in the past decade has led to a vastly improved understanding of how cells replicate and divide. There role in behavior is not yet clear, but could be involved in the transport or availability of zinc. Recent research has shown zinc to be far more important than previously believed and low levels of zinc are associated with behavior disorders. Many of the patients of the Carl Pfeiffer Treatment Center suffer from behavior disorders. The most common ones are attention deficit hyperactive disorder (ADHD), oppositional defiant disorder (ODD), obsessive compulsive disorder (OCD), and conduct disorder (CD). These patients typically have a history of extensive counseling and multiple medications and many have experienced residential care. They represent a narrow and rather uncharacteristic segment of the general population. A high percentage of behavior disordered persons exhibit abnormal levels of copper, zinc, lead, cadmium, calcium, magnesium and manganese in blood, urine, and tissues, based on chemical analysis results from thousands of patients. With regard to zinc, this condition appears to involve a malfunction of the metal-binding protein metallothionein. Most of these patients have symptoms of zinc deficiency along with depressed levels of zinc in their blood plasma. The high incidence of zinc deficiency in assaultive young males was illustrated in a recent study1 which found elevated serum copper and depressed plasma zinc concentration, compared to normal controls. This study confirmed our clinical observations of zinc depletion in more than 4,000 behavior disordered patients. Our clinical observations and research have indicated that the copper/zinc ratio appears to be more decisively important than either of the individual metals alone. Zinc deficiency often results in elevated blood levels of copper, due to the dynamic competition of these metals in the body. Elevated blood copper has been associated with episodic violence, hyperactivity, learning disabilities, and depression. DIAGNOSIS OF ZINC DEFICIENCY Zinc deficiency is difficult to diagnose since no single laboratory test or combination of tests is decisive in every case. For example, blood levels are sometimes normal in zinc deficient persons due to homeostasis. Urine and hair tissue levels are often elevated in zinc deficiency because of "short circuiting" of zinc through the body and high rates of excretion. The two principal factors which lead our Center's physicians to a diagnosis of zinc deficiency are: 1) depressed plasma zinc, and 2) presence of clinical symptoms of zinc depletion which are alleviated by zinc supplementation2, 3, 4, 5, 6, and 7. Since zinc tolerance tests show plasma levels to be affected for 6 hours following zinc supplementation8 and 9, zinc supplements are avoided for 24 hours prior to sampling of plasma. The clinical symptoms associated with zinc deficiency or depletion include the following: * Eczema, acne, and/or psoriasis10, 11, 12, 13, and 14, * Poor wound healing, including leg ulcers and oral lesions15 and 16, * Lines of Beau on the fingernails17, * Growth retardation18, 19, 20, and 21, * Delayed sexual maturation22, * Hypogeusia or poor taste acuity23 and 24, and * Chronic immunodeficiency and frequent infections25 and 26. A "working diagnosis" of zinc deficiency can be made if clinical symptoms of zinc deficiency are clearly evident from the initial physical examination and medical history. Usually more than one or the above symptoms are present in zinc deficiency. This initial diagnosis is later supported or negated by laboratory analysis for plasma zinc along with observed response (or non-response) to zinc supplementation. The Carl Pfeiffer Treatment Center generally retests plasma zinc and evaluates symptoms after 4-6 months of treatment to determine if dosages need adjustment. TREATMENT OF ZINC DEPLETION Zinc depletion is corrected by supplementation with zinc (picolinate or gluconate) along with augmenting nutrients including L-cysteine, pyridoxine, ascorbic acid, and vitamin E. Manganese is also useful in promoting proper metallothionein function. If copper levels are elevated, effective treatment must also enhance the release of copper from tissues and copper excretion. L-cysteine helps mobilize and excrete copper while enhancing zinc absorption. Correction of zinc deficiency is best accomplished under the care of a physician or nutritionist who is experienced in metal metabolism disorders. Indiscriminant dosages of zinc to persons who do not need it can cause anemia and imbalanced trace metals. Treatment of mild or moderate zinc depletion can take months to complete. Some cases of severe zinc depletion require a year or more to resolve. Achievement of a proper zinc balance is slowed by growth spurts, injury, illness, or severe stress. In addition, persons with malabsorption or Type A blood respond to treatment more slowly. DISCUSSION We find that zinc deficient individuals usually respond well to inexpensive supplementation with zinc and augmenting nutrients. Many patients who previously experienced years of counseling, psychotherapy, aggressive medication programs, and/or residential treatment become greatly improved and respond to less intensive (and less expensive) therapies. Zinc deficiency can be corrected, but not cured. If treatment is discontinued, the prior zinc deficiency will reemerge with all symptoms gradually returning. Zinc deficiency, like diabetes, requires life long treatment. Fortunately, it is a simple, low cost, safe treatment. The Center involves the collaboration of biochemists and medical doctors. We believe that this coupling of disciplines provides an ideal capability for biochemical evaluation and medical treatment. REFERENCES 1. Walsh, W.J., Isaacson, H.R., Rahman, F., Hall, A., and Young, I.J., "Elevated blood copper:zinc ratios in assaultive young males", Neuroscience Annual Meeting, Abstract of Papers, Miami Beach, 1994 (In Print). 2. Cunnane, S.C., Zinc: Clinical and Biochemical Significance, CRC Press, Inc., Boca Raton, FL (1988). 3. Prasad, A.S., "Deficiency of zinc in man and its toxicity", in Trace Elements in Human Health and Disease, Vol. 1, Academic Press, New York, 1976. 4. Prasad, A.S., "Clinical and biochemical spectrum of zinc deficiency in human subjects", in Current Topics in Nutrition and Disease, Vol 6, New York, 1982. 5. Smith, J.C., Holbrook, J.T., and Danford, D.E., "Analysis and evaluation of zinc and copper in human plasma and serum", J. Amer. College of Nutr., 4:627-638 (1985). 6. Kleimola, V., et al, "The zinc, copper, and iron status in children with chronic diseases", in Trace Element Analytical Chemistry in Medicine and Biology, Walter de Gruyter, New York (1983). 7. Reding, P., DuChateau, J., and Bataille, C., "Oral zinc supplementation improves hepatic encephalopathy", Lancet, ii, 493 (1984). 8. Pohit, J., Saha, K.C., and Pal, B., "A zinc tolerance test", Clin. Chim. Acta, 114: 279 (1981). 9. Pecoud, A., Donzel, P., and Schelling, J.L., "Effects of foodstuffs on the absorption of zinc sulphate", Clin. Pharmacol. Ther., 17, 469 (1975). 10. Molokhia, M.M. and Portnoy, B., "Zinc and copper in dermatology", in Zinc and Copper in Medicine, Charles C. Thomas, Springfield, IL (1980). 11. Schmidt, K., et.al., "Determination of trace element concentrations in psoriatic and non-psoriatic scales with special attention to zinc", in Trace Element Analytical Chemistry in Medicine and Biology, Vol. 1, Walter de Gruyter, New York (1980). 12. McMillan, E.M., and Rowe, D., "Plasma zinc in psoriasis. Relation to surface area involvement", Br. J. Dermatol., 108, 301 (1983). 13. Ecker, R.J. and Schroeder, A.L., "Acrodermatitis and acquired zinc deficiency", Arch. Dermatol., 114: 937 (1978). 14. Withers, A.F., Baker, H., and Musa, M, "Plasma zinc in psoriasis", Lancet, ii: 278 (1968). 15. Van Rij, A.M., "Zinc supplements in surgery", in Zinc and Copper in Medicine, Charles C. Thomas, Springfield, IL (1982). 16. Henzel, J.H., et al., "Zinc concentrations within healing wounds: significance of post-operative zincuria on availability and requirements during tissue repair", Arch. Surg., 349: 357 (1970). 17. Weismann, K., "Lines of Beau: Possible markers of zinc deficiency", Acta Dermatol. Venereol., 57: 88 (1977). 18. Collipp, P.J., et al., "Zinc deficiency: Improvement in growth and growth hormone levels with oral zinc therapy", Ann. Nutr. Metab., 26: 287 (1982). 19. Hambridge, K.M., and Walravens, P.A., "Zinc deficiency in infants and preadolescent children", in Trace Elements in Human Health and Disease, Vol. 1, Prasad, A.S. and Oberleas, D., Eds., Academic Press, New York (1976). 20. Golden, B.E. and Golden, M.H.N., "Effect of zinc supplementation on the dietary intake, rate of weight gain and energy cost of tissue deposition in children recovering from severe malnutrition", Am. J. Clin. Nutr., 34: 900 (1981). 21. Laditan, A.O. and Ette, S.I., "Plasma zinc and copper during the acute phase of protein-energy malnutrition (PEM) and after recovery", Trop. Geogr. Med., 34: 77 (1982). 22. Sandstead, H.H., Prasad, A.S., et al., "Human zinc deficiency, endocrine manifestations, and response to treatment", Amer. J. Clin. Nutr., 20:422 (1967). 23. Heinkin, R.I., and Bradley, D.F., "Hypogeusia corrected by nickel and zinc", Life Sci., 9: 701 (1970). 24. Sprenger, K.B.G. et al., "Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study", Kidney Int., Suppl. 16: 5315 (1983). 25. Cunningham-Rundles, C., et al., "Zinc deficiency, depressed thymic hormones and T-lymphocyte dysfunction in patients with hypogammaglobulinemia", Clin. Immunol. Immunopathol., 21: 387 (1981). 26. Good, R.A., et al., "Zinc and immunity", in Clinical, Biochemical, and Nutritional Aspects of Trace Elements, Prasad, A.S. Ed., Alan R. Liss, New York (1982). Health Research Institute Pfeiffer Treatment Center HRI Pharmacy 4575 Weaver Parkway - Warrenville, IL 60555-4039 (630) 505-0300 - (630) 836-0667 fax Questions or Comments:info@HRIPTC.org | Home Page | Services | Pharmacy | Research | Education | Patient Info | Directions | All contents Copyright (c) 2004 Health Research Institute. All rights reserved. HRI is a Not-for-Profit 501c3.

Labels: , , , , , ,

Biochemical Individuality and Nutrition

Biochemical Individuality and Nutrition by Bill Walsh, Ph.D. Pfeiffer Treatment Center Introduction Each of us has innate biochemical factors which influence personality, behavior, mental health, immune function, allergic tendencies, etc. Scientists tell us that the number of different genetic combinations possible in a child from the same two parents exceeds 42 million. It’s interesting to note that we do not possess a combination of characteristics from our parents, but instead have a diverse collection of characteristics from many ancestors on both sides of the family. Except for identical twins, each human being has unique biochemistry resulting in quite diverse nutritional needs. Shakespeare was correct when he wrote "One man’s meat is another man’s poison." For example, some of us are genetically suited for a vegetable-based diet and others are not. Some persons can satisfy their nutritional needs by diet alone and others must have nutritional supplements to overcome genetic aberrations. Because of genetic differences in the way our bodies process foods, most of us are quite deficient in certain nutrients and overloaded in others. Even with an ideal diet, most of us have certain nutrients that are at very low levels with many times the RDA required to achieve a healthy balance. The nutrients in overload must be carefully avoided in vitamin supplements or serious health problems can develop. After studying the biochemistry of 10,000 persons, I’ve learned that the greatest mischief is usually caused by nutrients that are stored in excessive amounts, rather than those at depleted levels. The most common nutrients in overload include copper, iron, folic acid, calcium, methionine, manganese, choline, and omega-6 fatty acids. Of course, these same nutrients may be in deficiency in other persons. I am amused by supplement manufacturers who attempt to develop the ideal combination of vitamins, minerals, and amino acids for the general population. This is a bit like trying to determine the ideal shoe size for the population. The truth is that multiple vitamins and minerals are too indiscriminate, and may do as much harm as good. Each of us should ask the question, "Who am I nutritionally?" The answer to this question is important for all, but may be especially critical for persons with mental health problems. Nutrients and Mental Health As we enter the new millennium, the medical and scientific communities agree on the tremendous influence of neurotransmitters on behavior disorders, ADHD, depression, and schizophrenia. Most persons with these disorders were born with a predisposition for these problems due to genetically-aberrant levels of specific neurotransmitters. Our mental health is dependent upon having the proper amounts of these critical brain chemicals. Some psychiatrists express their scorn for nutrient therapies, claiming that they are too puny to have any real clinical potency. They often say, "You really need a drug medication to get the job done for a serious condition like depression." My favorite response begins by asking the question, "Where do our neurotransmitters come from?" The brain is a chemical factory which produces serotonin. dopamine, norepinephrine, and other brain chemicals 24 hours a day. The only raw material for these syntheses are nutrients, namely amino acids, vitamins, minerals, etc. If the brain receives improper amounts of these nutrient building blocks, we can expect serious problems with our neurotransmitters. For example, some depression patients have a genetic pyrrole disorder which renders them grossly depleted in vitamin B-6. These individuals cannot efficiently create serotonin since B-6 is an important co-factor in the last step of its synthesis. Many of these persons report benefits from Prozac, Paxil, Zoloft, or other serotonin-enhancing medications. However, similar benefits may also be achieved by simply giving these patients sufficient amounts of B-6 along with augmenting nutrients. Most neurotransmitter problems appear to be genetic in nature and involve abnormal absorption, metabolism or storage of key nutrients. As neuroscience advances, biochemical treatments to correct brain chemistry become better defined. Nutrient therapy can be very potent and does not involve side effects, since no molecules foreign to the body are needed. This therapeutic approach may eventually eliminate the need for most psychiatric medications. Biochemical Factors In Behavior Disorders, ADHD and Mental Illness The Pfeiffer Treatment Center has amassed a large database of biochemical information from more than 10,000 patients with mental health problems. Examination of this data shows that most of these persons have striking abnormalities in specific nutrients required for neurotransmitter production. The most common chemical imbalances we encounter include the following: Over-Methylation Many persons who suffer from anxiety and depression are over-methylated which results in excessive levels of dopamine, norepinephrine and serotonin. Typical symptoms include chemical and food sensitivities, underachievement, upper body pain, and an adverse reaction to serotonin-enhancing substances such as Prozac, Paxil, Zoloft, St. John’s Wort, and SAMe. They have a genetic tendency to be very depressed in folates, niacin, and Vitamin B-12, and biochemical treatment focuses on supplementation of these nutrients. These persons are also overloaded in copper and methionine and supplements of these nutrients must be strictly avoided. Under-Methylation Many patients with obsessive-compulsive tendencies, oppositional-defiant disorder, or seasonal depression are under-methylated which is associated with low serotonin levels. They generally exhibit seasonal allergies, perfectionism, competitiveness, and other distinctive symptoms and traits. They have a genetic tendency to be very depressed in calcium, magnesium, methionine, and Vitamin B-6 with excessive levels of folic acid. These under-methylated persons may benefit nicely from Paxil, Zoloft, and other serotonin-enhancing medications, although nasty side effects are common. A more natural approach is to directly correct the underlying problem using methionine, calcium, magnesium, and B-6. SAMe, St. John’s Wort, Kava Kava, and inositol are also very useful in treating these individuals. Metal-Metabolism A common problem in ADHD, behavior disorders, and hormonal depression is an genetic inability to control copper, zinc, manganese, and other trace metals in the body due to improper functioning of the metallothionine protein. These patients are often deficient in zinc, manganese, cysteine, serine, and vitamin B-6 and overloaded in copper, lead, and cadmium. They must avoid supplements and "enriched" foods containing copper. In addition we recommend they drink bottled water and limit use of swimming pools and jacuzzis treated with copper sulfate anti-algae agents. Foods to be limited due to high copper content include shellfish, chocolate, and carob. Elevated copper levels are associated with hormonal imbalances and a classic symptom is intolerance to estrogen. Biochemical treatment focuses on stimulation of metallothionein using zinc, manganese, cysteine, serine, and Vitamin B-6. Pyrrole Disorder A common feature of many behavior and emotional disorders is pyroluria, an inborn error of pyrrole chemistry which results in a dramatic deficiency of zinc, Vitamin B-6, and arachidonic acid. Common symptoms include explosive temper, emotional mood swings, poor short-term memory, and frequent infections. These patients are easily identified by their inability to tan, poor dream recall, abnormal fat distribution, and sensitivity to light and sound. The decisive laboratory test is analysis for kryptopyrroles in urine. Treatment centers on zinc and B-6 supplements together with omega-6 essential fatty acids. Glucose Dyscontrol Our database indicates a significant number of our patients have chronic low blood glucose levels. This problem doesn’t appear to be the cause of behavior disorders, depression, etc., but instead is an aggravating factor which can trigger striking symptoms. Typical symptoms include drowsiness after meals, irritability, craving for sweets, trembling, anxiety, and intermittent poor concentration and focus. Treatment includes chromium, manganese, and other glucose-stabilizing nutrients, but the primary focus of treatment is on diet. These patients benefit from six or more small meals daily with emphasis on complex carbohydrates and protein. In essence, they cannot tolerate large meals or quick sugars. Complex carbohydrates provide the necessary glucose in a slow, gradual manner and may be thought of as "time-release" sugar. Toxic Substances Occasionally we encounter a patient whose condition has resulted from a heavy-metal overload (lead, cadmium, mercury, etc.) or toxic levels of pesticides or other organic chemicals. Our database indicates that persons with a metallothionein disorder are especially sensitive to toxic metals, and that over-methylation is associated with severe chemical sensitivities. Effective treatment requires a three-part approach: (1) avoidance of additional exposures, (2) biochemical treatment to hasten the exit of the toxic from the body, and (3) correction of underlying chemical imbalances to minimize future vulnerability to the toxic. Malabsorption Although only 10% of our database case histories involve serious malabsorption, more than 90% of autistics exhibit this problem. There are three primary classes of absorption problems: (1) stomach problems, including excessive or insufficient HCl levels, (2) incomplete digestion in the small intestine, and (3) problems at the brush-border of the intestine where most nutrients are absorbed into the portal blood stream. The consequences can include nutrient deficiencies, irritation of the intestinal tract, candida, and mental health problems. Incomplete breakdown of protein and fats can adversely affect brain neurotransmission, and is associated with impulsivity and academic underachievement. Treatment depends on the type of malabsorption present and may involve adjustment of stomach HCl levels, digestive enzymes which survive stomach acid, nutrients to enhance digestion, and special diets. Essential Fatty Acids The brain is 20% fat (by dry weight) and these fatty substances fulfill very important functions. The myelin sheaths which surround our brain cells contain essential fatty acids which are directly involved in receptor formation and nerve transmission. A 1998 Symposium at the National Institute of Mental Health presented strong evidence of the important roles for omega-3 oils (especially EPA and DHA) and omega-6 oils (especially AA and DGLA) in ADHD, depression, and schizophrenia. A recent Harvard study showed EPA and DHA supplements to be more effective than psychiatric medications in combating bipolar depression. Typical American diets usually result in insufficient omega-3 and excessive omega-6, and some nutritionists routinely recommend supplements of omega-3 oils. However, biochemical individuality also exists with oils and certain persons are innately low in omega-6 oils. A review of symptoms and specialized plasma and red-cell-membrane lab tests can identify individual needs. Health Research Institute Pfeiffer Treatment Center HRI Pharmacy 4575 Weaver Parkway - Warrenville, IL 60555-4039 (630) 505-0300 - (630) 836-0667 fax Questions or Comments:info@HRIPTC.org | Home Page | Services | Pharmacy | Research | Education | Patient Info | Directions | All contents Copyright (c) 2004 Health Research Institute. All rights reserved. HRI is a Not-for-Profit 501c3.

Labels: , , , , , , , ,

Calcium Imbalance

Proper Name: Calcium Common Name: Calcium Evidence of Efficacy: statement to the effect of Calcium deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between calcium and aggression1,2, anxiety3,4,5,6,7 and ADHD8,9, bipolar disorder10,11,12,13,14,15,16,17, depression18,19,20,21,22,23 and premenstrual syndrome24,25,26,27,28. References: 1. Walsh, William J., analytical chemist, Argonne National Laboratory; Sci News 124:122-2, 1983. 2. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Bioscocial 2(1), 1981. 3. Carlson RJ. Longitudinal observations of two cases of organic anxiety syndrome. Psychsomatics 27(7):529-31, 1986. 4. Lawlor BA. Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry. 1988 Aug;49(8):317-8. 5. Crammer JL. Calcium metabolism and mental disorder. Psychol Med 7(4):557-60, 1977. 6. Houssain M. Neurological and psychiatric manifestations in idiopathic hypoparathyroidism: Response to treatment. J Neurol Neurosurg Psychiatry 33:153-6, 1970. 7. Joborn C etal. Psychiatric symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci 91(1):77-87, 1986. 8. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. Deficiency of certain trace elements in children with hyperactivity. Psychiatr Pol. 1994 May-Jun;28(3):345-53. 9. Walker S III. Drugging the American child: We’re too cavalier about hyperactivity. J Learn Disabil 8:354, 1975. 10. Bowden CL, Huang LG, Javors MA, Johnson JM, Seleshi E, McIntyre K, Contreras S, Maas JW. 11. Calcium function in affective disorders and healthy controls. Biol Psychiatry. 1988 Feb 15;23(4):367-76. 12. Groat RD, Mackenzie TB. The appearance of mania following intravenous calcium replacement. J Nerv Ment Dis 168:562-3, 1980. 13. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Harris RA. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry. 1989 Jul;46(7):632-8. 14. Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry. 1992 Jan;149(1):118-20. 15. Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatry Clin Neurosci. 1992 Winter;4(1):3-14. 16. Carman JS, Wyatt RJ. Calcium: pacesetting the periodic psychoses. Am J Psychiatry. 1979 Aug;136(8):1035-9. 17. Carman JS, Wyatt RJ. Calcium: bivalent cation in the bivalent psychoses. Biol Psychiatry. 1979 Apr;14(2):295-336. 18. Depression and hypercalcemia. Am J Med. 1996 Jul;101(1):111-7. 19. Joborn C etal. Psychiatric symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci 91(1):77-87, 1986. 20. Alarcon RD, Franceschini JA. Hyperparathyroidism and paranoid psychosis. Br J Psychiatry. 1984 Nov;145:477-86. 21. Webb WL Jr, Gehi M. Electrolyte and fluid imbalance: neuropsychiatric manifestations. Psychosomatics. 1981 Mar;22(3):199-203. 22. Linder J, Brismar K, Beck-Friis J, Saaf J, Wetterberg L.Calcium and magnesium concentrations in affective disorder: difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand. 1989 Dec;80(6):527-37. 23. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999;39(2):63-70. 24. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr. 2000 Apr;19(2):220-7. 25. Goei GS, Abraham GE. Effect of a nutritional supplement, optivite, on symptoms of premenstrual tension. J Reprod Med. 1983 Aug;28(8):527-31. 26. Abraham GE. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med. 1983 Jul;28(7):446-64. 27. Alvir JM, Thys-Jacobs S. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacol Bull. 1991;27(2):145-8. 28. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med. 1989 May-Jun;4(3):183-9.

Labels: , , , , , ,

Potassium Imbalance

Proper Name: Potassium Common Name: Potassium Evidence of Efficacy: statement to the effect of Potassium deficiency or imbalance plays a role in the symptoms of mood disorders1. Observational and experimental studies have shown an association between potassium and aggression2,3,4, anxiety5 , bipolar disorder6,7,8,9, and depression10,11. References: 1. Webb WL, Gehi M. Electrolyte and fluid imbalance: Neuropsychiatric manifestations. Psychosomatics 22(3):199-203, 1981 2. William J. Walsh, analytical chemist, Argonne National Laboratory – reported in Sci News 124:122-5, 1983 3. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981 4. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977 5. McCleane GJ, Watters CH. Pre-operative anxiety and serum potassium. Anaesthesia 45(7):583-5, 1990 6. Klemfuss H. Dietary potassium effects on lithium concentration and toxicity in humans. Biol Psychiatry 37:42-7, 1995 7. Jefferson JW. Potassium supplementation in lithium patients: a timely intervention or premature speculation? J Clin Psychiatry 53:10, 1992 8. Bkaskara Rao Tripuraneni, fellow in child psychiatry, Harbo-UCLA Medical Center, Torrance, California – reported in Clin Psychiatry News 18(10):3, October, 1990 and presented to the 143rd Annual Mtg of the Am Psychiatric Assoc, May 12-17, 1990, Abstracts NR 100 and NR 210 9. Cater RE. The use of sodium and potassium to reduce toxicity and toxic side effects from lithium. Med Hypotheses 20(4):359-83, 1986 10. Webb WL, Gehi M. Electrolyte and fluid imbalance: Neuropsychiatric manifestations. Psychosomatics 22(3):199-203, 1981 11. Cox JR et al. Changes in sodium, potassium and fluid spaces in depression and dementia. Gerontology Clin 13:232-45, 1971 Aggressive Behavior

Labels: , , , , ,

Selenium Imbalance

Proper Name: Selenium Common Name: Selenium Evidence of Efficacy: statement to the effect of Selenium deficiency or imbalance plays a role in the symptoms of mood disorders1. Observational and experimental studies have shown an association between selenium and anxiety1, depression2,3, and schizophrenia4,5,6,7,8,9,10. References: 1. Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 29(11):1092-8, 1991. 2. Hawkes WC, Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 39:121-8, 1996. 3. Benton D, Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 29(11):1092-8, 1991. 4. Brown JS Jr. Role of selenium and other trace elements in the geography of schizophrenia. Schizophr Bull 20(2):387-98, 1994. 5. Foster HD. Schizophrenia and esophageal cancer: comments on similarities in their spatial distributions. J Orthomol Med 5(3):129-34, 1990. 6. Foster HD. The geography of schizophrenia: possible links with selenium and calcium deficiencies, inadequate exposure to sunlight and industrialization. J Orthomol Med 3(3):135-40, 1988. 7. Alertsen AR, Aukrust A, Skaug OE. Selenium concentrations in blood and serum from patients with mental diseases. Acta Psychiatr Scand 74(2):217-19, 1986. 8. Buckman TD, Kling AS, Eiduscon S, et al. Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiatry 22(11):1349-56, 1987. 9. Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 32(5):805-7, 1986. 10. Berry T. A selenium transport protein model of a sub-type of schizophrenia. Med Hypotheses 43(6):409-14, 1994.

Labels: , , , ,

Manganese Imbalance

Proper Name: Manganese Common Name: Manganese Evidence of Efficacy: statement to the effect of Manganese deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between manganese and aggression1,2,3,4,5,6, ADHD7,8,9 , and schizophrenia10,11,12,13,14,15. References: 1. Roger D. Masters, Nelson A. Rockefeller Professor of Government, Dartmouth College, Hanover, New Hampshire. Unpublished data, June, 1995. 2. Marlowe M, Bliss L, Schneider HG. Hair trace element content of violence prone male children. J Advancement Med 7(1):5-18, 1994. 3. Gottschalk LA et al. Abnormalities in hair trace-elements as indicators of aberrant behavior. Compr Psychiatry 32:229-37, 1991. 4. Schmidt K, Wier WR, ASch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981. 5. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A repot on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977. 6. Schauss AG. Comparative hair mineral analysis results of 21 elements in a random behaviorally “normal” 19-59 year old population and violent adult criminal offenders. Int J Biosoc Res 1:21-41, 1981. 7. Collipp PJ, Chen SY, Maitinsky S. Manganese in infant formulas and learning disability. Ann Nutr Metab 27:488-94, 1983. 8. Keen CL, Bell JG, Lonnerdal B. The effect of age on manganese uptake and retention from milk and infant formulas in rats. J Nutr 116:395-402, 1986. 9. Barlow PJ. A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses 11(3):309-18, 1983. 10. Barlow P. Hair metal analysis and its significance to certain diseases. Presentation at the 2nd Annual Trace Minerals in Health Seminar. Boston, MA, September 8-9, 1979. 11. Pfeiffer CC. Observations on trace and toxic elements in hair and serum. J Orthomol Psychiatry 3(4):259-64, 1974. 12. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenics. J Orthomol Psychiatry 12:215-34, 1983. 13. Pfeiffer CC, Iliev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Neurobiol, p. 141. 1972. 14. Hoskins RG. The manganese treatment of schizophrenic disorders. J Nerv Ment Dis 79:59-62, 1934. 15. English WM. Report of the treatment with manganese chloride in dementia praecox. Can Med Asoc J 21:96-149, 1929.

Labels: , , , ,

Vitamin B6 Imbalance

Proper Name: Pyridoxine Hydrochloride Common Name: Vitamin B6 Evidence of Efficacy: statement to the effect of Vitamin B6 deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between vitamin B6 and aggression1, anxiety2,3,4, ADHD5,6,7,8,9,10,11,12, bipolar disorder13,14, depression15, 16 ,17 ,18 ,19 ,20 ,21 ,22 ,23 ,24 ,25 ,26, obsessive compulsive disorder27,28, premenstrual syndrome29, 30, 31, 32, 33,3 4,3 5,36 ,37, 38, ,39 ,40, 41, 42,43 ,44, 45, 46, 47, 48, 49, 50 ,5 1,52, 53,and schizophrenia54, 55, 56, 57, 58, 59,6 0,6 1,62 ,63 ,64 .65 References: 1. Noted in McLaren DS. Clinical manifestations of nutritional disorders, in ME Shils, VR Young, Eds. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 2. Heseker H, Kubler W, Pudel V, Westenhoffer J. Psychological disorders as early symptoms of a mild-moderate vitamin deficiency. Ann N Y Acad Sci 669:352-7, 1992. 3. Hoes MJ et al. Hyperventilation syndrome, treatment with L-tryptophan and pyridoxine; Predictive value of xanthurenic acid excretion. J Orthomol Psychiatry 10(1):7-15, 1981. 4. Buist RA. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev 5:1-4, 1985. 5. Coleman M et al. Serotonin in Down’s syndrome. Amsterdam, North Holland, 1973. 6. Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 29(9):931-41, 1991. 7. Haslam RH, Dalby JT. Blood serotonin levels in the attention-deficit disorder. Letter. N Engl J Med 309(31):1328-9, 1983. 8. Brenner A. The effects of megadoses of selected B complex vitamins on children with hyperkinesis: Controlled studies with long-term follow-up. J Learn Disabil 15(5):258-64, 1982. 9. Klieger JA, Altshuler CH, Krakow L, Hollister L. Abnormal pyridoxine metabolism in toxemia of pregnancy. Ann N Y Acad Sci 166:288-96, 1969. 10. Coleman M et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A double-blind crossover comparison with methylphenidate. Biol Psychiatry 14(5):741-51, 1979. 11. Brenner A, Wapnir R. A pyridoxine-dependent behavioral disorder unmasked by Isoniazid. Am J Dis Child 132:773-6, 1978. 12. Bhagavan HN et al. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics 55:437-41, 1975. 13. Moller SE et al. Tryptophan availability in endogenous depression – relation to efficacy of L-tryptophan treatment. Adv Biol Psychiatry 10:30-46, 1983. 14. The pharmacokinetics of oral L-tryptophan: Effects of dose and concomitant pyridoxine, allopurinol or nicotinamide administration. Adv Biol Psychiatry 10:67-81, 1983. 15. Noted in McLaren DS. Clinical manifestations of nutritional disorders, in ME Shils, VR Young, Eds. Modern Nutrition in Health and Disease, Seventh Edition. Philadelphia, Lea & Febiger, 1988. 16. Bell I et al. Complex vitamin patterns in geriatric and young adult inpatients with major depression. J Am Geriatr Soc 39:252-7, 1991. 17. Stewart TW, Harrison W, Quitkin F, et al. Low B6 levels in depressed outpatients. Biol Psychiatry 19(4):613-16, 1984. 18. Russ CS et al. Vitamin B6 status of depressed and obsessive-compulsive patients. Nutr Rep Int 27(4):867-73, 1983. 19. Carney MW, Ravindran A, Rinsler MG, et al. Thiamine, riboflavin and pyridoxine deficiency in psychiatric inpatients. Br J Psychiatry 141:271-2, 1982. 20. Carney MW, Williams DG, Sheffield BF. Thiamin and pyridoxine lack in newly-admitted psychiatric patients. Br J Psychiatry 135:249-54, 1979. 21. Nobbs B. Pyridoxal phosphate status in clinical depression. Letter. Lancet i:405, 1974. 22. Bermond P. Therapy of side effects of oral contraceptive agents with vitamin B6. Acta Vitaminol Enzymol 4(1-2):45-54, 1982. 23. Adams PW, Wynn V, Rose DP, et al. Effect of pyridoxine hydrocholoride (vitamin B6) upon depression associated with oral contraception. Lancet ii:899-904, 1973. 24. Adams PW, Wynn V, Seed M, Folkard J. Vitamin B6, depression, and oral contraception. Letter. Lancet ii:516-17, 1974. 25. Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology 32(2):98-105, 1995. 26. Hallert C, Astrom J, Walan A. Reversal of psychopathology in adult coeliac disease with the aid of pyridoxine (vitamin B6). Scand J Gastroenterol 18(2):299-304, 1983. 27. Yaryura-Tobias JA. Presentation to the Third World Congress of Biological Psychiatry, Stockholm – reported in Clinical Psychiatrty News. September, 1981. 28. Yaryura-Tobias JA, Bhagavan HN. L-tryptophan in obsessive-compulsive disorders. Am J Psychiatry 134(11):1298-9, 1977. 29. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 47(4):636-41, 1988. 30. Gallant MP, Bowering J, Short SH, et al. Pyridoxine and magnesium status in women with premenstrual syndrome. Nutr Res 7:243-52, 1987. 31. Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32(6):435-41, 1987. 32. Richie CD, Singkamani R. Plasma pyridoxal-5’-phosphate in women with the premenstrual syndrome. Hum Nutr Clin Nutr 40C:75-80, 1986. 33. Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology 35:1466-8, 1985; Waterston JA, Gilligan BS. Pyridoxine neuropathy. Med J Aust 146:640-2, 1987. 34. Guy Abraham – personal communication reported in Piesse JW. Nutrition factors in the premenstrual syndrome: A review. Int Clin Nutr Rev 4(2):54-81, 1984. 35. Abraham GE. Nutrition and the premenstrual tension syndromes. J Appl Nutr 36(2):103-17, 1985; Hargrove JT, Abraham GT. Effect of vitamin B6 on infertility in women with the premenstrual syndrome. Infertility 2:315: 1979. 36. Leklem JE. Vitamin B6: The pill, pregnancy and premenstrual syndrome. Abstract. J Am Coll Nutr. 11(5):624, 1992. 37. Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of premenstrual syndrome – a review. Br J Obstet Gynaecol 97(9):847-52, 1990. Berman MK et al. Vitamin B-6 in premenstrual syndrome. J Am Diet Assoc 90(6):859-61, 1990. 38. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: A randomized crossover trial. J R Coll Gen Pract 39:364-8, 1989. 39. Brush MG, Bennett T, Hansen K. Pyridoxine in the treatment of premenstrual syndrome: A retrospective survey in 630 patients. Br J Clin Pract 42(11):448-52, 1988. 40. Kendall KE, Schnurr PP. The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet Gynecol 70(2):145-9, 1987. 41. David R. Rubinow, biological psychiatry branch, National Institute of Mental Health (USA) – quoted by Clin Psychiatry News, December, 1987. 42. Hagen I et al. No effect of vitamin B-6 against premenstrual tension: A controlled clinical study. Acta Obstet Gynecol Scand 64:667, 1985. 43. Williams MJ, Harris RI, Dean BC. Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res 13:174-9, 1985. 44. Barr W. Pyridoxine supplements in the premenstrual syndrome. Practitioner 228:425-7, 1984. 45. Mattes JA, Martin D. Pyridoxine in premenstrual depression. Hum Nutr Appl Nutr 36(2):131-3, 1982. 46. Abraham GE, Hargrove JT. Effect of vitamin B-6 on premenstrual symptomatology in women with premenstrual tension syndrome: A double-blind crossover study. Infertility 3:155-65, 1980. 47. Day JB. Clinical trials in the premenstrual syndrome. Curr Med Res Opin (Suppl 6) 5:40-5, 1979. 48. Kerr GD. The management of the premenstrual syndrome. Curr Med Res Opin (Suppl 4) 4:29-34, 1977. 49. Stokes J, Mendels J. Pyridoxine and premenstrual tension. Letter. Lancet i:1177-8, 1972. 50. Piesse JW. Nutrition factors in the premenstrual syndrome. Int Clin Nutr Rev 4(2):54-81, 1984. 51. Lee CM, Leklem JE. Blood magnesium constancy with vitamin B-6 supplementation in pre- and post-menopausal women. Ann Clin Lab Sci 14(2):151-4, 1984. 52. Abraham GE et al. Effect of vitamin B6 on plasma and red blood cell magnesium levels in premenopausal women. Ann Clin Lab Sci 11(4):333-6, 1981. 53. Holley J et al. Effect of vitamin B6 nutritional status on the uptake of [3H]-oestradiol into the uterus, liver and hypothalamus of the rat. J Steroid Biochem 18:161-6, 1983. 54. Pfeiffer CC, Audette L. Pyroluria – Zinc and B6 deficiencies. Int Clin Nutr Rev 8(3):107-10; 1988. 55. Pfeiffer CC. The schizophrenias ’76. Biol Psychiatry 2:773-5, 1976. 56. Pfeiffer CC, Bacchi D. Copper, zinc, manganese, niacin and pyridoxine in the schizophrenias. J Appl Nutr 27:9-39, 1975. 57. Pfeiffer CC. Observations on trace and toxic elements in hair and serum. J Orthomol Psychiatry 3(4):259-64, 1974. 58. Cruz R, Vogel WH. Pyroluria: A poor marker in chronic schizophrenia. Am J Psychiatry 135(10):1239-40, 1978. 59. Parry GJ. Sensory neuropathy with low-dose pyridoxine. Neurology 35:1466:8, 1985. 60. Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry 29(9):931-41, 1991. 61. Brooks SC et al. An unusual schizophrenic illness responsive to pyridoxine HCl (B6) subsequent to phenothiazine and butyrophenone toxicities. Biol Psychiatry 18(11):1321-8, 1983. 62. Yamauchi M. Effects of L-dopa and vitamin B6 on electroencephalograms of schizophrenic patients: A preliminary report. Folia Psychiatrica et Neurologica Japonica 30(2):121-51, 1976. 63. Sandyk R, Pardeshi R. Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patients. J Neurosci 53(3-4):225-32, 1990. 64. Petrie WM, Ban TA, Anath JV. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia. Int Pharmacopsychiatry 16(4):245-50, 1981. 65. Ananth JV, Ban TA, Lehmann HE. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Can Psychiatr Assoc J 18:377-83, 1973.

Labels: , , , , , , , ,

Magnesium Imbalance

Proper Name: Magnesium Common Name: Magnesium Evidence of Efficacy: Magnesium deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between magnesium and aggression 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, anxiety 11, 12, 13, 14, 15, ADHD 16, 17, 18, bipolar disorder 19, 20 ,21, depression 22,23,24,25,26,27,28,29,30,31,32,33,34,35, premenstrual syndrome 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, and schizophrenia 58, 59, 60, 61, 62, 63, 64, 65 ,66 ,67 ,68 ,69, 70. References: 1. Izenwasser SE et al. Stimulant-like effects of magnesium on aggression in mice. Pharmacol Biochem Behav 25(6):1195-9, 1986. 2. Henrotte JG. Type A behavior and magnesium metabolism. Magnesium 5:201-10, 1986. 3. Bennett CPW, McEwen LM, McEwen HC, Rose EL. The Shipley Project: treating food allergy to prevent criminal behaviour in community settings. J Nutr Environ Med 8:77-83, 1998. 4. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 5. Kantak KM. Magnesium deficiency alters aggressive behavior and catecholamine function. Behav Neurosci 102(2):304-11, 1988. 6. Izenwasser SE, Garcia-Valdez K, Kantak KM. Stimulant-like effects of magnesium on aggression in mice. Pharmacol Biochem Behav 25(6):1195-9, 1986. 7. Struempler RE et al. Hair mineral analysis and disruptive behavior in clinically normal young men. J Learn Disabil 18(10):609-12, 1985. 8. Banki CM, Vojnik M, Papp Z, et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20(2):163-71, 1985. 9. Schmidt K, Wier WR, Asch M. Clinical ecology treatment approach for juvenile offenders. J Behav Ecology: Biosocial 2(1), 1981. 10. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 "incorrigible" adolescents. Am Lab 107:22-49, 1977. 11. Buist RA. Anxiety neurosis: The lactate connection. Int Clin Nutr Rev 5:1-4, 1985. 12. Seelig MS, Berger AR, Spieholz N. Latent tetany and anxiety, marginal Mg deficit, and normocalcemia. Dis Nerv Syst 36:461-5, 1975. 13. Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res 7(3/4):313-28, 1994. 14. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 15. Weston PG et al. Magnesium sulphate as a sedative. Am J Med Sci 165:431-3, 1923. 16. Durlach J. Clinical aspects of chronic magnesium deficiency, in MS Seelig, Ed. Magnesium in Health and Disease. New York, Spectrum Publications, 1980. 17. Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 10(2):143-8, 1997. 18. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 10(2):149-56, 1997. 19. George MS, Rosenstein D, Rubinow DR, et al. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res 51(2):139-46, 1994. 20. Kirov GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms. Neuropsychobiology 1994;30(2-3):73-8, 1994. 21. Chouinard G, Beauclair L, Geiser R, Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 14(2):171-180, 1990. 22. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 23. Linder J et al. Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand 80:527-37, 1989. 24. Frazer A et al. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 5(2):103-13, 1983. 25. Bjorum N. Electrolytes in blood in endogenous depression. Acta Psychiatr Scand 48:59-68, 1972. 26. Cade JFJA. A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med J Aust 1:195-6, 1964. 27. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 28. Hall RCW, Joffe JR. Hypomagnesemia: Physical and psychiatric symptoms. JAMA 224:1749-51, 1973. 29. Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Br J Psychiatry 115:1375-7, 1969. 30. Frizel D et al. Plasma calcium and magnesium in depression. Br J Psychiatry 115:1375-7, 1969. 31. Hasey GM, D'Alessandro E, Cooke RG, Warsh JJ. The interface between thyroid activity, magnesium, and depression: A pilot study. Biol Psychiatry 33:133-5, 1993. 32. Linder J et al. Calcium and magnesium concentrations in affective disorder: Difference between plasma and serum in relation to symptoms. Acta Psychiatr Scand 80:527-37, 1989. 33. Frazer A et al. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 5(2):103-13, 1983]. 34. Banki CM et al. Aminergic studies and cerebrospinal fluid cations in suicide. Ann N Y Acad Sci 487:221-30, 1986. 35. Banki CM et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20:163-71, 1985. 36. Posaci C, Erten O, Uren A, Acar B. Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452-5, 1994. 37. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 38. Chuong CJ, Dawson EB., Magnesium levels in premenstrual syndrome. Nutr Res 14(11):1623-34, 1994. 39. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 47:636-41, 1988. 40. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667;70, 1986. 41. Stebbing JB et al., Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 42. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 43. Stewart A., Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 44. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 23(6):667-70, 1986. 45. Stebbing JB et al., Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 46. Abraham GE. Magnesium deficiency in premenstrual tension. Magnesium Bull 1:68-73, 1982. 47. Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 34(11):2364-6, 1981. 48. Rosenstein DL et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-61, 1994. 49. Stewart A., Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 50. Stebbing JB et al. Reactive hypoglycaemia and magnesium. Magnesium Bull 4(2):131-4, 1982. 51. Brown RC, Bidlack WR. Regulation of glucuronyl transferase by intracellular magnesium, in Proceedings of the International Symposium on Magnesium and its Relationship to Cardiovascular, Renal and Metabolic Disorders. Los Angeles, 1985:24. 52. Curry DL et al. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 101:203, 1977. 53. Abraham GE. Management of the premenstrual tension syndromes: Rationale for a nutritional approach, in J Bland, Ed. 1986: A Year in Nutritional Medicine. New Canaan, CT, Keats Publishing, 1986:125-66. 54. Brown RC, Bidlack WR. Regulation of glucuronyl transferase by intracellular magnesium, in Proceed Int Sympos Magnesium and its Relationship to Cardiovascular, Renal and Metabolic Disorders. Los Angeles, 1985:24. 55.Cunnane SC, Horrobin DF. Parnteral linoleic and gamma-linolenic acids ameliorate the gross effects of zinc deficiency. Proc Soc Exp Biol Med 164:583, 1980. 56. Facchinetti F, Bolrella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 78(2):177-81, 1991. 57. Facchinetti F et al. Magnesium prophylaxis of menstrual migraine: effects of intracellular magnesium. Headache 31:298-304, 1991. 58. Levine J, Rapoport A, Mashiah M, Dolev E. Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients. Neuropsychobiology 33(4):169-72, 1996. 59. Kirow GK, Birch NJ, Steadman P, Ramsey RG. Plasma magnesium levels in a population of psychiatric patients: correlation with symptoms. Neuropsychobiology 30(2-3):73-8, 1994. 60. Kanofsky JD et al. Is iatrogenic hypomagnesemia common in schizophrenia? Abstract. J Am Coll Nutr 10(5):537, 1991. 61. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 23(2):79-81, 1990. 62. Chhatre SM et al. Serum magnesium levels in schizophrenia. Ind J Med Sci 39(11):259-61, 1985. 63. Paul EA et al. Serum calcium and magnesium in schizophrenia. Relationship to clinical phenomena and neuroleptic treatment. Br J Psych 133:143-9, 1978. 64. Daly RM, Gold G. Serum magnesium levels in nonacute schizophrenics. N Y State J Med 76:188-9, 1976. 65. Hakim AH et al. A comparative study of serum calcium and magnesium in cases of endogenous depression, reactive depression, schizophrenia and conversion reaction. J Assn Phys Ind 23:513-17, 1975. 66. Pandey SK et al. An estimation of magnesium and calcium in serum and CSF in schizophrenia. J Assn Phys Ind 21:203-5, 1973. 67. Chugh TD et al. Magnesium in schizophrenia. Ind J Med Res 61:998-1001, 1973. 68. Cade JFJ. A significant elevation of plasma magnesium level in schizophrenia and depressive states. Med J Aust 1:195-6, 1964. 69. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 70. Levine J, Rapoport A, Mashiah M, Dolev E. Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients. Neuropsychobiology 33(4):169-72, 1996.

Labels: , , , , , , , ,

Copper imbalance

Proper Name: Copper Common Name: Copper Evidence of Efficacy: statement to the effect of Copper deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between copper and ADHD1,2,3, depression4,5,6, premenstrual syndrome7, and schizophrenia8,9,10,11,12,13,14,15,16,17,18,19,20. References: 1. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 2. Brenner A. Trace mineral levels in hyperactive children responding to the Feingold diet. J Pediatr 94 (60):944-5, 1979. 3. Pfeiffer CC, Mailloux R. Excess copper as a factor in human diseases. J Orthomol Med 2(3):171-82, 1987. 4. Hansen Cr Jr et al. Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 18(3):395-401, 1983. 5. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 6. Ali SA et al. Blood levels of vanadium, caesium, and other elements in depressive patients. J Affect Disord 9:187-91, 1985. 7. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 8. Kornhuber J, Lange KW, Kruzik P, et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients. Biol Psychiatry 36(1):31-4, 1994. 9. Shore D et al. CSF copper concentrations in chronic schizophrenia. Am J Psychiatry 140(6):754-7, 1983. 10. Tyrer SP et al. CSF copper in schizophrenia. Am J Psychiatry 136(7):937-9, 1979. 11. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 12. Olatunbosun DA at al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:119-21, 1975. 13. Pfeiffer CC, Illiev V. A study of zinc deficiency and copper excess in the schizophrenias. Int Rev Biol Suppl 1, 1972. 14. Heilmeyer L, Keiderling W, Struve C. Kupfer and eisen als. Korpereigene Wirkstoffe und Ihre Bedeutung Beim Krankheitgeschehen. Fischer, Jena, Germany, 1941. 15. Pfeiffer CC, LaMola S. Zinc and manganese in the schizophrenias. J Orthomol Psychiatry 12:215-34, 1983. 16. Bowman MB, Lewis MS. The copper hypothesis of schizophrenia: a review. Neurosci Biobehav Rev 6:321-8, 1982. 17. Gillin JC et al. Zinc and copper in patients with schizophrenia. Encephale 8(3):435-44, 1982. 18. Mattke JD, Adler M. Mode of action of D-penicillamine in chronic schizophrenia. Dis Nerv Sys 32:388, 1971. 19. Affleck JW et al., Penicillamine and schizophrenia – A clinical trial. Br J Psychiatry 115:173, 1969. 20. Nicholson GA et al. Effect of D-penicillamine on schizophrenic patients. Lancet i:344, 1966.

Labels: , , , , , ,

Zinc Imbalance

Proper Name: Zinc Common Name: Zinc Evidence of Efficacy: statement to the effect of Zinc deficiency or imbalance plays a role in the symptoms of mood disorders. Observational and experimental studies have shown an association between zinc and aggression2,3,4,5,6, ADHD7,8,9,10,11,12,13, depression14,15,16,17,18,19, and premenstrual syndrome20,21,22,23,24. References: 1. Walwork JC et al. Distribution of minerals and catecholamines in rat brain: effects of zinc deficiency, in CJ Frederickson et al, Eds. The Neurobiology of Zinc, Part B: Deficiency, Toxicity and Pathology (Neurology and Neurobiology V. 11B). New York, Alan R. Liss, 1984:49-64. 2. Prasad AS. Clinical manifestations of zinc deficiency. Nutr Rev 41(7):197, 1983. Schauss AG et al. A critical analysis of the diets of chronic juvenile offenders, Part II. J Orthomol Psychiatry 8(4):222-6, 1979. 3. William J. Walsh, analytical chemist, Argonne National Laboratory – reported in Sci News 124:122-5, 1983. 4. Von Hilsheimer G, Philpott W, Buckley W, Klotz SC. Correcting the incorrigible. A report on 229 “incorrigible” adolescents. Am Lab 107:22-49, 1977. 5. William J. Walsh. Zinc deficiency, metal metabolism, and behavior disorders. Unpublished monograph. Health Research Institute, 1804 Centre Point Dr., Suite 106, Naperville, IL 60503, March 1995. 6. Bennett CPW, McEwen LM, McEwen HC, Rose EL. The Shipley Project: treating food allergy to prevent criminal behavior in community settings. J Nutr Environ Med 8:77-83, 1998. 7. Ward NI. Assessment of chemical factors in relation to child hyperactivity. J Nutr Environ Med 7:333-42, 1997. 8. Bekaroglu M, Aslan Y, Gedik Y, et al. Relationships between serum free fatty acids and zinc, and attention deficity hyperactivity disorder: a research note. J Child Psychol Psychiatry 37(2):225-7, 1996. 9. Kozielec T, Starobrat-Hermelin B, Kotkowiak L. [Deficiency of certain trace elements in children with hyperactivity.] Psychiatr Pol 28(3):345-53, 1994. 10. Ward NI et al. The influence of the chemical additive tartrazine on the zinc status of hyperactive children – a double-blind placebo-controlled study. J Nutr Med 1:51-7, 1990. 11. Arnold LE, Votalato NA, Kleykamp D, et al. Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neruosci 50(1-2):103-7, 1990. 12. Barlow PJ. A pilot study on the metal levels in the hair of hyperactive children. Med Hypotheses 11(3):309-18, 1983. 13. Golub MR, Takeuchi PT, Keen CL, et al. Activity and attention in zinc-deprived adolescent monkeys. Am J Clin Nutr 64:908-15, 1996. 14. Tasman-Jones C. Zinc deficiency states. Adv Intern Med 26:97-114, 1980. 15. Maes M, Vandoolaeghe E, Neels H, et al. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42(5):349-58, 1997. 16. Maes M, D’Haese PC, Scharpe S, et al. Hypozincemia in depression. J Affect Disord 31(2):135-40, 1994. 17. Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35(4):272-4, 1991. 18. McLoughlin IJ, Hodge JS. Zinc in depressive disorder. Acta Psychiatr Scand 82(6), 451-3, 1990. 19. Little KY, Castellanos X, Humphries LL, Austin J. Altered zinc metabolism in mood disorder patients. Biol Psychiatry 26:646-8, 1989. 20. Posaci C, Erten O, Uren A, Acar B. Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 73(6):452-5, 1994. 21. Choung C, Dawson E. Zinc and copper levels in premenstrual syndrome. Fert Steril 62:313-20, 1994. 22. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Cin Nutr 47(4):636-41, 1988. 23. Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 32:435-41, 1987. 24. Chuong CJ et al, Baylor College of Medicine, Houston – presented at the 46th Annual Mtg. Of the Am. Fertility Society, Washington, DC, 1991.

Labels: , , , , , , ,

Walsh - reduced violent behavior due to nutrient therapy

Reduced violent behavior following biochemical therapy William J. Walsh*, Laura B. Glab, Mary L. Haakenson Pfeiffer Treatment Center, 4575 Weaver Parkway, Warrenville, IL 60555, United States Received 5 May 2003; received in revised form 23 June 2004; accepted 29 June 2004 Abstract Reduced violent behavior following biochemical therapy. We conducted an outcome study to measure the effectiveness of biochemical therapy for 207 consecutive patients presenting with a diagnosed behavior disorder. The treatment protocols were based on clinical evaluation and our past experience in the treatment of 8000 patients with behavior disorders at the Pfeiffer Treatment Center (PTC) over a 10-year period. Each test subject was screened for chemical imbalances previously found in high incidence in this population, including metal-metabolism disorders, methylation abnormalities, disordered pyrrole chemistry, heavy-metal overload, glucose dyscontrol, and malabsorption. The clinical procedure included a medical history, assay of 90 biochemical factors, and a physical examination. Standardized treatment protocols were applied for each imbalance that was identified. The frequencies of physical assaults and destructive episodes were determined using a standardized behavior scale before and after treatment, with follow-up ranging from 4 to 8 months. Results: Seventy-six percent of the test subjects achieved compliance during the treatment period. The remaining 24% were reported to have discontinued the therapy. A reduced frequency of assaults was reported by 92% of the compliant assaultive patients, with 58% achieving elimination of the behavior. A total of 88% of compliant destructive patients exhibited a reduced frequency of destructive incidents and 53% achieved elimination of the behavior. Statistical significance was found for reduced frequency of assaults (t=7.74, pb0.001) and destructive incidents (t= 8.77, pb0.001). The results of this outcome study strongly suggest that individualized biochemical therapy may be efficacious in achieving behavioral improvements in this patient population.

Labels: , , , , , ,

Thursday, June 28, 2007

Neuroarcheology of Childhood Trauma

Child Trauma Academy Home Child Trauma Academy Materials Child Trauma Academy Materials Child Trauma Academy Materials About Child Trauma Academy Child Trauma Academy Services Child Trauma Academy Materials Our Impact Resources & Links Forum The Neuroarcheology of Childhood Maltreatment The Neurodevelopmental Costs of Adverse Childhood Events Bruce D. Perry, M.D., Ph.D. The ChildTrauma Academy www.ChildTrauma.org For: "The Cost of Child Maltreatment: Who Pays? We All Do" (Ed., B. Geffner) Haworth Press July 27, 2000 Introduction Childhood maltreatment has profound impact on the emotional, behavioral, cognitive, social and physical functioning of children. Developmental experiences determine the organizational and functional status of the mature brain and, therefore, adverse events can have a tremendous negative impact on the development of the brain. In turn, these neurodevelopmental effects may result in significant cost to the individual, their family, community and, ultimately, society. In essence, childhood maltreatment alters the potential of a child and, thereby, robs us all. The present chapter will review some of those costs from a neurodevelopmental perspective. The premise is that when the core principles of neurodevelopment are understood, the costs of adverse childhood events and maltreatment become obvious. Following a brief presentation of the key concepts of neurodevelopment, two primary forms of maltreatment will be considered: (1) neglect and (2) traumatic stress. Maltreatment of children often involves both neglect and trauma; a more complete understanding of the complex neurodevelopmental impact of the combination, however, is best understood after presenting the potential effects of each separately. This chapter presents the current articulation of a neurodevelopmental perspective of childhood maltreatment originally outlined in 1994 (Perry. 1994) and further elaborated over the last five years (Perry, Pollard, Blakley, Baker, & Vigilante. 1995) (Perry & Pollard. 1998) This most recent articulation outlines the issue of maltreatment through the lens of developmental neurobiology and coins a descriptive phrase, "neuroarcheology," to capture the impact of adverse events on the developing brain, with the implicit suggestion that experiences leave a 'record' within the matrix of the brain. The nature and location of this record will depend upon the nature of the experience and the time in development when the event took place – much as with the archeological record of the earth. While this phrase may be simplistic to some, it conveys important conceptual principles about the nature of childhood experience which have been lacking all too often in clinical and research formulations regarding maltreatment. Not a single psychometric instrument measuring traumatic or adverse events, for example, uses time of trauma as a meaningful variable despite the fact that it may be the most important determinant of functional outcome following maltreatment. The neuroarcheological perspective on childhood experience, therefore, simply posits that the impact of a childhood event (adverse or positive) will be a reflection of (1) the nature, intensity, pattern and duration of the event and (2) that the resulting strengths (e.g., language) or deficits (e.g., neuropsychiatric symptoms) will be in those functions mediated by the neural systems that are most rapidly organizing (i.e., in the developmental "hot zone") at the time of the experience. Brain Organization and Function The human brain is the remarkable organ that allows us to sense, process, perceive, store and act on information from outside and inside the body to carry out the three prime directives required for the survival of our species: (1) survive, (2) affiliate and mate and then, (3) protect and nurture dependents. In order to carry out these core and overarching responsibilities, thousands of inter-related functions have evolved. In the human brain, structure and function have co-evolved. As we have a hierarchy of increasingly complex functions related to our optimal functioning, our brain has evolved a hierarchical structural organization (see Table 1). This hierarchy starts with the lower, simpler brainstem areas and increases in complexity up through the neocortex (Figure 1). In each of these many areas of the brain are neural systems that mediate our many brain-related functions (Figure1; Table1). The 'lower' parts of the brain (brainstem and midbrain) mediate simpler regulatory functions (e.g., regulation of respiration, heart rate, blood pressure, body temperature) while more complex functions (e.g., language and abstract thinking) are mediated by the more complex neocortical structures of the human brain. This hierarchical structure is the heart of a neuroarcheological understanding of adverse childhood events. This structure becomes the multi-layered soil within which the fossilized evidence of maltreatment can be found – each layer organizing at a different time and each layer reflecting the experiences –good and bad - of that era in the individual's life. Key insights to understanding human functioning, then, will come from understanding neurodevelopment. neuroarcheology1.jpg (33179 bytes) Figure 1: Hierarchical Organization of the Human Brain: The brain can be divided into four interconnected areas: brainstem, diencephalons, limbic and neocortex. The complexity of structure, cellular organization and function increases from the lower, simpler areas such as the brainstem to the most complex, the neocortex. Neurodevelopment Our brain's complex structure is comprised of 100 billion neurons and ten times as many glial cells – all interconnected by trillions of synaptic connections – and communicating in a non-stop, ever-changing dynamic of neurochemical activity. The brain doesn't just pop into existence. This most complex of all biological systems in the known universe is a product of neurodevelopment – a long process orchestrating billions upon billions of complex chemical transactions. It is through these chemical actions that a human being is created. The developing child is a remarkable phenomenon of nature. In a few short years, one single cell – the fertilized egg – becomes a walking, talking, learning, loving, and thinking being. This physical transformation is equivalent to a 6-foot tall, 200 pound man growing to the size of Connecticut in three years. In each of the billions and billions of cells in the body, a single set of genes has been expressed in millions of different combinations with precise timing. Development is a breathtaking orchestration of precision micro-construction that allows the healthy development of a human being. And the most remarkable and complex of all the organs in the human body is the human brain. In order to create the brain, a small set of pre-cursor cells must divide, move, specialize, connect and create specialized neural networks that form functional units. The key processes in neurodevelopment are summarized below. Core Processes of Neurodevelopment 1. Neurogenesis: The brain starts as a few cells present early in the first weeks of life. From a few specialized cells in the unformed brain, come billions of nerve cells and trillions of glia. This, of course, requires that cells be "born." Neurogenesis is the birth of new neurons. The vast majority of neurogenesis takes place in utero during the second and third trimester. At birth, the vast majority of neurons, literally more than 100 billion, used for the remainder of life are present. Few neurons are born after birth, although researchers have demonstrated recently that neurogenesis can and does take place in the mature brain (Gould, Reeves, Graziano, & Gross. 1999). This is a very significant observation and may be one of the important physiological mechanisms responsible for the brain's plasticity (i.e., capacity to restore function) following injury. Despite being present at birth, these neurons have yet to organize into completely functional systems. Many neurons need to mature themselves and undergo a set of processes that create the functional neural networks of the mature brain (Table 2). 2. Migration: Developing neurons move. Often guided by glial cells and a variety of chemical markers (e.g., cellular adhesion molecules, nerve growth factor: NGF), neurons cluster, sort, move and settle into a location in the brain that will be their final "resting" place. It is the fate of some neurons to settle in the brainstem, others in the cortex, for example. More than one half of all neurons are in the cortex. The processes of cortical cell migration and fate mapping are some of the most studied in all of developmental neuroscience (Rakic. 1981) (Rakic. 1996). It is clear that both genetic and environmental factors play important roles in determining a neuron's final location. Migration takes place primarily during the intrauterine and immediate perinatal period but continues throughout childhood and, possibly, to some degree into adult life. A host of intrauterine and perinatal insults – including infection, lack of oxygen, alcohol and various psychotropic drugs can alter migration of neurons and have profound impact on functioning (Perry. 1988). Table 1. A Neuroarcheological Chart of Development: Functional Organization neuroarcheology2.jpg (63967 bytes) 3. Differentiation: Neurons mature. Each of the 100 billion neurons in the brain has the same set of genes, yet each neuron is expressing a unique combination of those genes to create a unique identity. Some neurons are large, with long axons; others short. Neurons can mature to use any of a hundred different neurotransmitters such as norepinephrine, dopamine, serotonin, CRF or substance P. Neurons can have dense dendritic fields receiving input from hundreds of other neurons, while other neurons can have a single linear input from one other neuron. Each of these thousands of differentiating "choices" come as a result of the pattern, intensity and timing of various microenvironmental cues which tell the neuron to turn on some genes and turn off others. Each neuron undergoes a series of "decisions" to determine their final location and specialization. These decisions, again, are a combination of genetic and microenvironmental cues. The further along in development, the more differentiated the neuron, the more sensitive it becomes to the environmental signals. From the intrauterine period through early childhood (and to some degree beyond) neurons are very sensitive to experience-based signals, many of which are mediated by patterned neuronal activity in the neural network in which they reside. Neurons are literally designed to change in response to chemical signals. Therefore, any experience or event that alters these neurochemical or microenvironmental signals during development can change the ways in which certain neurons differentiate, thereby altering the functional capacity of the neural networks in which these neurons reside. 4. Apoptosis: Some developing neurons die. In many areas of the brain, there are more neurons born than are needed for any given function. Many of these neurons are redundant and when unable to adequately "connect" into an active neural network will die (Kuan, Roth, Flavell, & Rakic. 2000). Research in this area suggests that these neurons may play a role in the remarkable flexibility present in the human brain at birth. Depending upon the challenges of the environment and the potential needs of the individual, some neurons will survive while others will not. Again, this process appears to have genetic and environmental determinants. Neurons that make synaptic connections with others and have an adequate level of activation will survive; those cells that have little activity resorb. This is one example of a general principle of activity-dependence ("use it or lose it") that appears to be important in many neural processes related to learning, memory and development. 5. Arborization: As neurons differentiate, they send out tiny fiber-like extensions from their cell body. These dendrites become the receptive area where other neurons connect. It is in this receptive field that dozens to hundreds of other neurons are able to send neurochemical signals to the neuron. The density of these dendritic branches appears to be related to the frequency and intensity of incoming signals. When there is high activity, the dendritic network extends, essentially branching out in the same fashion as a bush may create new branches. This arborization allows the neuron to receive, process and integrate complex patterns of activity that will, in turn, determine its activity. Again, the arborization process appears to be to some degree activity-dependent. The density of the dendritic arborization appears to be related to the complexity and activity of incoming neural activity. In turn, these neural signals are often dependent upon the complexity and activity of the environment of the animal (Diamond, Law, Rhodes, et al. 1966; Greenough, Volkmar, & Juraska. 1973). 6. Synaptogenesis: Developing neurons make connections with each other. The major mechanism for neuron-to-neuron communication is 'receptor-mediated' neurotransmission that takes place at specialized connections between neurons called synapses. At the synapse, the distance between two neurons is very short. A chemical (classified as a neurotransmitter, neuromodulator or neurohormone) is released from the 'presynaptic' neuron and into the extra-cellular space (called the synaptic cleft) and binds to a specialized receptor protein in the membrane of the 'postsynaptic' neuron. By occupying the binding site, the neurotransmitter helps change the shape of this receptor which then catalyzes a secondary set of chemical interactions inside the postsynaptic neuron that create second messengers. The second messengers such as cyclic AMP, inositol phosphate and calcium will then shift the intracellular chemical milieu which may even influence the activity of specific genes. This cascade of intracellular chemical responses allows communication from one neuron to another. A continuous dynamic of synaptic neurotransmission regulates the activity and functional properties of the chains of neurons that allow the brain to do all of its remarkable activities. These neural connections are not random. They are guided by important genetic and environmental cues. In order for our brain to function properly, neurons, during development, need to find and connect with the "right" neurons. During the differentiation process, neurons send fiber-like projections (growth cones) out to make physical contact with other neurons. This process appears to be regulated and guided by certain growth factors and cellular adhesion molecules that attract or repel a specific growth cone to appropriate target neurons. Depending upon a given neuron's specialization, these growth cones will grow (becoming axons) and connect to the dendrites of other cells and create a synapse. During the first eight months of life there is an eight-fold increase in synaptic density while the developing neurons in the brain are "seeking" their appropriate connections (Huttenlocher. 1979) (Huttenlocher. 1994). This explosion of synaptogenesis allows the brain to have the flexibility to organize and function in with a wide range of potential. It is over the next few years, in response to patterned repetitive experiences that these neural connections will be refined and sculpted. 7. Synaptic sculpting: The synapse is a dynamic structure. With ongoing episodic release of neurotransmitter, occupation of receptors, release of growth factors, shifts of ions in and out of cells, laying down of new microtubules and other structural molecules, the synapse is continually changing. A key determinant of change in the synapse appears to be the level of presynaptic activity. When there is a consistent active process of neurotransmitter release, synaptic connections will be strengthened with actual physical changes that make the pre- and postsynaptic neurons come closer and the process of neurotransmission more efficient. When there is little activity, the synaptic connection will literally dissolve. The specific axonal branch to a given neuron will go away. Again, this powerful activity-dependent process appears to be very important for understanding learning, memory and the development. At any given moment – all throughout life – we are making and breaking synaptic connections. For the majority of life we are at equilibrium; the rate of creating new synaptic connections is equal to the rate of resorbing older, unused connections. While somewhat simplistic, it appears that the synaptic sculpting is a "use it or lose it" process. During the first eight months following birth the rate of creating new synapses far outstrips the rate of resorbing unused connections. By age one, however, and from then through early childhood, the rate of resorbing new connections is faster than the rate of creating new synapses. By adolescence, in most cortical areas at least, this process again reaches equilibrium. 8. Myelination: Specialized glial cells wrap around axons and, thereby, create more efficient electrochemical transduction down the neuron. This allows a neural network to function more rapidly and efficiently, thereby allowing more complex functioning (e.g., walking depends upon the myelination of neurons in the spinal cord for efficient, smooth regulation of neuromotor functioning.) The process of myelination begins in the first year of life but continues in many key areas throughout childhood with a final burst of myelination in key cortical areas taking place in adolescence. Table 2: Key Processes in Neurodevelopment neuroarcheology3.jpg (68908 bytes) * This refers to the age at which approximately 10% of this specific function is taking place. In most cases, there is evidence that some of these processes have started to some degree. Almost all of these processes continue in some form throughout life, the table is designed to illustrate the relative importance of childhood for the majority of activity in each of these processes. **These are crude estimates based upon data from multiple sources. The major point it to demonstrate that shifting activity from neurogenesis to myelination. All of the neurodevelopmental processes described above are dependent upon both genetic and environmentally determined microenvironmental cues (e.g., neurotransmitters, neuromodulators, neurohormones, ions, growth factors, cellular adhesion molecules and other morphogens). Disruption of the pattern, timing or intensity of these cues can lead to abnormal neurodevelopment and profound dysfunction. The neuroarcheological perspective suggests that the specific dysfunction will depend upon the timing of the insult (e.g., was the insult in utero during the development of the brainstem or at age two during the active development of the cortex), the nature of the insult (e.g., is there a lack of sensory stimulation from neglect or an abnormal persisting activation of the stress response from trauma?), the pattern of the insult (i.e., is this a discreet single event, a chronic experience with a chaotic pattern or an episodic event with a regular pattern?). While we are only beginning to understand the complexity of neurodevelopment, there are several key principles that emerge from the thousands of studies and years of focused research on these neurodevelopmental processes. These principles, as outlined below, suggest that while the structural organization and functional capabilities of the mature brain can change throughout life, the majority of the key stages of neurodevelopment take place in childhood. The core principles of neurodevelopment that support a neuroarcheological perspective of childhood adverse events are summarized below. Core Principles of Neurodevelopment 1. Nature and nurture: For too many years, any conceptual approach to human behavior has been tainted by the nature versus nurture debate. Do genes cause human behavior or is human behavior a product of learning, education and experience? Ultimately, this debate polarizes and distracts from more complex understandings of human functioning. Genes are designed to work in an environment. Genes are expressed by microenvironmental cues, which, in turn, are influenced by the experiences of the individual. How an individual functions within an environment, then, is dependent upon the expression of a unique combination of genes available to the human species. We don't have the genes to make wings. And what we become depends upon how experiences shape the expression – or not - of specific genes we do have. We do have the genes to make forty sounds – and we can have the experiences that turn this genetically determined capacity into a powerful, transforming tool – language. Yet, there are many sad examples of cruel experiments of humanity, where a young child was raised in an environment deprived of language. This child, despite the genetic potential to speak and think and feel in complex humane ways, did not express that potential fully. Genetic potential without appropriately timed experiences can remain unexpressed. Nature and nurture – we are nothing without both; we require both and we are products of both. The influence of gene-driven processes, however, shifts during development. In the just fertilized ovum, all of the chemical processes that are driving development are very dependent upon a genetically determined sequence of molecular events. By birth, however, the brain has developed to the point where environmental cues mediated by the senses play a major role in determining how neurons will differentiate, sprout dendrites, form and maintain synaptic connections and create the final neural networks that convey functionality. By adolescence, the majority of the changes that are taking place in the brain of that child are determined by experience, not genetics. The languages, beliefs, cultural practices, and complex cognitive and emotional functioning (e.g., self esteem) by this age are primarily experience-based. 2. Sequential Developmental: The brain develops in a sequential and hierarchical fashion; organizing itself from least (brainstem) to most complex (limbic, cortical areas). These different areas develop, organize and become fully functional at different times during childhood. At birth, for example, the brainstem areas responsible for regulating cardiovascular and respiratory function must be intact for the infant to survive, and any malfunction is immediately observable. In contrast, the cortical areas responsible for abstract cognition have years before they will be 'needed' or fully functional. This means that each brain area will have its own timetable for development. The neurodevelopmental processes described above will be most active in different brain areas at different times and will, therefore, either require (critical periods) or be sensitive to (sensitive periods) organizing experiences (and the neurotrophic cues related to these experiences). The neurons for the brainstem have to migrate, differentiate and connect, for example, before the neurons for the cortex. The implications of this for a neuroarcheological formulation are profound. Disruptions of experience-dependent neurochemical signals during these periods may lead to major abnormalities or deficits in neurodevelopment. Disruption of critical neurodevelopmental cues can result from 1) lack of sensory experience during sensitive periods (e.g., neglect) or 2) atypical or abnormal patterns of necessary cues due to extremes of experience (e.g., traumatic stress, see below). Insults during the intrauterine period, for example, will more likely influence the rapidly organizing brainstem systems as opposed to the more slowly organizing cortical areas. The symptoms from the intrauterine disruption will alter functions mediated by the brainstem and could include sensory integration problems, hyper-reactivity, poor state regulation (e.g., sleep, feeding, self-soothing), tactile defensiveness and altered regulation of core neurophysiological functions such as respiration, cardiovascular and temperature regulation. This does not mean that neocortical systems are unaffected by disrupting the development of the brainstem. Indeed, one of the most important aspects of the sequential development is that important organizing signals for any given brain area or system (e.g., patterns of neural activity, neurotransmitters acting as morphogens) come from previously organized brain areas or systems. Due to the sequential development of the brain, disruptions of normal developmental processes early in life (e.g., during the perinatal period) that alter development of the brainstem or diencephalon will necessarily alter the development of limbic and cortical areas. This is so because many of the organizing cues for normal limbic and neocortical organization originate in the lower brain areas. Any developmental insult can have a cascade effect on the development of all "downstream" brain areas (and functions) that will receive input from the effected neural system. 3. Activity-dependent neurodevelopment: The brain organizes in a use-dependent fashion. As described above, many of the key processes in neurodevelopment are activity dependent. In the developing brain, undifferentiated neural systems are critically dependent upon sets of environmental and micro-environmental cues (e.g., neurotransmitters, cellular adhesion molecules, neurohormones, amino acids, ions) in order for them to appropriately organize from their undifferentiated, immature forms (Lauder. 1988; Perry. 1994) (Perry & Pollard. 1998). Lack, or disruption, of these critical cues can alter the neurodevelopmental processes of neurogenesis, migration, differentiation, synaptogenesis - all of which can contribute to malorganization and diminished functional capabilities in the specific neural system where development has been disrupted. This is the core of a neuroarcheological perspective on dysfunction related adverse childhood events (Perry. 1994) (Perry & Pollard. 1998; Perry. 1998). These molecular cues that guide development are dependent upon the experiences of the developing child. The quantity, pattern of activity and nature of these neurochemical and neurotrophic factors depends upon the presence and the nature of the total sensory experience of the child. When the child has adverse experiences – loss, threat, neglect, and injury – there can be disruptions of neurodevelopment that will result in neural organization that can lead to compromised functioning throughout life (see Neglect section, below). A neuroarcheological perspective would predict that the dysfunction resulting from a specific adverse event is related to the disrupted (or altered) development of the neural system that is, during the adverse event, most rapidly developing. The degree of disruption is related to the rate of change in the respective neural system. The already organized and functioning neural system is less vulnerable to a developmental insult than the rapidly changing, energy-hungry and microenvironmental cue-sensitive developing system. This is so because of a principle called biological relativity. In any dynamic system, the impact of an event or experience (disruptive or positive) is greatest on the most actively changing or dynamic parts of that system. The power of any experience, therefore, is greatest during the most rapid phases of development. Events taking place during a neural system's most active phase of organization will have more impact than events after the system has organized. 4. Windows of Opportunity/Windows of Vulnerability: The sequential development of the brain and the activity-dependence of many key aspects of neurodevelopment suggest that there must be times during development when a given developing neural system is more sensitive to experience than others (Table 3). In healthy development, that sensitivity allows the brain to rapidly and efficiently organize in response to the unique demands of a given environment to express from its broad genetic potential those characteristics which best fit that child's world. If the child speaks Japanese as opposed to English, for example, or if this child will live in the plains of Africa or the tundra of the Yukon, different genes can be expressed, different neural networks can be organized from that child's potential to best fit that family, culture and environment. We all are aware of how rapidly young children can learn language, develop new behaviors and master new tasks. The very same neurodevelopmental sensitivity that allows amazing developmental advances in response to predictable, nurturing, repetitive and enriching experiences make the developing child vulnerable to adverse experiences. Sensitive periods are different for each brain area and neural system, and therefore, for different functions. The sequential development of the brain and the sequential unfolding of the genetic map for development mean that the sensitive periods for neural system (and the functions they mediate) will be when that system is in the developmental 'hot zone' – when that area is most actively organizing. The brainstem must organize key systems by birth; therefore, the sensitive period for those brainstem-mediated functions is during the prenatal period. The neocortex, in contrast, has systems and functions organizing throughout childhood and into adult life. The sensitive periods for these cortically mediated functions are likely to be very long. With an understanding of the shifting vulnerability of the developing brain to experience, a neuroarcheological perspective becomes apparent. If there are disrupting adverse events during development, they will be mirrored by a matched dysfunctional development in the neural systems whose functioning the adverse experience most altered during the event. If the disruption were the absence of light during the first year of life – the systems most altered would be related to vision. If the disruption activates the stress response, the disruption will be in the neural systems mediating the stress response. The severity and chronicity of the specific dysfunction will be related to the vulnerability of the system affected. Adverse experiences influence the mature brain but in the developing brain, adverse experiences literally play a role in organizing neural systems. It is much easier to influence the functioning of a developing system than to reorganize and alter the functioning of a developed system. Adverse childhood events, therefore, can alter the organization of developing neural systems in ways that create a lifetime of vulnerability. Table 3: Shifting Developmental Activity across Brain Regions neuroarcheology4.jpg (35426 bytes) The simple and unavoidable conclusion of these neurodevelopmental principles is that the organizing, sensitive brain of an infant or young children is more malleable to experience than a mature brain. While experience may alter the behavior of an adult, experience literally provides the organizing framework for an infant and child. Because the brain is most plastic (receptive to environmental input) in early childhood, the child is most vulnerable to variance of experience during this time. In the second half of this chapter two primary forms of extreme childhood adverse experience will be discussed in context of the neuroarcheological perspective of adverse childhood events. The Neurodevelopmental Impact of Neglect in Childhood Neglect is the absence of critical organizing experiences at key times during development. Despite its obvious importance in understanding child maltreatment, neglect has been understudied. Indeed, deprivation of critical experiences during development may be the most destructive yet the least understood area of child maltreatment. There are several reasons for this. The most obvious is that neglect is difficult to "see." Unlike a broken bone, maldevelopment of neural systems mediating empathy, for example, resulting from emotional neglect during infancy, is not readily observable. Another important, yet poorly appreciated, aspect of neglect is the issue of timing. The needs of the child shift during development; therefore, what may be neglectful at one age is not at another. The very same experience that is essential for life at one stage of life may be of little significance or even inappropriate at another age. We would all question the mother who held, rocked and breastfed her pubescent child. Touch, for example, is essential during infancy. The untouched newborn may literally die; in Spitz' landmark studies, the mortality rates in the institutionalized infants was near thirty percent (Spitz. 1945; Spitz. 1946). If one doesn't touch an adolescent for weeks, however, no significant adverse effects will result. Creating standardized protocols, procedures and "measures" of neglect, therefore, are significantly confounded by the shifting developmental needs and demands of childhood. Finally, neglect is understudied because it is very difficult to find large populations of humans where specific and controlled neglectful experiences have been well documented. In some cases, these cruel experiments of humanity have provided unique and promising insights (see below). In general, however, there will never be – and there never should be – the opportunity to study neglect in humans with the rigor that can be applied in animal models. With these limitations, however, what we do know about neglect during early childhood supports a neuroarcheological view of adverse childhood experience. The earlier and more pervasive the neglect is, the more devastating the developmental problems for the child. Indeed, a chaotic, inattentive and ignorant caregiver can produce pervasive developmental delay (PDD; (Anonymous. 1994)) in a young child (Rutter, Andersen-Wood, Beckett, et al. 1999). Yet the very same inattention for the same duration if the child is ten will have very different and less severe impact than inattention during the first years of life. There are two main sources of insight to childhood neglect. The first is the indirect but more rigorous animal studies and the second is a growing number of descriptive reports with severely neglected children. Environmental Manipulation and Neurodevelopment: Animal Studies Some of the most important studies in developmental neurosciences in the last century have been focusing on various aspects of experience and extreme sensory experience models. Indeed, the Nobel Prize was awarded to Hubel and Weisel for their landmark studies on development of the visual system using sensory deprivation techniques (Hubel & Wiesel. 1963). In hundreds of other studies, extremes of sensory deprivation (Hubel & Wiesel. 1970; Greenough, Volkmar, & Juraska. 1973) or sensory enrichment (Greenough & Volkmar. 1973; Diamond, Krech, & Rosenzweig. 1964; Diamond, Law, Rhodes, et al. 1966) have been studied. These include disruptions of visual stimuli (Coleman & Riesen. 1968), environmental enrichment (Altman & Das. 1964; Cummins & Livesey. 1979), touch (Ebinger. 1974; Rutledge, Wright, & Duncan. 1974), and other factors that alter the typical experiences of development (Uno, Tarara, Else, & et.al. 1989; Plotsky & Meaney. 1993; Meaney, Aitken, van Berkal, Bhatnagar, & Sapolsky. 1988). These findings generally demonstrate that the brains of animals reared in enriched environments are larger, more complex and functional more flexible than those raised under deprivation conditions. Diamond's work, for example, examining the relationships between experience and brain cytoarchitecture have demonstrated a relationship between density of dendritic branching and the complexity of an environment (for a good review of this and related data see (Diamond & Hopson. 1998)). Others have shown that rats raised in environmentally enriched environments have higher density of various neuronal and glial microstructures, including a 30% higher synaptic density in cortex compared to rats raised in an environmentally deprived setting (Bennett, Diamond, Krech, & Rosenzweig. 1964; Altman & Das. 1964). Animals raised in the wild have from 15 to 30% larger brain mass than their offspring who are domestically reared (Darwin. 1868; Rohrs. 1955; Rohrs & Ebinger. 1978; Rehkamper, Haase, & Frahm. 1988). Animal studies suggest that critical periods exist during which specific sensory experience was required for optimal organization and development of the part of the brain mediating a specific function (e.g., visual input during the development of the visual cortex). While these phenomena have been examined in great detail for the primary sensory modalities in animals, few studies have examined the issues of critical or sensitive periods in humans. What evidence there is would suggest that humans tend to have longer periods of sensitivity and that the concept of critical period may not be useful in humans. It is plausible, however, that abnormal micro-environmental cues and atypical patterns of neural activity during sensitive periods in humans could result in malorganization and compromised function in a host of brain-mediated functions. Indeed, altered emotional, behavioral, cognitive, social and physical functioning has been demonstrated in humans following specific types of neglect. The majority of this information comes from the clinical rather than the experimental disciplines. The Impact of Neglect in Early Childhood: Clinical Findings Over the last sixty years, many case reports, case series and descriptive studies have been conducted with children neglected in early childhood. The majority of these studies have focused on institutionalized children. As early as 1833, with the famous Kaspar Hauser, feral children had been described (Heidenreich. 1834). Hauser was abandoned as a young child and raised from early childhood (likely around age two) until seventeen in a dungeon, experiencing relative sensory, emotional and cognitive neglect. His emotional, behavioral and cognitive functioning was, as one might expect, very primitive and delayed. At autopsy, Hauser's brain was noted to have a small cerebrum (cortex) with few and non-distinct cortical gyri. These findings are consistent with cortical atrophy (or underdevelopment), a condition we have reported in children following severe total global neglect in childhood (Perry & Pollard. 1997). In the early forties, Spitz described the impact of neglectful caregiving on children in foundling homes (orphanages). Most significant, he was able to demonstrate that children raised in fostered placements with more attentive and nurturing caregiving had superior physical, emotional and cognitive outcomes (Spitz. 1945; Spitz. 1946). Some of the most powerful clinical examples of this phenomenon are related to profound neglect experiences early in life. In a landmark report of children raised in a Lebanese orphanage, the Creche, Dennis (1973) described a series of findings supporting a neuroarcheological model of maltreatment. These children were raised in an institutional environment devoid of individual attention, cognitive stimulation, emotional affection or other enrichment. Prior to 1956 all of these children remained at the orphanage until age six, at which time they were transferred to another institution. Evaluation of these children at age 16 demonstrated a mean IQ of approximately 50. When adoption became common, children adopted prior to age 2 had a mean IQ of 100 by adolescence while children adopted between ages 2 and 6 had IQ values of approximately 80 (Dennis. 1973). This graded recovery reflected the neuroarcheological impact of neglect. A number of similar studies of children adopted from neglectful settings demonstrate this general principle. The older a child was at time of adoption, (i.e., the longer the child spent in the neglectful environment) the more pervasive and resistant to recovery were the deficits. Money and Annecillo (1976) reported the impact of change in placement on children with psychosocial dwarfism (failure to thrive). In this preliminary study, 12 of 16 children removed from neglectful homes recorded remarkable increases in IQ and other aspects of emotional and behavioral functioning. Furthermore, they reported that the longer the child was out of the abusive home the higher the increase in IQ. In some cases IQ increased by 55 points (Money & Annecillo. 1976). A more recent report on a group of 111 Romanian orphans (Rutter & English and Romanian Adoptees study team. 1998; Rutter, Andersen-Wood, Beckett, et al. 1999) adopted prior to age two from very emotionally and physically depriving institutional settings demonstrate similar findings. Approximately one half of the children were adopted prior to age six months and the other half between six months and 2 years old. At the time of adoption, these children had significant delays. Four years after being placed in stable and enriching environments, these children were re-evaluated. While both groups improved, the group adopted at a younger age had a significantly greater improvement in all domains. These observations are consistent with the experiences of our clinic research group working with maltreated children. Over the last ten-year we have worked with more than 1000 children neglected in some fashion. We have recorded increases in IQ of over 40 points in more than 60 children following removal from neglectful environments and placed in consistent, predictable, nurturing, safe and enriching placements (Perry et al., in preparation). In addition, in a study of more than 200 children under the age of 6 removed from parental care following abuse and neglect we demonstrated significant developmental delays in more than 85% of the children. The severity of these developmental problems increased with age, suggesting, again, that the longer the child was in the adverse environment - the earlier and more pervasive the neglect - the more indelible and pervasive the deficits. The impact of deprivation can be approximated by sensory chaos. Indeed, sensory deprivation is much less clinically significant than sensory chaos. The vast majority of children suffering from neglect do so because their experiences are chaotic, dysynchronous, inconsistent and episodic rather than consistent, predictable and continuous. The organizing brain requires patterns of sensory experience to create patterns of neural activity that, in turn, play a role in guiding the various neurodevelopmental processes involved in healthy development. When experience is chaotic or sensory patterns are not consistent and predictable, the organizing systems in the brain reflect this chaos and, typically, organize in ways that result in dysregulation and dysynchronous. Imagine trying to learn a language if you only heard random words without the context, grammar and syntax of the language (i.e., the patterns of use). Even if you heard and perceived all words, you could not develop language. Random exposure to words absent an organizing pattern leads to abnormal development of speech and language. Our clinical group has evaluated many children capable of parroting advertising phrases from television but incapable of simple verbal communication. This requirement for consistent, repetitive and patterned stimuli holds for all experience – cognitive, emotional, social and physical. Repetitive, patterned, consistent experience allows the brain to create an internal representation of the external world. A child growing up in the midst of chaos and unpredictability will develop neural systems and functional capabilities that reflect this disorganization. The Impact of Neglect in Early Childhood: Neurobiological Findings All of these reported developmental problems – language, fine and large motor delays, impulsivity, disorganized attachment, dysphoria, attention and hyperactivity, and a host of others described in these neglected children – are caused by abnormalities in the brain. Despite this obvious statement, very few studies have examined directly any aspect of neurobiology in neglected children. The reasons include a lack of capacity, until the recent past, to examine the brain in any non-invasive fashion. Our group has examined various aspects of neurodevelopment in neglected children (Perry & Pollard. 1997). Neglect was considered global neglect when a history of relative sensory deprivation in more than one domain was obtained (e.g., minimal exposure to language, touch and social interactions). Chaotic neglect is far more common and was considered present if history was obtained that was consistent with physical, emotional, social or cognitive neglect. When possible history was obtained from multiple sources (e.g., investigating CPS workers, family, police). The neglected children (n= 122) were divided into four groups: Global Neglect (GN; n=40); Global Neglect with Prenatal Drug Exposure (GN+PND; n=18); Chaotic Neglect (CN; n=36); Chaotic Neglect with Prenatal Drug Exposure (CN+PND; n=28). Measures of growth were compared across group and compared to standard norms developed and used in all major pediatric settings. Dramatic differences from the norm were observed in FOC (the frontal-occipital circumference, a measure of head size and in young children a reasonable measure of brain size). In the globally neglected children the lower FOC values suggested abnormal brain growth. For these globally neglected children the group mean was below the 8th percentile. In contrast, the chaotically neglected children did not demonstrate this marked group difference in FOC. Furthermore in cases where MRI or CT scans were available, neuroradiologists interpreted 11 of 17 scans as abnormal from the children with global neglect (64.7 %) and only 3 of 26 scans abnormal from the children with chaotic neglect (11.5 %). The majority of the readings were "enlarged ventricles" or "cortical atrophy." While the actual size of the brain in chaotically neglected children did not appear to be different from norms, it is reasonable to hypothesize that organizational abnormalities exist and that with function MRI studies these abnormalities will be more readily detected. These findings strongly suggest that when early life neglect is characterized by decreased sensory input (e.g., relative poverty of words, touch and social interactions) there will be a similar effect on human brain growth as in other mammalian species. The human cortex grows in size, develops complexity, makes synaptic connections and modifies as a function of the quality and quantity of sensory experience. Lack of type and quantity of sensory-motor and cognitive experiences lead to underdevelopment of the cortex – in rats, non-human primates and humans. Studies from other groups are beginning to report similar altered neurodevelopment in neglected children. In the study of Romanian orphans described above, the 38 % had FOC values below the third percentile (greater than 2 SD from the norm) at the time of adoption. In the group adopted after six months, fewer than 3 % and the group adopted after six months 13 % had persistently low FOCs four years later (Rutter & English and Romanian Adoptees study team. 1998; O'Connor, Rutter, & English and Romanian Adoptees study team. 2000). Strathearn (Strathearn et al., submitted) has followed extremely low birth weight infants and shown that when these infants end up in neglectful homes they have a significantly smaller head circumference at 2 and 4 years, but not at birth. This is despite having no significant difference in other growth parameters. Finally in a related population, maltreated children and adolescents with post-traumatic stress disorder (PTSD), De Bellis and colleagues found that subject children have significantly smaller intracranial and cerebral volumes than matched controls on MRI scan. Brain volume in these children correlated "robustly and positively" with the age of onset of PTSD trauma, and negatively with the duration of abuse, suggesting that traumatic childhood experiences may adversely affect brain development. Specific brain areas were affected differentially, in reflection of their importance in the stress response, further support of a neuroarcheological formulation of adverse childhood experience (De Bellis, Keshavan, Clark, et al. 1999). While deprivations and lack of specific sensory experiences are common in the maltreated child, the traumatized child experiences developmental insults related to discrete patterns of over-activation of neurochemical cues. Rather than a deprivation of sensory stimuli, the traumatized child experiences over-activation of important neural systems during sensitive periods of development. The Neurodevelopmental Impact of Traumatic Stress in Childhood Each year in United States more than five million children are exposed to some form of extreme traumatic stressor. These traumatic events include natural disasters (e.g., tornadoes, floods, hurricanes), motor vehicle accidents, life threatening illness and associated painful medical procedures (e.g., severe burns, cancer), physical abuse, sexual assault, witnessing domestic or community violence, kidnapping and sudden death of a parent, among others (Pfefferbaum. 1997; Anonymous. 1998). These events, posing an actual or perceived threat to the individual, activate a stress response. During the traumatic event, the child's brain mediates the adaptive response. Brainstem and diencehpalic stress-mediating neural systems are activated. These systems include the hypothalamic-pituitary-adrenal (HPA) axis, central nervous system (CNS) noradrenergic (NA), dopaminergic (DA) systems and associated CNS and peripheral systems that provide the adaptive emotional, behavioral, cognitive and physiological changes necessary for survival (Perry. 1994; Perry & Pollard. 1998). Individual neurobiological responses during traumatic stress are heterogeneous (Perry, Pollard, Blakley, Baker, & Vigilante. 1995). The specific nature of a child's responses to a given traumatic event may vary with the nature, duration and the pattern of traumatic stressor and the child's constitutional characteristics (e.g., genetic predisposition, age, gender, history of previous stress exposure, presence of attenuating factors such as supportive caregivers). Whatever the individual response, however, the extreme nature of the external threat is matched by an extreme and persisting internal activation of the neurophysiological systems mediating the stress response and their associated functions (Perry, Pollard, Blakley, Baker, & Vigilante. 1995; Perry & Pollard. 1998). As described above, neural systems respond to prolonged, repetitive activation by altering their neurochemical and sometimes, microarchitectural (e.g., synaptic sculpting) organization and functioning. This is no different for the neural systems mediating the stress response. Following any traumatic event children will likely experience some persisting emotional, behavioral, cognitive and physiological signs and symptoms related to the, sometimes temporary, shifts in the activity of these neural systems originating in the brainstem and diencephalon. In general, the longer the activation of the stress-response systems (i.e., the more intense and prolonged the traumatic event), the more likely there will be a 'use-dependent' change in these neural systems (for review see (Perry & Pollard. 1998)). In some cases, then, the stress-response systems do not return to the pre-event homeostasis. In these cases, the signs and symptoms become so severe, persisting and disruptive that they reach the level of a clinical disorder (Perry. 1998). In a new context and in the absence of any true external threat, the abnormal persistence of a once adaptive response becomes maladaptive. Post traumatic stress-related clinical syndromes Post traumatic stress disorder (PTSD) is a clinical syndrome that may develop following extreme traumatic stress (DSM IV) (Anonymous. 1994). Like all other DSM IV diagnoses, it is likely that heterogeneous pathophysiologies underlie the cluster of diagnostic signs and symptoms labeled PTSD. There are six diagnostic criteria for PTSD: 1) extreme traumatic stress accompanied by intense fear, horror or disorganized behavior; 2) persistent re-experiencing of the traumatic event such as repetitive play or recurring intrusive thoughts; 3) avoidance of cues associated with the trauma or emotional numbing; 4) persistent physiological hyper-reactivity or arousal; 5) signs and symptoms present for more than one month following the traumatic event and 6) clinically significant disturbance in functioning. Posttraumatic stress disorder has been studied primarily in adult populations, most commonly combat veterans and victims of sexual assault. Despite high numbers of traumatized children, the clinical phenomenology, treatment and neurophysiological correlates of childhood PTSD remain under studied. The clinical phenomenology of trauma-related neuropsychiatric sequelae is poorly characterized (Terr. 1991; Mulder, Fergusson, Beautrais, & Joyce. 1998). Most of the studies of PTSD have been following single discreet trauma (e.g., a shooting). The least characterized populations are very young children and children with multiple or chronic traumatic events. Clinical presentations If during development, this stress response apparatus are required to be persistently active, the stress response apparatus in the central nervous system will develop in response to constant threat. These stress-response neural systems (and all functions they mediate – including sympathetic-parasympathetic tone, level of vigilance, regulation of mood, attention and sleep) will be poorly regulated, often overactive and hypersensitive. It is highly adaptive for a child growing up in a violent, chaotic environment to be hypersensitive to external stimuli, to be hypervigilant, and to be in a persistent stress-response state. It is important to realize that children exposed to traumatic stress during development literally organize their neural systems to adapt to this kind of environment. In contrast, an adult with no previous traumatic stress can develop PTSD. The cardiovascular reactivity and physiological hypersensitivity that the adult develops, however, is cue specific. This means that they will demonstrate increased heart rate, startle response and other neurophysiological symptoms when exposed to a cue from the original trauma (e.g., the Vietnam vet hearing a helicopter). In contrast, young children will develop a generalized physiological hyper-reactivity and hypersensitivity to all cues that activate the stress response apparatus. This generalized change results when the traumatic stress literally provides the organizing cues for their developing stress response neurobiology (Perry. 1999). Clinically, this is very easily seen in children who are exposed to chronic neurodevelopmental trauma. These children are frequently diagnosed as having attention deficit disorder (ADD-H) with hyperactivity (Haddad & Garralda. 1992). This is somewhat misleading, however. These children are hypervigilant; they do not have a core abnormality of their capacity to attend to a given task. These children have behavioral impulsivity, and cognitive distortions all of which result from a use-dependent organization of the brain (Perry, Pollard, Blakley, Baker, & Vigilante. 1995). During development, these children spent so much time in a low-level state of fear (mediated by brainstem and diencehpalic areas) that they consistently were focusing on non-verbal but not verbal cues. In our clinical population, children raised in chronically traumatic environments demonstrate a prominent V-P split on IQ testing (n = 108; WISC Verbal = 8. 2; WISC Performance = 10.4, Perry et al., in preparation). Often these children are labeled as learning disabled. We have seen these V-P splits in children in the juvenile justice system, child protective system and in the specialized clinical populations referred to our ChildTrauma clinic. These children are also characterized by persisting physiological hyperarousal and hyperactivity (Perry, Pollard, Baker, Sturges, Vigilante, & Blakley. 1995; Perry. 1994; Perry. 2000). These children are observed to have increased muscle tone, frequently a low grade increase in temperature, an increased startle response, profound sleep disturbances, affect regulation problems and anxiety (Kaufman. 1991; Ornitz & Pynoos. 1989; Perry. 2000). In addition, our studies indicate that a significant portion of these children have abnormalities in cardiovascular regulation (Perry, Pollard, Baker, Sturges, Vigilante, & Blakley. 1995; Perry. 2000). All of these symptoms are the result of a use-dependent organization of the brain stem nuclei involved in the stress response apparatus. Children with PTSD may present with a combination of problems including impulsivity, distractibility and attention problems (due to hypervigilance), dysphoria, emotional numbing, social avoidance, dissociation, sleep problems, aggressive (often re-enactment) play, school failure and regressed or delayed development. In most studies examining the development of PTSD following a given traumatic experience, twice as many children suffer from significant post-traumatic signs or symptoms (PTSS) but lack all of the criteria necessary for the diagnosis of PTSD (Friedrich. 1998). In these cases, the clinician may identify the trauma-related symptom as being part of another neuropsychiatric syndrome. The clinician is often unaware of ongoing traumatic stressors (e.g., domestic or community violence) or the family makes no association between the present symptoms and past events (e.g., car accident, death of a relative, exposure to violence) and may provide no relevant history to aid the clinician in the differential. As a result, PTSD is frequently misdiagnosed and PTSS are under recognized. Children with PTSD as a primary diagnosis are often labeled with Attention Deficit Disorder with Hyperactivity (ADHD), major depression, oppositional-defiant disorder, conduct disorder, separation anxiety or specific phobia. Ackerman and colleagues examined the prevalence of PTSD and other neuropsychiatric disorders in 204 abused children (ages 7 to 13) (Ackerman, Newton, McPHerson, Jones, & Dykman. 1998). Thirty four percent of these children met criteria for PTSD. Over fifty percent of the children in this study suffering both physical and sexual abuse had PTSD. Using structured diagnostic interview, the majority of these children met diagnostic criteria for three or more Axis I diagnoses in addition to PTSD. Indeed, only 6 of 204 children met criteria for only PTSD. The broad co-morbidity reported in this study echoes previous studies. Incidence and prevalence Children exposed to various traumatic events have much higher incidence (from 15 to 90+ %) and prevalence rates than the general population (Pfefferbaum. 1997). Furthermore, the younger a child is the more vulnerable they appear to be for the development of trauma-related symptoms. The percentage of children developing PTSD following a traumatic event is significantly higher than the percentage of adults developing PTSD following a similar traumatic stress. Several studies published in 1998 confirm previous reports of high prevalence rates for PTSD in child and adolescent populations. Thirty five percent of a sample of adolescents diagnosed with cancer met criteria for lifetime PTSD (Pelcovitz, Kaplan, Goldenberg, Mandel, Lehane, & Guarrera. 1994); 15 % of children surviving cancer had moderate to severe PTSS (Stuber, Kazak, Meeske, et al. 1997); 93 % of a sample of children witnessing domestic violence had PTSD (Kilpatrick & Williams. 1998); over 80 % of the Kuwaiti children exposed to the violence of the Gulf Crisis had PTSS (Hadi & Llabre. 1998); 73 % of juvenile male rape victims develop PTSD (Ruchkin, Eisemann, & Hagglof. 1998); 34 % of a sample of children experiencing sexual or physical abuse and 58 % of children experiencing both physical and sexual abuse all met criteria for PTSD (Ackerman, Newton, McPHerson, Jones, & Dykman. 1998). In all of these studies, clinically significant symptoms, though not full PTSD, were observed in essentially all of the children or adolescents following the traumatic experiences. Vulnerability and resilience Not all children exposed to traumatic events develop PTSD. A major research focus has been identifying factors (mediating factors) that are associated with increased (vulnerability) or decreased (resilience) risk for developing PTSD following exposure to traumatic stress (Kilpatrick & Williams. 1998). Factors previously demonstrated to be related to risk can be summarized in these broad categories: 1) characteristics of the child (e.g., subjective perception of threat to life or limb, history of previous traumatic exposures, coping style, general level of anxiety, gender, age); 2) characteristics of the event (e.g., nature of the event, direct physical harm, proximity to threat, pattern and duration); 3) characteristics of family/social system (e.g., supportive, calm, nurturing vs. chaotic, distant, absent, anxious) (Briggs & Joyce. 1997; Stuber, Kazak, Meeske, et al. 1997; Winje & Ulvik. 1998). Each of these mediating factors can be related to the degree to which they either prolong or attenuate the child's stress-response activation resulting from the traumatic experience. Factors that increase stress-related reactivity (e.g., family chaos) will make children more vulnerable while factors that provide structure, predictability, nurturing and sense of safety will decrease vulnerability. Persistently activated stress-response neurophysiology in the dependent, fearful child will predispose to a 'use-dependent' changes in the neural systems mediated the stress response, thereby resulting in post-traumatic stress symptoms (see Table 4). Table 4. Post-traumatic Stress Disorder: Risk and Attenuating Factors neuroarcheology5.jpg (94803 bytes) Long-term costs of childhood trauma PTSD is a chronic disorder. Untreated, PTSS and PTSD remit at a very low rate. Indeed the residual emotional, behavioral, cognitive and social sequelae of childhood trauma persist and appear to contribute to a host of neuropsychiatric problems throughout life (Fergusson & Horwood. 1998) including attachment problems (Bell & Belicki. 1998; Alexander, Anderson, Brand, Schaeffer, Grelling, & Kretz. 1998), eating disorders (Rorty & Yager. 1996), depression (Winje & Ulvik. 1998; Fergusson & Horwood. 1998), suicidal behavior (Molnar, Shade, Kral, Booth, & Watters. 1998), anxiety (Fergusson & Horwood. 1998), alcoholism (Fergusson & Horwood. 1998; Epstein, Saunders, Kilpatrick, & Resnick. 1998), violent behavior (O'Keefe. 1995), mood disorders (Kaufman. 1991) and, of course, PTSD (Ford & Kidd. 1998; Schaaf & McCanne. 1998). Childhood trauma impacts other aspects of physical health throughout life, as well (Hertzman & Wiens. 1996; Orr, Lasko, Metzger, Berry, Ahern, & Pitman. 1998; Felliti, Anda, Nordenberg, et al. 1998). Adults victimized by sexual abuse in childhood are more likely to have difficulty in childbirth, a variety of gastrointestinal and gynecological disorders and other somatic problems such as chronic pain, headaches and fatigue (Rhodes & Hutchinson. 1994). The Adverse Childhood Experiences study (Felliti, Anda, Nordenberg, et al. 1998) examined exposure to seven categories of adverse events during childhood (e.g., sexual abuse, physical abuse, witnessing domestic violence: events associated with increase risk for PTSD). This study found a graded relationship between the number of adverse events in childhood and the adult health and disease outcomes examined (e.g., heart disease, cancer, chronic lung disease, and various risk behaviors). With four or more adverse childhood events, the risk for various medical conditions increased 4- to 12-fold. Clearly studies of this sort will help clarify the true costs of childhood maltreatment. Summary and Future Directions The remarkable property of the human brain, unlike any other animal species, is that it has the capacity to take the accumulated experience of thousands of previous generations and absorb it within one lifetime. This capability is endowed by the design of our neural systems. Neurons and neural systems are designed to change in response to microenvironmental events. In turn, our experiences influence the pattern and nature of these microenvironmental signals, allowing neural systems to create a biological record of our lives. The brain, then, becomes an historical organ. In its organization and functioning are memorialized our accumulated, synthesized and transformed experiences. And there is no greater period of sensitivity to experience than when the brain is developing. Indeed, as described above, the neuroarcheological record of maltreatment has pervasive and chronic impact on the child. An event that lasts a few months in infancy can rob a child's potential for a lifetime. The true costs of childhood maltreatment will never be appreciated, and can never be avoided, until clinicians, researchers and policy makers become aware of the core concepts of neurodevelopment and the neuorarcheology of child maltreatment. Acknowledgements This work was supported, in part, by the Brown Family Foundation, the Hogg Foundation for Mental Health, Children's Justice Act/Court Improvement Act, Texas Department of Protective and Regulatory Services, Maconda O'Connor and the Pritzker Cousins Foundation. References Ackerman, P.T., Newton, J.E., McPHerson, W.B., Jones, J.G., & Dykman, R.A. (1998). Prevalence of post traumatic stress disorder and other psychiatric diagnoses in three groups of abused children (sexual, physical, and both). Child Abuse & Neglect, 22, 759-774. Alexander, P.C., Anderson, C.L., Brand, B., Schaeffer, C.M., Grelling, B.Z., & Kretz, L. (1998). Adult attachment and longterm effects in survivors of incest. Child Abuse & Neglect, 22, 45-61. Altman, J., & Das, G.D. (1964). Autoradiographic examination of the effects of enriched environment on the rate of glial multipication in the adult rat brain. Nature, 204, 1161-1165. Bell, D., & Belicki, K. (1998). A community-based study of well-being in adults reporting childhood abuse. Child Abuse & Neglect, 22, 681-685. Bennett, E.L., Diamond, M.L., Krech, D., & Rosenzweig, M.R. (1964). Chemical and anatomical plasticity of the brain. Science, 146, 610-619. Briggs, L., & Joyce, P.R. (1997). What determines post-traumatic stress disorder symptomatology for survivors of childhood sexual abuse? Child Abuse & Neglect, 21, 575-582. Coleman, P.D., & Riesen, A.H. (1968). Environmental effects on cortical dendritc fields: I. rearing in the dark. Journal of Anatomy (London), 102, 363-374. Cummins, R.A., & Livesey, P. (1979). Enrichment-isolation, cortex length, and the rank order effect. Brain Research, 178, 88-98. Darwin, C. (1868). The variations of animals and plants under domestication. London:J. Murray De Bellis, M.D., Keshavan, M.S., Clark, D.B., Casey, B.J., Giedd, J.N., Boring, A.M., Frustaci, K., & Ryan, N.D. (1999). Developmental traumatology part II: brain development. Biol Psychiat, 45, 1271-1284. Dennis, W. (1973). Children of the Creche. New York: Appleton-Century-Crofts. Diamond, M.C., & Hopson, J. (1998). Magic Trees of the Mind: How to nurture your child's intelligence, creativity, and healthy emotions from birth through adolescence. New York: Dutton. Diamond, M.C., Krech, D., & Rosenzweig, M.R. (1964). The effects of an enriched environment on the histology of the rat cerebral cortex. Comparative Neurology, 123, 111-119. Diamond, M.C., Law, F., Rhodes, H., Lindner, B., Rosenzweig, M.R., Krech, D., & Bennett, E.L. (1966). Increases in cortical depth and glia numbers in rats subjected to enriched environments. Comparative Neurology, 128, 117-126. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition (DSM IV). (1994). Washington, DC: American Psychiatric Association. Ebinger, P. (1974). A cytoachitectonic volumetric comparison of brains in wild and domestic sheep. Z.Anat.Entwicklungsgesch, 144, 267-302. Epstein, J.N., Saunders, B.E., Kilpatrick, D.G., & Resnick, H.S. (1998). PTSD as a mediator between childhood rape and alcohol use in adult women. Child Abuse & Neglect, 22, 223-234. Felliti, V.J., Anda, R.F., Nordenberg, D., Wiallamson, D.F., Spitz, A.M., Edwards, V., Koss, M.P., & Marks, J.S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14, 245-258. Fergusson, D.M., & Horwood, L.J. (1998). Exposure to interparental violence in childhood and psychological adjustment in young adulthood. Child Abuse & Neglect, 22, 339-357. Ford, J.D., & Kidd, P. (1998). Early childhood trauma and disorders of extreme stress and predictors of treatment outcome with chronic posttramatic stress disorder. Journal of Traumatic Stress, 11, 743-761. Friedrich, W.N. (1998). Behavioral manifestations of child sexual abuse. Child Abuse & Neglect, 22, 523-531. Gould, E., Reeves, A.J., Graziano, M.S.A., & Gross, C.G. (1999). Neurogenesis in the neocortex of adult primates. Science, 286, 548-552. Greenough, W.T., & Volkmar, F.R. (1973). Pattern of dendritic branching in occipital cortex of rats reared in complex environments. Experimential Neurology, 40, 491-504. Greenough, W.T., Volkmar, F.R., & Juraska, J.M. (1973). Effects of rearing complexity on dendritic branching in frontolateral and temporal cortex of the rat. Experimental Neurology, 41, 371-378. Haddad, P., & Garralda, M. (1992). Hyperkinetic syndrome and disruptive early experiences . British Journal of Psychiatry, 161, 700-703. Hadi, F.A., & Llabre, M.M. (1998). The Gulf crisis experience of Kuwaiti children: Psychological and cognitive factors. Journal of Traumatic Stress, 11, 45-56. Heidenreich, F.W. (1834). Kaspar Hausers verwundung, krankeit und liechenoffnung. Journal der Chirurgie und Augen-Heilkunde, 21 (1834), 91-123. Hertzman, C., & Wiens, M. (1996). Child development and long-term outcomes: a population health perspective and summary of successful interventions. Soc.Sci.Med., 43, 1083-1095. Hubel, D.H., & Wiesel, T.N. (1963). Receptive fields of cells in striate cortex of very young, visually inexperienced kittens. Journal of Neurophysiology, 26, 994-1002. Hubel, D.H., & Wiesel, T.N. (1970). The period of susceptibility to the physiological effects of unilateral eye closure in kittens. Journal of Physiology, 206, 419-436. Huttenlocher, P.R. (1979). Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Research, 163, 195-205. Huttenlocher, P.R. (1994). Synaptogenesis in human cerebral cortex. In G. Dawson & K.W. Fischer (Eds.), Human Behavior and the Developing Brain. (pp. 35-54). New York: Guilford. Kaufman, J. (1991). Depressive disorders in maltreated children. Journal of the American Academy of Child and Adolescent Psychiatry, 30 (2), 257-265. Kilpatrick, K.L., & Williams, L.M. (1998). Potential mediators of post-traumatic stress disorder in child witnesses to domestic violence. Child Abuse & Neglect, 22, 319-330. Kuan, C.-Y., Roth, K.A., Flavell, R.A., & Rakic, P. (2000). Mechanisms of programmed cell death in the developing brain . Trends in Neuroscience, 23, 291-297. Lauder, J.M. (1988). Neurotransmitters as morphogens. Progress in Brain Research, 73, 365-388. Meaney, M.J., Aitken, D.H., van Berkal, C., Bhatnagar, S., & Sapolsky, R.M. (1988). Effect of neonatal handling on age-related impairments associated with the hippocampus. Science, 239 :766-768. Molnar, B.E., Shade, S.B., Kral, A.H., Booth, R.E., & Watters, J.K. (1998). Suicidal behavior and sexual/physical abuse among street youth. Child Abuse & Neglect, 22, 213-222. Money, J., & Annecillo, C. (1976). IQ changes following change of domicile in the syndrome of reversible hyposomatotropinism (psychosocial dwarfism): pilot investigation . Psychoneuroendocrinology, 1, 427-429. Mulder, R.T., Fergusson, D.M., Beautrais, A.L., & Joyce, P.R. (1998). Relationship between dissociation, childhood sexual abuse, childhood physical abuse, and mental illness in a general population sample. American Journal of Psychiatry, 155, 806-811. O'Connor, C., Rutter, M., & English and Romanian Adoptees study team. (2000). Attachment disorder behavior following early severe deprivation: extension and longitudinal follow-up. J.Am.Acad.Child Adolesc.Psychiatry, 39, 703-712. O'Keefe, M. (1995). Predictors of child abuse in maritally violent families. Journal of Interpersonal Violence, 10, 3-25. Ornitz, E.M., & Pynoos, R.S. (1989). Startle modulation in children with post-traumatic stress disorder. American Journal of Psychiatry, 147, 866-870. Orr, S.P., Lasko, N.B., Metzger, L.J., Berry, N.J., Ahern, C.E., & Pitman, R.K. (1998). Psychophysiologic assessment of women with posttraumatic stress disorder resulting from childhood sexual abuse. Journal of Consulting and Clinical Psychology, 66, 906-913. Pelcovitz, D., Kaplan, S., Goldenberg, B.A., Mandel, F., Lehane, J., & Guarrera, J. (1994). Post-traumatic stress disorder in physically abused adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 33: (305). 312 Perry, B.D. (1988). Placental and blood element neurotransmitter receptor regulation in humans: potential models for studying neurochemical mechanisms underlying behavioral teratology. Progress in Brain Research, 73, 189-206. Perry, B.D. (1994). Neurobiological sequelae of childhood trauma: post-traumatic stress disorders in children. In M. Murberg (Ed.), Catecholamines in Post-traumatic Stress Disorder: Emerging Concepts. (pp. 253-276). Washington, D.C.: American Psychiatric Press. Perry, B.D. (1998). Anxiety Disorders. In C.E. Coffey & R.A. Brumback (Eds.), Textbook of Pediatric Neuropsychiatry. (pp. 579-594). Washington, D.C: American Psychiatric Press, Inc. Perry, B.D. (1999). The memories of states: how the brain stores and retrieves traumatic experience. In J.M. Goodwin & R. Attias (Eds.), Splintered Reflections: Images of the Body In Trauma. (pp. 9-38). New York: Basic Books. Perry, B.D. (2000). The neurodevelopmental impact of violence in childhood. In D. Schetky & E. Benedek (Eds.), Textbook of Child and Adolescent Forensic Psychiatry. Washington, D.C.: American Psychiatric Press, Inc. Perry, B.D., & Pollard, R. (1997). Altered brain development following global neglect in early childhood. Proceedings from the Society for Neuroscience Annual Meeting (New Orleans), (abstract) Perry, B.D., & Pollard, R. (1998). Homeostasis, stress, trauma, and adaptation: A neurodevelopmental view of childhood trauma. Child and Adolescent Psychiatric Clinics of North America, 7, 33-51. Perry, B.D., Pollard, R.A., Baker, W.L., Sturges, C., Vigilante, D., & Blakley, T.L. (1995). Continuous heartrate monitoring in maltreated children. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Research, (abstract) Perry, B.D., Pollard, R.A., Blakley, T.L., Baker, W.L., & Vigilante, D. (1995). Childhood trauma, the neurobiology of adaptation and use-dependent development of the brain: How states become traits. Infant Mental Health Journal, 16, 271-291. Pfefferbaum, B. (1997). Posttraumatic stress disorder in children: A review of the past 10 years. J.Am.Acad.Child Adolesc.Psychiatry, 36, 1503-1511. Pfefferbaum, B. (Ed.) (1998). Stress in Children. Philadelphia: W.B. Saunders Company. Plotsky, P.M., & Meaney, M.J. (1993). Early, postnatal experience alters hypothalamic corticotropin releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Molec Brain Res, 18, 195-200. Rakic, P. (1981). Development of visual centers in the primate brain depends upon binocular competition before birth. Science, 214, 928-931. Rakic, P. (1996). Development of cerebral cortex in human and non-human primates. In M. Lewis (Ed.), Child and Adolescent Psychiatry: A Comprehensive Textbook. (pp. 9-30). New York: Williams and Wilkins. Rehkamper, G., Haase, E., & Frahm, H.D. (1988). Allometric comparison of brain weight and brain structure volumes in different breeds of the domestic pigeon, columbia livia f. d. Brain Behav.Evol., 31, 141-149. Rhodes, N., & Hutchinson, S. (1994). Labor experiences of childhood sexual abuse survivors. Birth, 21, 213-220. Rohrs, M. (1955). Vergleichende untersuchungen an wild- und hauskatzen. Zool.Anz., 155, 53-69. Rohrs, M., & Ebinger, P. (1978). Die beurteilung von hirngrobenunterschieden zwischen wild- und haustieren. Z.zool.Syst.Evolut.-forsch, 16, 1-14. Rorty, M., & Yager, J. (1996). Histories of childhood trauma and complex post-traumatic sequelae in women with eating disorders. The Psychiatric Clinics of North America, 19, Ruchkin, V.V., Eisemann, M., & Hagglof, B. (1998). Juvenile male rape victims: Is the level of post-traumatic stress related to personality and parenting. Child Abuse & Neglect, 22, 889-899. Rutledge, L.T., Wright, C., & Duncan, J. (1974). Morphological changes in pyramidal cells of mammalian neocortex associated with increased use. Experimental Neurology, 44, 209-228. Rutter, M., Andersen-Wood, L., Beckett, C., Bredenkamp, D., Castle, J., Grootheus, C., Keppner, J., Keaveny, L., Lord, C., O'Connor, T.G., & English and Romanian Adoptees study team. (1999). Quasi-autistic patterns following severe early global privation. J.Child Psychol.Psychiat., 40, 537-49. Rutter, M., & English and Romanian Adoptees study team. (1998). Developmental catch-up, and deficit, following adoption after severe global early privation. J.Child Psychol.Psychiat., 39, 465-476. Schaaf, K.K., & McCanne, T.R. (1998). Relationship of childhood sexual, physical and combined sexual and physical abuse to adult victimization and posttraumatic stress disorder. Child Abuse & Neglect, 22, 1119-1133. Spitz, R.A. (1945). Hospitalism: An inquiry into the genesis of psychiatric conditions in early childhood. Psychoanalytic Study of the Child, 1:53-74. Spitz, R.A. (1946). Hospitalism: A follow-up report on investigation described in Volume I, 1945. Psychoanalytic Study of the Child, 2:113-117. Strathearn,L.; Gray,P.H.; O'Callaghan,M.J.; Wood,D.W. (submitted) Cognitive neurodevelopment in extremely low birth weight infants: nature vs. nurture revisited Stuber, M.L., Kazak, A.E., Meeske, K., Barakat, L., Guthrie, D., Garnier, H., Pynoos, R., & Meadows, A. (1997). Predictors of posttraumatic stress symptoms in childhood cancer survivors . Pediatrics, 100, 958-964. Terr, L. (1991). Childhood traumas: an outline and overview. American Journal of Psychiatry, 148, 1-20. Uno, H., Tarara, R., Else, J., & et.al. (1989). Hippocampal damage associated with prolonged and fatal stress in primates . Journal of Neuroscience, 9, 1705-1711. Winje, D., & Ulvik, A. (1998). Long-term outcome of trauma in children: The psychological consequences of a bus accident. J.Child Psychol.Psychiat., 39, 635-642

Labels: , , , , , ,